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1.1.? Introduction?
After? centuries? of? predominantly? underweight?associated? deaths,? overweight? and?
obesity? now? kill? more? people? than? underweight.1? Even? though? obesity? can? be?
prevented? by? balancing? food? intake? and? energy? expenditure,? its? prevalence? is? still?
steadily?increasing;?in?the?Netherlands,?now?more?than?half?of?the?adult?population?is?
overweight?and?15%?is?obese.1,2?As?excess?fat?mass?increases,?the?risk?to?develop?type?
2? diabetes?mellitus? (T2D),? increases? in? parallel.3?5?Obese? individuals? and? individuals?
with?T2D?are?at?increased?risk?to?develop?cardiovascular?disease?(CVD);?CVD?accounts?
for? 52%? of? deaths? in? T2D.6?When? individuals? develop? T2D,? two? core? processes? are?
usually?at?play:?insulin?resistance?and?beta?cell?dysfunction.7?Here,?we?will?review?both?
processes,? as? well? as? their? potential? contributors,? in?more? detail.? In? addition,? we?
address?vascular? function?as?a?potential?mediator?of?CVD,?as?well?as?a?surrogate? for?
CVD?risk.??
1.2.? Insulin?resistance?
Insulin?resistance?can?be?regarded?as?a?decreased?sensitivity?to?the?metabolic?actions?
of?insulin?that?promote?glucose?disposal.?Typically,?skeletal?muscle?is?the?primary?site?
of?action?for?insulin?induced?glucose?disposal,?although?other?tissues?like?liver,?adipose?
tissue?and?skin?contribute?as?well.8?10?In?response?to?insulin,?myocytes?and?adipocytes?
translocate?glucose?transporter?4?(GLUT4)?from?the?cytosol?to?the?plasma?membrane?
to?facilitate?cellular?glucose?entry;?this?rapidly?lowers?plasma?glucose?levels.11,12?In?an?
insulin?resistant?state,?this?response?is?blunted.13?15?
?
The?gold?standard? to?measure? insulin?sensitivity? is?by?means?of?a?euglycemic? insulin?
clamp,?during?which? insulin? is? infused?at?a?fixed?rate?while? isoglycemia? is?maintained?
through? a? variable? infusion?of?20%? glucose.16,17?When? steady? state? is? achieved,? the?
rate? of? glucose? perfusion? then? approximates? the? whole? body? glucose? disposal?
(WBGD).16,17?This?method?is?described?in?more?detail?in?chapter?three.?
?
To?link?obesity?to?insulin?resistance,?several?tissue?specific?pathways,?including?visceral?
and? subcutaneous? adipose? tissue,? liver? and? muscle,? have? been? proposed.? These?
pathways?have,?however,?never?been?studied?simultaneously;?hence,?whether? these?
pathways?act?independently?of?each?other?has?not?been?elucidated.?
1.2.1.?Adipose?tissue?
A?large?organ?with?considerable?plasticity,?adipose?tissue?is?capable?of?storing?massive?
amounts?of?energy? in? the? form?of? triacylglycerol;?adipose? tissue? consists?of? roughly?
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3???1010?adipocytes?with?an?average? size?of?70? ?m.18?With?excess?energy? intake?and?
subsequent?obesity,?adipocyte?hyperplasia?(increase?in?cell?numbers,?up?to?9???1010)?or?
hypertrophy? (increase? in? cell? size,?up? to?120? ?m)? can?occur? to?various?degrees;? the?
former? is?considered?a? favorable? response?and? the? latter?pathological.19?22? In?health,?
subcutaneous?adipose?tissue? (SAT)? is?the? largest?compartment?and?the?vast?majority?
of?excess?energy?is?stored?there.?It?has?been?hypothesized?that?with?persistent?positive?
energy?balances,? the?capacity?of?SAT?will?be? reached?and?storage?of? free? fatty?acids?
(FFAs)?will? shift? to? ectopic? sites,? predominantly? visceral? adipose? tissue? (VAT).20,22,23?
When?SAT?fails?to?store?additional?FFAs,?adipocyte?hypertrophy? is?typically?observed;?
this?may?result?from?impaired?adipocyte?proliferation?due?to?insufficient?angiogenesis?
with?ensuing?hypoxia?(Figure?1.1).19,20,24?
?
Ex? vivo,? hypertrophic? adipocytes? are? capable? of? producing? interleukin?6? (IL?6),? IL?8,?
leptin,?and?tumor?necrosis?factor?(TNF);25?it?has?been?suggested?that?this?may?lead?to?
massive? accumulation? of?macrophages? in? adipose? tissue.19,24,26?29?While? under? lean?
conditions?most?adipose?tissue?macrophages?display?an?anti?inflammatory?or?so?called?
“M2"? phenotype,? obesity? induces? polarization? toward? the? inflammatory? “M1”?
state.26,30? These? M1?macrophages,? in? turn,? produce? even? more? inflammatory?
cytokines? (e.g.,? TNF);? this?maintains? local? inflammation? and?may? result? in? systemic?
low?grade?inflammation?(LGI),?which?contributes?to?insulin?resistance.19,26,29?32?
?
Although?many?mechanisms? in? the? adipose? tissue? of? obese? individuals? have? been?
proposed? to? trigger?macrophage? accumulation? and?polarization? (e.g.,? adipocyte? cell?
death,? lipotoxicity?by?FFAs,? increased? insulin? levels,?hyperglycemia,?and?hypoxia19,33),?
the?exact?driver?of?macrophage? accumulation? and? activation?has? remained?unclear.?
Recently,? several? studies? in?mice?demonstrated? that?natural? killer? (NK)? cells? control?
macrophage?accumulation?and?polarization?via? the?production?of? interferon?gamma?
(IFN?),?TNF?or? IL?6? in?AT,?which?was?associated?with? impaired? insulin?sensitivity?and?
glucose? handling.33?35? NK? cells,? which? are? innate? lymphoid? cells? specialized? in?
surveilling,?recognizing?and?eliminating?virally? infected,?transformed?or?stressed?cells,?
are?known?to?produce?cytokines?to?shape?an?inflammatory?environment.36?Moreover,?
it?has?been?shown?that?obesity?is?associated?with?an?activated?phenotype?of?NK?cells?in?
human? adipose? tissue.37? However,? neither? NK? cells’? involvement? in? macrophage?
accumulation? and? polarization? in? adipose? tissue,? nor? their? contribution? to? ensuing?
insulin?resistance?has?been?investigated?in?humans.??
?
Besides? LGI,? VAT? and? SAT?may? both? contribute? to? insulin? resistance? by? increased?
lipolysis,?as?well?as?adipokine?dysregulation.38?40?Although?these?mechanisms?may?be?
present?in?SAT?as?well?as?VAT,?they?may?contribute?to?insulin?resistance?to?a?different?
extent.?This?disparity?may,?at?least?in?part,?arise?from?SAT’s?higher?ability?to?expand?its?
capillary?network?compared?to?VAT.22,41?Hence,?compared?to?SAT,?VAT?may?be?more?
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1?
potent? to? contribute? to? insulin? resistance? though? LGI,? dysregulation? of? adipokine?
release,?and? lipolysis.22,38?42? Interestingly,?although?SAT? is?considered?to?contribute?to?
insulin? resistance? independent? from?VAT,38? a? fat?distribution?pattern?with?high? SAT?
and?low?VAT?volumes?is?considered?a?metabolically?healthy?phenotype.43?
?
?
?
?
?
?
?
?
?
?
?
?
?
?
?
?
?
?
?
?
?
Figure?1.1?–?Healthy?and?unhealthy?adipose? tissue?expansion.? (A)?Healthy?adipose? tissue? (AT)?expansion?
consists?of?an?enlargement?of?adipose?tissue?through?effective?recruitment?of?adipogenic?precursor?cells?to?
the?adipogenic?program,?along?with?an?adequate?angiogenic?response?and?appropriate?remodeling?of?the?
extracellular?matrix.?There?are?strong?individual?differences?with?respect?to?the?potential?for?adipose?tissue?
expansion.? (B)? In? contrast,? pathological? adipose? tissue? expansion? consists? of? massive? enlargement? of?
existing? adipocytes? (i.e.,? hypertrophy),? limited? angiogenesis,? and? ensuing? hypoxia.? As? a? result,? hypoxia?
inducible? factor? 1??? (HIF?1?)? is? induced,? which? in? turn? can? cause? the? induction? of? a? fibrotic? program.?
Ultimately,? M1?stage? macrophages? prevail,? leading? to? an? inflammatory? phenotype? that? is? strongly?
associated?with?systemic?insulin?resistance.?Reproduced?from?Sun?et?al.,?with?permission.19?
?
1.2.2.? Intrahepatic?lipids?
The? liver? is? a? key? regulator? in? glucose? metabolism;? it? is? able? to? maintain?
normoglycemia?in?a?fasted?state?through?glycogenolysis?and?gluconeogenesis,?as?well?
as? store?glucose? in? the? fed? state? through?glycogenesis.10?With?prolonged?periods?of?
energy? excess,? liver? biopsies?may? reveal? ectopic? fat? storage? in?macrovesicular? fat?
globules?in?hepatocytes,?as?well?as?hepatic?injury,?illustrated?by?formation?of?Mallory’s?
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hyaline?bodies? in?ballooned?hepatocytes?which?may?contain?microvesicular?fat.44?The?
macrovesicular? lipid? pool? in? hepatocytes? has? a? variable? composition,? which? may?
include? saturated? fatty?acids,?diacylglycerols?and?ceramides,?which?are?suggested? to?
exert? local? lipotoxic? effects.45?47? In? liver? biopsies,? non?alcoholic? fatty? liver? disease?
(NAFLD)? is?confirmed?when? ??5%?of?hepatocytes?are? fatty,? in? the?absence?of?excess?
alcohol?consumption?or?other?conditions.44?Over? time,?NAFLD?may?progress? to?non?
alcoholic?steatohepatitis?(NASH)?and?cirrhosis,?some?will?even?develop?hepatocellular?
carcinoma.48,49?Moreover,?incidence?of?T2D?and?the?risk?of?CVD?appear?to?be?higher?in?
individuals? with? NAFLD,? compared? to? those? without.48?54? Therapies? proven? to? be?
effective?to?treat?NAFLD?are?weight?loss?interventions,?pioglitazone,?and?vitamin?E.55,56?
?
The?gold?standard?to?quantify? IHL?and?diagnose?NAFLD? is?by? liver?biopsy.44?However,?
non?invasive? imaging? techniques? like? proton? magnetic? resonance? spectroscopy?
(1H?MRS)? and? other? magnetic? resonance? imaging? (MRI)? sequences? (e.g.,? modified?
Dixon? (mDixon))? have?been? validated? against? liver? biopsies? and? proven? accurate? to?
quantify? IHL? and? diagnose? NAFLD.57?60? 1H?MRS? is? even? considered? to? be? the? gold?
standard? to? diagnose? NAFLD? non?invasively,44,49,61? although? mDixon? is? just? as,? or?
possibly? even? more,? accurate? (Supplementary? Table? S1.1).58,59,62? Of? note,? other?
techniques? like?computed? tomography,?ultrasound,?or?enzyme?scores?are? inferior? to?
these?MRI?based?techniques?(Supplementary?Table?S1.1).59,63?66?
?
The?contribution?of? IHL?to? insulin?resistance? is?debated;? it? is?unclear?whether? insulin?
resistance? is?a?cause?or?a?consequence?of? IHL.?Lipotoxicity?of? IHL?with?a?detrimental?
lipid?composition,?LGI,?and? stimulation?of?hypertriglyceridemia?by? the? fatty? liver?are?
suggestive?of?a?causative?role?of? IHL? in? insulin?resistance,45?47,49,67?whereas?adipocyte?
insulin? resistance? and? subsequent? FFA?fluxes? towards? the? liver? suggest? IHL? is? a?
consequence?of?insulin?resistance.68,69?In?addition,?with?increased?IHL,?hepatic?glucose?
production? is?no? longer?suppressed? (i.e.,?hepatic? insulin? resistance),?which? results? in?
hyperglycemia.49,70?Nonetheless,? some? studies? have? suggested? that? IHL,? not?VAT,? is?
associated? with? insulin? resistance,71,72? whereas? others? argue? in? favor? of? mutually?
independent? contributions?of? IHL?and?VAT.68,73?However,? these?were? cross?sectional?
studies? in? some?of?which? individuals?were?matched?on?one?or?more? variables? (e.g.,?
VAT,? IHL).71,72? Hence,? studies? that? measure? these? potential? contributors?
simultaneously? in? a? random? sample? of? the? general? population? are? required? to?
determine? whether? or? not? they? are? mutually? independent? contributors? to? insulin?
resistance.??
1.2.3.?Microcirculation?
In?our?circulation,?arteries?branch?out? into?the?microvasculature,?which?encompasses?
blood?vessels?<?150??m?in?diameter?and?includes?arterioles,?capillaries?and?venules.74?
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In? skeletal? muscle,? the? primary? site? of? insulin?induced? glucose? uptake,? arterioles?
ultimately? branch? out? to? terminal? arterioles,? which? are? oriented? perpendicular? to?
muscle? fibers?and? supply? them?at? regular? intervals? (Figure?2.1).?A? terminal?arteriole?
and? its?12?20?capillaries? form? the?smallest?unit?of?control? for?capillary?perfusion;75?79?
venules? are?oriented? similar? to? the? arterioles? and? are? found?between? two? terminal?
arterioles.?As?capillaries?are?embedded? in?sarcolemma,? the?surface?area? for?nutrient?
exchange?is?further?increased.80,81?Muscle’s?vasculature?is?capable?of?regulating?blood?
flow?and?nutrient?exchange;?at?the?level?of?the?terminal?arterioles,?endothelial?surface?
area? can? be? increased? through? vasodilation? and? vasomotion.? Skeletal? muscle’s?
architecture,? regulation? of? vasomotor? tone,? mechanisms? of? vasomotion,?
transendothelial?nutrient?fluxes,?and?the?effects?of?exercise?and?insulin?are?described?
in?more?detail? in?chapter? two.?Nonetheless,? some?key? intracellular?mechanisms?and?
regulatory?mechanisms?are?summarized?below.?
?
The? inner? cellular? lining?of? the? vasculature,? the?endothelium,? is?a? key? regulator?not?
only?in?vasomotor?tone,?vasomotion?and?subsequent?perfusion,?but?also?in?blood?cell?
trafficking,? permeability,? proliferation,? and? hemostasis.82? The? endothelium? is? vastly?
heterogeneous?along? the?vascular? tree,?as?well?as?per?organ.82,83? In? skeletal?muscle,?
the?endothelium? is?continuous?and?non?fenestrated,82?which? is?why?endothelial?cells?
orchestrate?nutrient?transport?to?myocytes.?In?a?hyperinsulinemic?state,?insulin?binds?
to?the? insulin?receptor?on?the?endothelial?surface,?which?results? in?activation?of?both?
vasodilator?(through?insulin?receptor?substrate?1?(IRS?1),?phosphatidylinositol?3?kinase?
(PI3K),? phosphoinositide?dependent? kinase?1? (PDK?1),? protein? kinase? B? (Akt),? and?
endothelial?nitric?oxide? synthase? (eNOS),?which? results? in?nitric?oxide? (NO)? release)?
and?vasoconstrictor?pathways?(through?mitogen?activated?protein?kinase?(MAPK)?and?
extracellular?signal?regulated?kinase?1/2?(ERK1/2),?which?results?in?entothelin?1?(ET?1)?
production).84?92? Since? the? vasodilator? pathway? predominates? in? health,? a? net?
vasodilation?ensues?and,?hence,?hypoperfused?capillaries?and?microvascular?units?are?
recruited? (i.e.,? microvascular? recruitment? (MVR)).84,93?99? In? obesity,? endothelial?
dysfunction? develops;? through? inflammation? (e.g.,? TNF),? FFA,? angiotensin?II? and?
oxidative?stress,?the?vasodilator?pathway?is?inhibited,?which?may?blunt?insulin?induced?
vasodilation?or?even?result?in?paradoxical?vasoconstriction?(Figure?1.2).79,84,85,94,97?110?In?
addition,? insulin? is? transported?across? the?endothelium? in?an?NO?dependent?manner?
via?caveolae,?after?which?myocytes?are?stimulated?by?said? insulin?to?transport?GLUT4?
to? the?plasma?membrane.95,111?113?Although? its? activity? in?muscle’s? endothelium?has?
not? been? studied,? the? GLUT1? transporter,? which? has? a? high? capacity? for? glucose?
transport? even? in? the? absence? of? excess? insulin,? is? assumed? to? be? involved? in?
transendothelial? glucose? transport? in? skeletal? muscle,? similar? to? human? cardiac?
tissue.114?
?
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Figure?1.2?–? Insulin? signaling?pathways? in? the?endothelium? for? the?production?of?nitric?oxide? (NO)?and?
endothelin?1? (ET?1).? In? healthy? individuals,? hyperinsulinemia? results? in? a? net? vasodilation,? whereas? in?
obesity,?this?response? is?either?blunted?or?paradoxical?vasoconstriction?may?occur.?Several?circulating?and?
paracrine?factors?are? involved:?angiotensin?II?(AngII),?tumor?necrosis?factor?(TNF),?and?free?fatty?acid?(FFA)?
inhibit?the?phosphatidylinositol?3?kinase?(PI3K)?pathway?and?stimulate?the?mitogen?activated?protein?kinase?
(MAPK)?pathway?via?a?crosstalk?at?multiple?levels.?TNF?and?AngII?can?inhibit?IRS?1?through?c?Jun?N?terminal?
kinase? (JNK).?AngII? can?bind? to? the?angiotensin? type?1? receptor? (AT1R)? and? inhibit? IRS?1? and? lead? to? the?
production? of? reactive?oxygen? species? (ROS),?which? reduces?NO? bioavailability.? FFA? can? activate?protein?
kinase?C?theta?(PKC??),?which?results?in?activation?of?the?mitogen?activated?protein?kinase?(MAPK)?signaling?
pathway?as?well?as?in?inhibition?of?PI3K.?Adiponectin?can?stimulate?5??adenosine?monophosphate?activated?
protein? kinase? (AMPK),?which? stimulates? eNOS? and? inhibits? the?MAPK? pathway;? in? obesity,? adiponectin?
levels?are?decreased.?Graphical?design?by?Dr.?van?Varik.?
?
?
In?addition?to?MVR,?muscle?perfusion?may?also?be?regulated?through?vasomotion,?i.e.,?
rhythmic? vessel? diameter? oscillations.102,115? It? has? been? demonstrated? that? upon?
increased? metabolic? needs,? signals? originating? from? the? microvasculature? travel?
upstream? to? larger?arterioles?and?arteries,? thereby? influencing?vessel?diameter.116? In?
addition,? stimulation? of? individual? capillaries? can? trigger? vasomotor? responses? in?
arterioles.116?118? Moreover,? signaling? from? endothelial? to? smooth? muscle? cells? at?
myoendothelial? junctions? can? be? regulated? by? NO;? the? duration? of? conducted?
vasodilation?is?attenuated?by?reduced?NO?production.116,119?Collectively,?these?findings?
suggest? that? muscle? microcirculation? can? modulate? upstream? vasodilation? and?
vasomotion.? Interestingly,? vasomotion? may? regulate? microvascular? blood? flow?
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distribution? to?optimize?delivery?of?nutrients,? since?continuously?altering?blood? flow?
delivery? to? vessels? over? time? increases? the? number? of? endothelial? cells? exposed? to?
plasma? for? nutrient? or? hormone? exchange120?without? total? flow? or? cardiac? output?
being?changed.102?
?
A? captivating?potential? regulator?of? insulin’s?vascular?actions? is?perivascular?adipose?
tissue?(PVAT)? in?muscle’s?microcirculation.121?123?Since?adipocytes? in?PVAT?are? located?
in?the?vicinity?of?microvessels,?adipokines?released?from?PVAT?are?suggested?to?have?
paracrine?effects?on?the?microvasculature,?including?its?vasomotor?tone.103,121,123,124?In?
rodents,? it? has? been? observed? that? 1)?with? a? high?fat?diet,? PVAT?was? infiltrated?by?
bone?marrow?derived?immune?cells?and?had?become?inflammatory;125?2)?arteries?with?
excess?PVAT,?in?contrast?to?those?with?little?to?none,?displayed?endothelial?dysfunction?
when?on? a?high?fat?diet;126?3)?PVAT? from?obese?mice?was? shown? to? impair? insulin?
induced?vasodilation?in?arterioles?from?lean?mice;126?4)?PVAT?from?lean?mice?could?not?
restore? insulin?induced? vasodilation? in? arterioles? from? obese? mice;125? and? 5)? by?
inhibition? of? inflammation? in? obese? PVAT,? its? vasodilator? properties?were? restored,?
possibly? via? secretion?of?adiponectin?and? stimulation?of?AMPK?2,?which? resulted? in?
NO?production?and?inhibition?of?the?MAPK?pathway.126,127?Limited?data?is?available?in?
humans,? although? observations? in? humans? are? in? line?with? those? in? rodents.122,128?
Additional?studies?are?needed?to?address?PVAT’s?contribution?to? insulin?resistance? in?
humans.??
?
Of? note,? the? contributions? of? impaired?MVR? or? vasomotion? responses? to? obesity?
induced? insulin?resistance?have?never?been?studied? in?parallel?with?VAT,?SAT,?or? IHL.?
Moreover,? to? the? best? of? our? knowledge,? no? intervention? study? had? evaluated?
whether?MVR? can? be? improved? by? weight? loss,? nor? assessed? the? contribution? of?
changes?in?MVR?to?changes?in?insulin?resistance.?
1.3.? Beta?cell?function?
In?the?evolution?of?obesity?towards?T2D,?progressive?beta?cell?dysfunction?is?a?crucial?
process.? Initially,? beta?cell? function? (BCF)? typically? adapts? to? progressive? insulin?
resistance?in?obesity;?when?BCF?adaptation?is?inadequate,?hyperglycemia?and,?hence,?
T2D?develop.129?131??
?
In? glucose?tolerant? obese? individuals,? the? presence? of? insulin? resistance? induces?
upregulation? of? static? beta?cell? responses? such? as? basal? insulin? secretion? and? total?
stimulated?insulin?secretion;?this?can?be?interpreted?as?an?adjustment?of?the?set?point?
of? BCF? by? insulin? resistance.132? With? progressive? hyperglycemia,? static? beta?cell?
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responses?may,?possibly?due? to? the? toxic?effect?of?chronic?hyperglycemia,?ultimately?
fail132,133? and? beta?cell? dedifferentiation134?138? and? loss? of? beta?cell? mass? may?
develop.131,139,140?
?
Another? important? aspect?of?BCF? is? the? ability? to? appropriately? increase? the? insulin?
secretion?rate?(ISR)?to?cope?with?acute?changes?in?plasma?glucose?concentration?that?
results? from? nutrient? intake.? The? response? of? beta?cells? to? hyperglycemia? is? largely?
explained? by? a? number? of? dynamic? BCF? properties,? as? described? in?more? detail? in?
chapters? three? and? six? (e.g.,? Supplementary? Figure? S6.1),? as? well? as?
elsewhere.129,132,141?145?Briefly,?in?response?to?ingestion?of?a?meal,?ISR?can?be?measured?
and?mathematically?modeled.?From?this?model,?beta?cell?glucose?sensitivity?(??GS)?and?
its?modulation?by?beta?cell?potentiation?(the?effects?of?glucose?itself?and?non?glucose?
secretagogues? to?magnify? the? beta?cell? response? to? glucose? over? time),? as?well? as?
rapid? first? phase? insulin? release? (i.e.,? beta?cell? rate? sensitivity? (??RS))? can? be?
measured.141,142,145?
1.3.1.? Beta?cell?function?in?obesity?and?effects?of?weight?loss?
As?hyperglycemia?normally?develops? gradually?over? time,? it? is? conceivable? that?BCF?
may?already,?to?some?extent,? inadequately?adapt?to?the? level?of? insulin?resistance? in?
obese? non?diabetic? individuals.? Inadequate? obesity?induced? BCF? alterations,? their?
reversibility,?and?the?drivers?thereof?are,?however,?largely?unknown.?
?
Inconsistent?results?have?arisen?from?cross?sectional?studies?which?evaluated?dynamic?
BCF? in?obese,?non?diabetic? individuals.? In? some? studies,?both? ??GS?and?potentiation?
factor? ratio? (PFR;? a? ratio? between? late? and? early? potentiation)?were? decreased? in?
obese? individuals? with? normal146? or? impaired? glucose? tolerance.130,142,146?149? Yet,? in?
other?studies?in?obese?individuals?with?impaired?glucose?tolerance,?an?increase?in???GS?
or?PFR,?or?a? tendency? thereto,?was?observed.148?151?These? contradictory? results?may?
have?arisen?from?the?use?of?an?oral?glucose?tolerance?test?(OGTT)?by?some,130,142,146?149?
and?a?mixed?meal?test?(MMT)?by?others.145,148,149,151?Nonetheless,?in?these?studies?BCF?
was?often?not?sufficiently?adjusted?for?the?level?of?insulin?resistance.??
?
Several?non?controlled? trials?have? studied? the?effects?of?weight? loss,?by?either? low?
calorie? diet? or? bariatric? surgery,? on? various? aspects? of? BCF? in? obese? individuals.? In?
(morbidly)? obese? individuals?who? underwent? bariatric? surgery,? ??GS? and? PFR?were?
unchanged?two?years?post?surgery,?while???GS?was?decreased?one?year?post?surgery,?
although? insulin? resistance? was? markedly? improved? at? all? time? points? in? all?
studies.150,151? To?our? knowledge,?only?one?RCT? in?obese? individuals?has? studied? the?
effects?of?dietary?weight?loss,?which?demonstrated?that?BCF?was?unchanged,?albeit?in?
the?presence?of?markedly?improved?insulin?resistance.55?
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1.3.2.? Intrapancreatic?lipids?and?beta?cell?function?
Ectopic?fat?deposition?in?the?pancreas?is?one?of?the?proposed?contributors?to?beta?cell?
dysfunction.152?154?In?postmortem?studies,?obese?individuals?had?more?intrapancreatic?
lipid?(IPL)?compared?to?lean?individuals;155?157?most?fat?is?present?in?adipocytes?that?are?
primarily? located? in? the? interlobular? and? intralobular? spaces.158?160? Alternatively,?
triglycerides?might?accumulate?in?islets?and?disrupt?intracellular?processes?involved?in?
insulin?secretion,?as?demonstrated? in? rodents.161,162?Nonetheless,? IPL? is?suggested? to?
arise? from? prolonged? elevation? in? plasma? VLDL? due? to? increased? hepatic? VLDL?
production? in?NAFLD,?which?eventually? leads? to? increased?exposure?of?beta?cells? to?
FFA? and? impaired? BCF.49,154,161,163,164? Moreover,? NAFLD? may? induce? beta?cell?
dysfunction? via? fetuin?A? and? beta?cell? apoptosis? via? palmitate.165? Furthermore,? an?
increased?number?of?adipocytes? located?near?Langerhans’? islets?was?associated?with?
an? increased?number?of?macrophages?within? islets,165? suggestive?of? a? link?between?
local?inflammation?and?BCF.166?Another?potential?contributor?to?obesity?induced?beta?
cell? dysfunction? is? endothelial? dysfunction? of? pancreas’? microvasculature.?
Interestingly,? in? rodents,? hyperglycemia? was? able? to? increase? islet? blood? flow?
twofold;167? whether? this? is? insulin?induced? and? NO?dependent? is? unknown.? Other?
mechanisms? involved? in? the? interaction? between? endothelial? and? beta?cells? are?
described?into?more?detail?below?(Figure?1.3)?and?elsewhere.168?
?
Data?on?the?association?between? IPL?and?BCF? is,?however,?ambiguous.? In?obesity,?an?
association?between?IPL?and?some,?but?not?all,?aspects?of?BCF?was?observed,?albeit?not?
consistently.153,154,169?172?Moreover,?in?individuals?with?T2D,?no?association?between?IPL?
and?BCF?could?be?detected.154?The?discrepancy? in?IPL’s?association?with?BCF?between?
obese? individuals?on?the?one?hand?and?those?with?T2D?on?the?other,?may?be?due?to?
differences? in? the? localization? of? intrapancreatic? fat? depositions,? as? well? as? the?
association?between?IPL?and?diabetes?duration.158,173?Alternatively,?IPL?may?be?a?more?
important? contributor? to? early? beta?cell? dysfunction? in? obese? individuals? than?with?
progressive?hyperglycemia?or?T2D.?
?
In? non?controlled? studies? in? obese? individuals,? weight? loss? was? associated? with?
reduced? IPL,174,175? but? not?with? improved? BCF.175?Data? from? randomized? controlled?
weight? loss? trials?on?both?BCF?and? IPL? in?obese? individuals?have,? to? the?best?of?our?
knowledge,?not?been?reported.?
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Figure?1.3???Diagram?summarizing?the?main?factors?regulating?the?islet?beta?cell–endothelial?cell?axis.?Islet?
endothelial? cells? produce? factors? that? enhance? beta?cell? proliferation,? survival? and? function? under?
physiological? conditions,? including? hepatocyte? growth? factor? (HGF),? fibroblast? growth? factor? (FGF),?
connective? tissue? growth? factor? (CTGF)? and? thrombospondin?1? (THBS1).?Additional? islet? endothelial? cell?
secreted? factors? modulate? beta?cell? function;? for? example,? endothelin?1? increases? insulin? release? from?
isolated? mouse? islets,? possibly? by? triggering? calcium? influx? into? beta?cells.? Extracellular? matrix? (ECM)?
molecules?(e.g.,?fibronectin,?collagens,? laminins)?also?affect? insulin?expression?and?release?from?beta?cells,?
partly? via? integrins? (heterodimeric? cell?surface? receptors?with? broad? specificity? for? ECM?molecules)? and?
activation? of? downstream? signaling? pathways,? including? focal? adhesion? kinase? (FAK).? E?cadherin? and?
connexins?govern?cell–matrix?interaction?and?cell–cell?interactions,?respectively,?and?thus?may?also?mediate?
islet?endothelial–beta?cell?crosstalk.?Vice?versa,?beta?cell?secreted?factors?can?also? impact? islet?endothelial?
cell? function.? For? example,? beta?cell?derived? insulin? binds? to? the? insulin? receptor? on? endothelial? cells,?
resulting? in?downstream?activation?of?PI3K?and?Akt?and?subsequent?phosphorylation? (p)?and?activation?of?
eNOS,? leading? to? the? production? of? vasodilatory? NO.? Furthermore,? vascular? endothelial? growth? factor?
(VEGF),? required? for?maintenance?of?endothelial? fenestration?and?cell?viability,? is?produced?by? islet?beta?
cells?and?is?a?major?source?of?VEGF?in?the?islet.?Reprinted?from?Hogan?et?al.,?with?permission.168?
1.4.? Vascular?function?
As?mentioned?before,?obesity?is?associated?with?an?increased?risk?for?CVD;?moreover,?
vascular? dysfunction? has? been? implicated? to? contribute? to? CVD.82,176?188? Although?
microvascular?responses? like?MVR?and?vasomotion?are?also?(NO?dependent)?vascular?
function? tests? (paragraph?1.2.3),?we? aim? to?briefly? introduce?other? commonly?used?
vascular?function?tests?in?this?paragraph.?Their?methodology?is?addressed?in?chapters?
three?and?seven.?
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Since? a? healthy? vasculature? encompasses? many? physiological? functions? (e.g.,? NO?
production,? cushioning? of? blood? flow? pulsations,? barrier? function,? regulation? of?
hemostasis,?prevention?of?atherosclerosis,?and?maintenance?of?vascular?structure?and?
capillary?density),?virtually?all?of?these?functions?may?be?affected?to?some?degree?by?
obesity.? Over? the? years,? many? different? tests? have? been? developed? to? detect?
impairments?in?vascular?function.??
?
Flow?mediated?dilation? is? a? functional?marker?of? endothelial? function,? as? it? aims? to?
assess? the?capacity?of? the?endothelium? to? induce?vasodilation?via?NO?production.189?
Besides? its? vasodilatory? effects,? NO? also? has? anti?inflammatory,? anti?adhesive? and?
antithrombotic?effects.94,190?Moreover,? it?has?been?demonstrated?that? impaired?flow?
mediated?dilation?is?associated?with?an?increased?risk?of?incident?CVD.191?193?
?
Endothelial? function? can? also? be? assessed? by?measurements? like? peripheral? arterial?
tonometry,? which?measures? NO?dependent? digital? pulse? volume? amplitude? during?
hyperemia,194? or? plasma? biomarkers? of? endothelial? dysfunction.195,196? These? plasma?
biomarkers?are?molecules?that?are?either?expressed?by?endothelial?cells?and?are?shed?
into? the? circulation? in? their? soluble? form?via?proteolysis? (e.g.,?vascular?cell?adhesion?
molecule?1,? intercellular?adhesion?molecule?1,?endothelial? selectin)?or? released? into?
the? circulation? upon? injury? of? the? vascular? wall? (e.g.,? von? Willebrand?
factor).82,83,178?180,197? Increased? levels? of? these? plasma? biomarkers? of? endothelial?
dysfunction?are?also?associated?with?an?increased?risk?of?incident?CVD.181?186?
?
Obesity,?hyperglycemia,?and?hypertension?may? lead? to? structural? remodeling?of? the?
arterial?wall,? for? example? by? replacement?of? elastin? fibers?with? collagen? fibers? and?
cross?linking? by? advanced? glycation? end?products,198?200? which? results? in? arterial?
stiffening.?In?turn,?arterial?stiffness?results?in?impaired?cushioning?function?of?arteries,?
increased? pressure? and? flow? pulsatility,? and? transmission? of? pulsatile? load? to? the?
microcirculation.201?203?On? the?one?hand,? this?may? increase? (systolic)?blood?pressure?
and?decrease? coronary?perfusion;201,203?unsurprisingly,?arterial? stiffness? is?associated?
with? incident?CVD.187,188?On? the?other?hand,? the? increased?pulsatile? load? toward? the?
microcirculation,? like? the? retinal? arterioles,? is?particularly?harmful.201?204? It?has?been?
demonstrated? that? unfavorable? retinal? arteriolar? and? venular? calibers,? i.e.? wider?
venules?and?narrower?arterioles,?were?associated?with?incident?CVD.205,206?
?
Importantly,?it?should?be?noted?that?two?distinctive?objectives?to?use?vascular?function?
measurements?can?be?differentiated?in?clinical?trials:?as?a?surrogate?for?cardiovascular?
end?points?and? to?evaluate?certain?properties?of? the?vasculature?and? identify?causal?
mechanisms.?Although?we?used?vascular? function? for?both?purposes? in? this? thesis,? it?
should? be? noted? that? the? use? of? surrogate? outcomes? have? been? frequently?
criticized.207?213? In? Appendix? 1.1,? the? assumptions,? limitations? and? potential? of?
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surrogate?outcomes? are? further?discussed.?Nonetheless,? investigating? the? effects?of?
obesity?and?weight? loss?may?provide?valuable? insights.?Moreover,?to?our?knowledge,?
the?effects?of?obesity?on?the?vascular?function?measurements?mentioned?before?and?
in? chapter? three,?have?not?been? assessed? in? a? single? study,?nor?has? an?RCT?on? the?
effects?of?weight?loss?on?these?vascular?functions?been?performed.?
1.5.? Missing?links?
Previous?studies?have?investigated?whether?VAT,38,42,68,71?73,214?SAT,38,42,215,216?IHL,68,71?73,214?
or?MVR98,128,217? contribute? to? obesity?induced? peripheral? insulin? resistance.? Several?
studies?demonstrated?that?SAT’s?association?with? insulin?resistance?was? independent?
of?VAT;38,42?some?studies?argue?in?favor?of?mutually?independent?contributions?of?VAT?
and? IHL,68,73,214? whereas? others? find? that? IHL,? not? VAT,? is? associated? with? insulin?
resistance.71,72?For?MVR,? it?has?never?been?shown,?neither? in?muscle?nor? in?skin,?that?
its? effect?on?obesity?induced? insulin? resistance? is? independent? from?other?potential?
contributors.? Moreover,? although? the? beneficial? effect? of? weight? loss? on? insulin?
resistance? is? well? known,55,218? it? has? not? been? investigated? what? drives? this?
improvement.?Nonetheless,? it? is?crucial? to? identify?whether?VAT,?SAT,? IHL,?and?MVR?
act? independently? to? increase? obesity?induced? insulin? resistance,? as? mutual?
independence,? in? contrast? to?mutual?dependence,? implies? that?distinct?mechanisms?
can?be?targeted?to?improve?insulin?resistance.?
?
If?VAT?were? to?be?an? independent?contributor? to?obesity?induced? insulin? resistance,?
which? is? generally? accepted? in? literature,22,38?42,68,73? it? is? valuable? to? identify? the?
mechanisms? through? which? VAT? can? exert? this? effect.? Previous? studies? have?
demonstrated? that? VAT? can? contribute? to? insulin? resistance? through? increased?
lipolysis,?adipokine?dysregulation,?and?LGI.38?40?The? low?grade? inflammatory?response?
in?VAT? has? been? intensively? studied? and? signals? an? important? role? for?macrophage?
accumulation? and? inflammatory?polarization.19,24,26?32?What?drives? accumulation? and?
inflammatory?polarization?of?macrophages? in?human?VAT? is?still?open? for?debate.? In?
rodents,? infiltration? of? and? cytokine? release? by? NK? cells? in? VAT? in? response? to?
adipocyte? stress?have? recently?been?demonstrated? to?drive?macrophage? infiltration?
and?polarization.33?35?In?humans,?however,?the?role?of?NK?cells?in?VAT?has?never?been?
studied.?
?
Beta?cell? failure? is?a? sine?qua?non? for?hyperglycemia?and?T2D? to?develop,?yet? some?
obese? individuals?never?become?hyperglycemic.129?131? It?may?be?of? great? interest? to?
detect?early?signs?of?inadequate?beta?cell?responses?to?hyperglycemia?and?identify?its?
drivers,?as?it?could?not?only?lead?to?identification?of?individuals?at?risk?for?T2D,?but?also?
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identify? potential? targets? for? treatment.? Several? studies? have? investigated?whether?
obesity?induced? changes? in? BCF? could? be? detected129,130,142,146?151? and? demonstrated?
that? at? least? some? of? them?were? associated?with? progression? to? T2D.129,130? IPL? has?
been? implicated? by? some? to? be? associated?with?BCF,152?154,163? yet? conflicting? results?
have?arisen.154,169?172?Moreover,?the?effects?of?weight? loss?on?BCF?and? IPL?have?never?
been?studied?concurrently?in?an?RCT,?although?non?controlled?studies?found?that?both?
BCF150,151,175,219? as?well? as? IPL152,173?175?were? associated?with?weight? loss,? possibly? in?
parallel.175?
?
Finally,?it?has?been?generally?accepted?that?a?weight?loss?intervention,?either?through?
diet,?exercise?or?bariatric?surgery,?would?be?beneficial?for?vascular?function,220?prevent?
incident?T2D,221,222?and?curate?individuals?from?T2D.223?226?There?is?substantial?evidence?
to? support? the? latter? two? hypotheses,221?226? yet? only? few? RCTs? have? evaluated? the?
effect?of?weight?loss?on?vascular?function.227,228?In?addition,?those?studies?investigated?
macrovascular? function? by?means? of? FMD? or? cfPWV.227,228? Nonetheless,? it?may? be?
equally?valuable?to?evaluate?the?effect?of?a?weight?loss?intervention?on?microvascular?
health?and? function.?Not?only? in? the? light?of? insulin? resistance,?but?also? since?many?
complications? that? may? develop? in? T2D? arise? from? and? occur? in? the?
microcirculation.229,230? If? weight? loss? would? be? able? to? improve? macro?? and?
microvascular?function,?this?might?be?a?mechanism?through?which?incident?T2D?or?its?
macro?? and? microvascular? complications? could? be? averted.231?235? The? effects? of? a?
weight? loss? intervention? on?microvascular? function? in? particular? has,? however,? not?
been?evaluated? in?an?RCT.?Moreover,?most?RCTs?that? investigated?effects?on?FMD?or?
cfPWV?were?performed?in?participants?with?obesity?related?morbidities.227,236,237?Also,?
physical? exercise227,236? or? weight?loss? medication237? was? part? of? the? weight?loss?
regimens.?Hence,? the? effects? of? a?weight? loss? intervention? by? caloric? restriction? on?
micro??and?most?of?macrovascular?function?remains?to?be?demonstrated.?
1.6.? Outline?of?this?thesis?
In? chapter? two,?we? reviewed? the?distinctive?architecture?and?properties?of?muscle’s?
vasculature?and?described? the?hierarchical,?graded? control?of?muscle?perfusion? that?
arises?from?cooperative? interactions?among?the?factors?released? locally?by?myocytes,?
by? smooth?muscle?cells,?or?by?endothelial?cells?along?with? systemically?and?neurally?
delivered? signals.? Separately,? in? Appendix? 2.1,? we? present? a? commentary? that?
addressed?capillary?recruitment?in?skin.?
?
In? chapter? three,? we? assessed? the? reliability? and? measurement? error? of? several?
anthropometric,? vascular,? metabolic,? and? inflammatory? measurements? used?
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throughout?this?thesis,?as?well?as?describe?the?methodology?of?these?measurements.?
The? rationale? for? this? study? is? described? in? to?more? detail? in? the?methodological?
considerations?in?Appendix?1.1.?
?
In? chapter? four,? we? investigated,? in? an? RCT? with? a? weight? loss? intervention,? the?
mutually? independent?contributions?of?VAT,?SAT,? IHL?and?MVR?to?obesity?associated?
insulin? resistance.?Moreover,?we? investigated?whether?MVR? can? be? improved? by? a?
weight? loss? intervention?and?assessed? the?contributions?of?weight?loss? intervention?
induced?changes?in?VAT,?SAT,?IHL,?and?MVR?on?improvements?in?insulin?sensitivity.?We?
used?state?of?the?art?multiple?mediation?analyses?to?provide?a?deeper?understanding?
of? the?mutually? independence? of? these? variables;? the? rationale? for? this? statistical?
method? is? described? in? to? more? detail? in? the? methodological? considerations? in?
Appendix?1.1.??
?
In? chapter? five,? we? investigated? the? presence? of? NK? cells? in? human? VAT,? their?
association? with? macrophage? polarization,? and? their? effects? on? LGI? and? insulin?
resistance? in? four? separate? studies.? In? the? first? study,?NK? cells?were?quantified? and?
linked? to? macrophage? polarization? in? biopsies? from? VAT? and? SAT;? moreover,? a?
circulating? biomarker? for? VAT? NK? cells? is? presented.? In? the? second? study,? we?
investigated? whether? NK? cells? from? obese? individuals? directly? affect? macrophage?
polarization;?hence,?NK?cells?were?isolated?from?peripheral?blood?and?co?cultured?with?
human? monocyte?derived? macrophages.? In? the? third? study,? the? cross?sectional?
analyses?from?the?weight?loss?intervention?trial,?the?associations?of?VAT?NK?cells?to?LGI?
and? subsequent? insulin? resistance?were? investigated.?A? fourth? study,? the?Maastricht?
Study,?was? used? for? validation? of? these? associations? in? a? population?based? cohort?
study.??
?
In?chapter?six,?we?investigated,?in?an?RCT?with?a?weight?loss?intervention,?the?obesity?
associated? alterations? in? BCF,? and? explored? IPL? as? a? potential? contributor? thereof.?
Moreover,?we?investigated?whether?a?weight?loss?intervention?could?improve?BCF?and?
explored?whether?a?decrease?in?IPL?drove?improvements?in?BCF.?
?
In? chapter? seven,?we? investigated,? in? an? RCT?with? a?weight? loss? intervention,? the?
obesity?associated?alterations? in?macro??(FMD,?cfPWV,?peripheral?arterial?tonometry,?
and? central? augmentation? index)? and? microvascular? function? (retinal? vascular?
diameters),? as?well? as? circulating?biomarkers?of? endothelial?dysfunction? and? LGI.? In?
addition,?we? investigated?whether?a?weight?loss? intervention? could? improve?macro??
and?microvascular?function?and?reduce?levels?of?circulating?biomarkers?of?endothelial?
dysfunction?and?LGI.??
?
539883-L-sub01-bw-Kusters
Processed on: 13-1-2020 PDF page: 23
? General?introduction?
23?
1?
Finally,?in?chapter?eight,?we?discussed?the?key?findings?of?this?thesis?and?their?clinical?
implications,? highlighted? methodological? considerations,? and? identified? hypotheses?
worthwhile?to?investigate?in?future?research.?
??
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Table?S1.1?–?Comparison?of?various?modalities?to?diagnose?NAFLD?and?quantify?IHL?
? Biopsy?validated?
1H?MRS?
validated?
Continuous?
variable?
Different.?
NASH?
Small?
clinical?
trials?
Large?
(cohort)?
studies?
Post?
hoc? Burden? Costs?
Liver?biopsy? N/A? N/A? +? ++? +/?? ?? ?? ++? €€€€?
1H?MRS? ++? N/A? +? ?? ++? +/?? ?? +/?? €€€?
mDixon?MRI? ++? ++? +? ?? ++? +? ?? +/?? €€?
CT? +/?? +/?? +/?? ?? ?? ?? ?? +? €€?
Ultrasound? ++? ++? +/?? +/?? +/?? +? ?? ?? €/€€?
Enzyme?score? ?? +? +? ?? +/?? ++? +? ?? €?
Techniques? are? rated? whether? they? are? validated? against? liver? biopsies? and? 1H?MRS,? express? IHL? as? a?
continuous? variable,? can? differentiate? NASH? from? NAFLD,? are? suited? for? small? clinical? trials? and? large?
(cohort)?studies?and?can?be?assessed?after?the?study?is?completed?(i.e.,?post?hoc),?as?well?as?the?burden?for?
study?participants?and?the?costs.?1H?MRS?(r?=?0.70? ??0.93,?p?<?0.001,?Cohen’s?kappa?0.66? ??0.75;?sensitivity?
80%,?specificity?80%;?derived?from57?60),?mDixon?(r?=?0.94,?p?<?0.001;?sensitivity?77%,?specificity?87%;?derived?
from58,59)?and?ultrasound?(sensitivity?85%,?which?decreased?with? increased?BMI,?specificity?94%,?ROC?0.93,?
p<0.001;?as?published?in63)?are?well?validated?against?liver?biopsies;?CT?was?validated?but?performed?rather?
poorly? (sensitivity? 11?50%,? specificity? 77?100%,? accuracy? decreased?with? increased? BMI;? from59,64,65)? and?
enzyme? scores? were? not? biopsy? validated.66? MDixon? (r? =? 0.90?0.99;? ICC? =? 0.82?0.98;? Cohen’s? kappa?
0.79?0.90;?p<0.001;?derived?from58,62,238)?and?ultrasound59,63?are?well?validated?against?1H?MRS;?the?enzyme?
score?was?validated?in?a?single?cohort?only?(sensitivity?86%,?specificity?71%,?ROC?0.86;?from66),?whereas?CT?
was?validated?but?performed?rather?poorly.59?Liver?biopsies,?1H?MRS,?mDixon?and?enzyme?score?express?IHL?
as?a?continuous?variable,?whereas?CT?(Hounsfield?units)?and?ultrasound? (e.g.,? liver?to?kidney?contrast)?can?
be?reported?as?a?continuous?variable?that?serves?as?a?proxy?for?IHL.?Only?liver?biopsies?can?reliably?diagnose?
NASH,? yet?elastography? (e.g.,? transient?elastography;? r?=?0.74,?p? <?0.001;?ROC?0.62?0.71? for?presence?of?
NASH;? from239)? can? provide? some? information? on? NASH? status? as? it? is? measures? the? stiffness? of? liver?
parenchyma?as?a?proxy?for?fibrosis.?For?small?clinical?trials,?1H?MRS?or?mDixon?are?preferred?to?assess?IHL,?
although? sometimes? liver?biopsies? could?be?warranted? to?provide?additional? information?on?presence?or?
severity?of?NASH;?CT,?ultrasound? and? enzyme? scores? are? deemed? inferior? to?MRI?based? techniques.? For?
large? (cohort)? studies,? costs,? burden? and? time? consumption? often? outweigh? accuracy.? Hence,? enzyme?
scores,?ultrasound?and?mDixon?are?preferred?over?biopsies?and? 1H?MRS? (which?can?still?be?a?valid?option?
depending? on? a? facility’s? infrastructure).? We? consider? CT? unfit? for? large? (cohort)? studies? due? to? its?
inaccuracy,? radiation?exposure?and?costs.?The?enzyme?score? is? the?only? test? that?can?be?performed?upon?
completion?of?a? study?as? it?only? requires? stored? serum.?The?burden? for?participants? is?highest? for?a? liver?
biopsy,? still? rather? high? for? CT? because? of? radiation? exposure,? and? doubtful? for?MRI?based? techniques?
because?of?potential?claustrophobic?responses?and?noise.?Costs?of?each?technique?may?vary?per?institution,?
yet?often?biopsies?are?rather?expensive,?1H?MRS? is?more?expensive?than?mDixon?due?to? longer?acquisition?
time,?and?CT?and?ultrasound?are?still?more?expensive?than?laboratory?tests?on?serum.?N/A?is?noted?when?not?
applicable.?
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Appendix?1.1?–?Methodological?considerations?
Renown? and? recently? deceased? Dr.? Altman? once? argued? that? it? is,? unfortunately,?
common?in?research?to,?either?willfully?or?in?ignorance,?use?the?wrong?techniques,?use?
the?right?techniques?wrongly,?misinterpret?their?results,?report?results?selectively,?cite?
the? literature?selectively,?and?draw?unjustified?conclusions.240?243?He?went?on?to?state?
that?huge?amounts?of?money?are?wasted?on?research?that?is?seriously?flawed?through?
the?use?of? inappropriate?designs,?unrepresentative?samples,?small?samples,? incorrect?
methods?of?analysis,?and? faulty? interpretation;240?the? tremendous?amount?of?money?
wasted? was? later? even? quantified? by? others.244?Moreover,? Dr.? Altman? and? others?
argued? that? although?many? journals? lack? statistical? reviewers,? they? still? advance? to?
publish?misleading?research.240,241?In?spite?of?this?grim?assessment?of?medical?science,?
it?would? indeed? be? valuable? to? have? quality? assurance? built? in? at? the? beginning? of?
research,?not?the?end.241?
?
Several? quality? assessments,? including? analysis? of? reliability? and? responsiveness? of?
measurements,?can?reduce?bias?and?be?performed?before?a?clinical?trial?is?conducted.?
Moreover,?more?advanced?statistical?methods,? like?multiple?mediation?analyses,?can?
be? used? to? address?multiple? competing? hypothesis? in? a? single?model.? Such? quality?
assessments? and? statistical? analysis,? as? briefly? introduced? below,? are? unfortunately?
also? infrequently? reported,? reported? in? the? wrong? way,? or? disregarded? altogether?
(chapter?three).245?250?Finally,?it?is?valuable?to?recognize?that?many?outcomes?in?clinical?
studies?are?in?fact?surrogate?outcomes;?this?has?implications?for?the?interpretation?of?
data? and? treatment? strategies.? Here,? we? address? reliability? and? responsiveness? of?
measurements,?multiple?mediation?analysis,?and?surrogate?outcomes.?
Reliability?
An? essential? requirement? of? all?measurements? in? patient? care? and? research? is? that?
they?are?reliable.?Reliability?is?defined?as?‘the?extent?to?which?scores?for?patients?who?
have?not?changed?are?the?same?for?repeated?measurement?under?several?conditions,?
e.g.?over?time,?on?different?occasions?by?the?same?observer?(intra?observer),?or?on?the?
same?occasion?by?different?observers?(inter?observer).246,251?The?domain?reliability,?as?
defined? in? the? COSMIN? taxonomy,? is? divided? into? the? measurement? properties?
measurement? error? and,? again,? reliability.246,251? It? is? crucial? to? understand? the?
difference?between?measurement?error?and?reliability.??
?
Parameters?of?measurement?error?relate?to?the?concept?agreement,?i.e.?the?absolute?
difference?between?repeated?measurements,?and?can?be?expressed?as?standard?error?
of?the?measurement?(SEM)?and?the? limits?of?agreement?(Bland?and?Altman?method),?
as?described? in? to?more?detail? in? chapter? three?and?elsewhere.246,251,252? In?brief,? the?
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SEM?can?be?interpreted?as?the?standard?deviation?around?a?single?measurement?(e.g.,?
when?BMI? is?assessed?100?consecutive? times,? the?SD?of? these?measurements?equals?
the?SEM).246?For?the?limits?of?agreement,?often?visualized?in?Bland?Altman?plots,252?the?
difference?between?repeated?measurements?is?calculated?and?a?normal?distribution?of?
the? difference? scores? is? assumed.? The? limits? of? agreement? represent? the? mean?
difference?between?measurements?±?1.96?SD;?hence,?95%?of?the?difference?scores?will?
fall?between?the?limits?of?agreement.246,252?
?
Reliability?parameters?on?the?other?hand,?like?intraclass?correlation?coefficients?(ICC),?
which? range? in? value? from? 0? (totally?unreliable)? to? 1? (perfect? reliability),? relate? the?
random? error? variance? to? the? variance? among? subjects? in? a? population.246,253?256?
Consequently,? a?parameter?of? reliability? is? in? fact?only? valid? for? the?population? it? is?
measured?in?and?the?observers?it?is?measured?by.??
Responsiveness?
To?evaluate?changes?in?health?status?over?time,?measurement?instruments?should?be?
able? to? detect? these? changes;? i.e.,? the? measurement? instrument? should? be?
responsive.246,251?To?evaluate? responsiveness?of?a?measurement? instrument,?a? study?
design?should?be?chosen?in?which?it?is?reasonable?to?expect?that?(a?proportion?of?the)?
individuals? would? change? on? the? construct? under? investigation.? Otherwise,? if? the?
measurement?does?not?change?over?time,?it?would?be?problematic?to?decide?whether?
the? subjects? did? not? change,? or? whether? the? measurement? instrument? was? not?
responsive.246?Clearly,? responsiveness? is?only? relevant? for?measurement? instruments?
used? in? evaluative? applications;? if? an? instrument? is? only? used? for? discriminating?
between?patients?at?one?point?in?time,?responsiveness?is?not?an?issue.246,251?
?
When? a? gold? standard? for? change? is? available,? the? changes? in? the? measurement?
instrument? under? investigation? can? be? compared? to? changes? in? scores? of? the? gold?
standard.246? If? no? gold? standard? is? available,? hypotheses? are? tested? to? assess?
responsiveness.? For? example,? it? could? be? hypothesized? that?when? a?measurement?
instrument? is? responsive,? changes? in? the? measurement? instrument? would? be?
correlated? to? changes? in? scores? on? other? instruments? known? to? have? adequate?
responsiveness.246?
Multiple?mediation?
The? use? of?multiple?mediation? analyses,? compared? to?multivariate? regression,? can?
provide?a? superior? reflection?of? the? causal? chain?one? tries? to? investigate.?This?helps?
unravel? contributions? to? disease? etiology? and? to? develop? targeted,? effective?
therapies.257? Specifically,? the? advantage? of? testing? the?mediating? effect? of?multiple?
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variables? simultaneously? is? that? one? disentangles? whether? or? not? mediation? is?
independent? of? the? effect? of? the? other?mediators,? which? offers? the? possibility? to?
compare?competing?theories?against?one?another?within?a?single?model.258?260?
?
In?addition,?particularly?when?potential?mediators?have? little? random?error? (i.e.,? the?
measurement? is? precise? and? reflects? the? underlying? mechanism? well),? multiple?
mediation? analyses? can?be?used? to?estimate? the?proportion?of? the? total?effect? that?
independent?mediators?account?for.?A?mediated?proportion?is?essentially?the?product?
of?two?effects:?the?regression?coefficient?of?the?association?between?determinant?and?
mediator? on? one? hand,? and? the? regression? coefficient? of? the? association? between?
mediator? and?outcome? as? assessed?by?multivariate? regression? analysis? (i.e.,?with? al?
mediators? and? the? determinant? in? a? single? regression?model)? on? the? other.260? As?
multiple? mediator? models? are? in? fact? the? integrated? product? of? two? multivariate?
regression?models,? they?have? a? clear? advantage?over? the? conventional? approach?of?
analyzing?each?effect?with?separate?regression?analyses.?
?
Over? time,? several?modified?multiple?mediation?analyses?have?been?developed,? like?
serial?multiple?mediation,?repeated?measures?multiple?mediation,?and?a?combination?
of?both.259?261?The?serial?multiple?mediator?model?is?able?to?assess?mediation?when?it?is?
assumed? that? one?mediator? affects? another.260? This?way,? pathways? in?which? each?
mediator? is? presumed? to? affect? other? mediators? causally? downstream,? can? be?
investigated? as? well? as? the? proportion? of? each? pathway? of? the? total? effect?
quantified.260,261?Repeated?measures?multiple?mediation?can?be?used?when?data?from?
repeated?measurement?of? the?same?people?on?variables? in? the?mediation?process? is?
obtained,?as? in?an?RCT.261?This? is? considered?a?valuable?addition? to? regular?multiple?
mediation?analyses?where?determinant,?mediator,?and?outcome?are?measured?at?the?
same? moment? in? time.? Recently,? a? statistical? method? that? combines? serial? and?
repeated?measures?multiple?mediation? has? been? developed;261? this? allows? for? the?
assessment?of?multiple?serial?pathways?in?an?RCT,?for?example.?
Surrogate?outcomes?
Although? frequently? criticized,207?213? surrogate? outcomes? are? widely? used? in?
research262?266?and?new?drugs?are?even?commonly?approved?based?on?their?effect?on?a?
surrogate? outcome,? in? the? absence? of? an? effect? on? relevant? end? points.207,211,213,267?
Moreover,?as?end?points?show?substantially?smaller? responses? to? interventions? than?
surrogate?outcomes,212?many?of?the?widely?accepted?strategies?(e.g.,?for?T2D)?may?be?
based? on? artificially? inflated? expectations.207? In? addition,? the? use? and? limitations? of?
surrogate?outcomes?are?greatly?underreported?in?RCTs.210?
?
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The?acceptance?of?surrogate?outcomes?for?clinical?end?points?like?CVD?or?mortality?is,?
at?least?in?part,?due?to?the?high?costs,?requisition?of?a?large?sample?size,?and?increased?
follow?up? duration? of? RCTs? that? investigate? relevant? cardiovascular? end? points;?
surrogate? outcomes? are,? on? the? other? hand,? cheaper? and? easier? to?measure.207? In?
addition,? it? has? been? argued? that? innovation? is? delayed? or? obstructed? if? surrogate?
outcomes? were? to? be? disregarded.? Nonetheless,? surrogate? outcomes? should,?
preferably?strongly,?be?associated?with?the?incidence?of?relevant?end?points,?as?well?as?
be? involved? in? the? causal? pathway? of? the? relevant? end? point.?More? importantly,?
surrogate?outcomes?are?not? intrinsically? flawed;? they?can?be?helpful? in?treatment?as?
well?as?in?risk?stratification,?when?interpreted?appropriately.207?
?
??
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Abstract?
We?review?the?evolving?findings?from?studies?that?examine?the?relationship?between?
the? structural?and? functional?properties?of?skeletal?muscle’s?vasculature?and?muscle?
metabolism.?Unique?aspects?of? the?organization?of? the?muscle?microvasculature?are?
highlighted.? We? discuss? the? role? of? vasomotion? at? the? microscopic? level? and? of?
flowmotion?at?the?tissue? level?as?modulators?of?perfusion?distribution? in?muscle.?We?
then? consider? in? some? detail? how? insulin? and? exercise? each? modulate? muscle?
perfusion? at?both? the?microvascular? and?whole? tissue? level.?The? central? role?of? the?
vascular?endothelial?cell?in?modulating?both?perfusion?and?transendothelial?insulin?and?
nutrient? transport? is? also? reviewed.? The? relationship? between? muscle? metabolic?
insulin?resistance?and?the?vascular?action?of?insulin?in?muscle?continues?to?indicate?an?
important? role? for? the? microvasculature? as? a? target? for? insulin? action? and? that?
impairing?insulin’s?microvascular?action?significantly?affects?body?glucose?metabolism.?
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Introduction?
Muscle’s?microvasculature? is? the? final? interface? through?which? circulating?nutrients,?
hormones,?gases,?and?electrolytes?must?pass? in? journeying?to?and?from?the?systemic?
circulation.? It? has? evolved?multiple? structural? and? functional? adaptations? to? flexibly?
and?efficiently?fulfill?its?role?in?optimizing?muscle?function.?Here,?we?examine?how?the?
minute?to?minute?metabolic?activity?of?skeletal?muscle? is?coupled? to? the? function?of?
muscle’s?vasculature.?We?will?discuss?how?bulk?blood? flow?and? flow?distribution?can?
regulate?nutrient?delivery?to?muscle?microvasculature?as?well?as?how?transendothelial?
transport? processes? can? modulate? the? exchange? of? hormones? and? metabolites?
between?plasma?and? the?myocytes.?We? focus?on?acute? regulatory? relationships?and?
defer? discussion? of? chronic? vascular? or? myocyte? adaptation? to? environmental,?
nutritional,?and?most?pathological?processes.?
?
Muscle? blood? flow? has? been? measured? in? numerous? classical? limb? balance? and?
metabolic? tracer? studies? of? the? acute? effects? of? fasting,? feeding,? exercise,? and?
hormonal?manipulation?on?muscle?nutrient?exchange.?These?methods,?however,?treat?
muscle’s?vasculature?as?a? “black?box.”?Here,?we?consider?muscle?microvasculature’s?
specialized?architecture?and?how? that?architecture?might? impact?nutrient? fluxes? into?
and?out?of?the?muscle.?We?will?discuss?the?role?of?vasomotion?and?flowmotion?in?the?
regulation? of? microvascular? perfusion.? We? recognize? that? factors? acting? on? the?
endothelial?cell? (EC),?the?vascular?smooth?muscle?cell? (SMC),?or?pericytes?may?affect?
muscle?perfusion.?We?will?consider?in?more?detail?the?effect?insulin?and?exercise?have?
on? the? endothelium? and? directly? or? indirectly? on? the? vascular? SMC? to? influence?
nutrient?delivery.??
?
Beyond? muscle? perfusion,? we? will? consider? the? transit/transport? of? fatty? acids,?
glucose,? and? insulin? across? the? vascular? endothelium?of?muscle,? as? these?processes?
offer? another? pathway? whereby? the? vasculature?may? regulate?myocyte?metabolic?
function.? In? aggregate,? this? review?will? delineate? how? vascular? regulation? of? blood?
flow,? flow? distribution,? and? endothelial? function? coordinate? to? optimally? serve?
myocyte?function.?
Skeletal?muscle?architecture?
Pioneering? work? by? Spalteholz1? and? Krogh2,3? has? demonstrated? muscle’s? highly?
organized? vasculature.? Arterioles? branch? off? primary? arteries,? down? to? terminal?
arterioles,? oriented? perpendicular? to?muscle? fibers,? and? supplying? them? at? regular?
intervals?(1?mm).?Each?terminal?arteriole?supplies?15???20?capillaries?running?parallel?to?
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fibers,?with?many?anastomoses,? to? form?a? rich?network?around?muscle? fibers.?Each?
terminal?arteriole?with? its? capillaries? forms? the? smallest?unit?of? control? for? capillary?
perfusion?(referred?to?as?a?microvascular?unit).4?Venules?are?arrayed?as?arterioles?and?
found?between? two? terminal? arterioles.? Lymph? vessels?originate?within?muscle? and?
can?ascend?with?arterioles?or?venules?(Figure?2.1).5,6?
?
?
?
?
?
?
?
?
?
?
?
?
?
?
?
?
?
?
?
?
?
Figure?2.1?–?Schematic?representation?of?muscle’s?vascular?architecture.?Left:?Arterioles?branch?off?primary?
arteries,?down?to?terminal?arterioles,?oriented?perpendicular?to?muscle?fibers.?Top?right:?Two?muscle?fibers?
and?their?microvascular?units,?with?terminal?arterioles?as?smallest?unit?of?control?and?lymph?vessels?(green)?
ascending?along?arterioles?and?venules.?In?resting?muscle?(top?fiber),?the?microvasculature?is?intermittently?
and? not? equally? perfused,?whereas? in? insulin? or? exercise? stimulated?muscle? (bottom? fiber),? vasodilation?
occurs? at? the? level? of? the? terminal? arterioles? and? control? of? perfusion? shifts? upstream.? Bottom? right:?
Magnification? of? the? capillary? embedding? in? sarcolemma,? thereby? expanding? the? contact? area? between?
myocytes?and?endothelial?cells.?Mitochondria?in?myocytes?cluster?along?the?embedded?capillary,?in?that?way?
reducing?the?distance?oxygen?and?nutrients?need?to?diffuse.?
?
?
The?proximity?between?muscle?fibers?and?capillaries?is?underscored?by?recent?findings?
showing? capillaries? embedded? in? grooves? indenting? the? sarcolemma? and? expanding?
the? contact? area?between?myocytes? and?ECs.?Moreover,?muscle? fiber?mitochondria?
appear?to?cluster?along?these?grooves,?thereby?reducing?the?distance?oxygen?and?fatty?
acids?need?to?diffuse.7?Recent?elegant?imaging?studies?have?also?shown?that?muscle’s?
“mitochondrial? reticulum”? is? further? specialized? with? respiratory? complexes? that?
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generate?membrane?potential?(e.g.,?complexes?III?and?IV)?enriched?in?the?perivascular?
region? of? the?mitochondrial?matrix,?whereas? components? using? the? proton?motive?
force? for? ATP? synthesis? are? distributed? more? within? the? fiber.? This? arrangement?
minimizes? oxygen? diffusion? distances? and? may? allow? conductive? distribution? of?
proton?motive?force.8?
?
Although?arterioles?and?venules?are?organized? similarly? in?most?mammalian? skeletal?
muscles,? some?differences? in?microvascular? architecture? exist?between? aerobic? and?
anaerobic?muscles.? Aerobic?muscles? typically? have?more? capillaries,? larger? capillary?
length? per? fiber,? and?more? capillary? branches? per? fiber,9? and?microvessels?may? be?
embedded?deeper? in?sarcolemma?and?have?more?perivascular?mitochondria.7?These?
are?all?adaptations?that?could?facilitate?gas?and?nutrient?exchange.?Muscle’s?vascular?
architecture?down? to? the? level?of? terminal?arterioles?allows?blood? flow?and?nutrient?
exchange? to? be? regulated? at? several? levels.? Total? skeletal? muscle? blood? flow? can?
increase?with?rising?arterial?pressure?and?maintained?muscle?resistance?artery?tone?or?
by?vasodilation?of?resistance?arterioles?with?maintained?pressure.?Terminal?arterioles?
can? increase? the? endothelial? surface? area? by? increasing? the? fraction? of? perfused?
capillaries?through?vasodilation?and?SMC?driven?vasomotion,?thus?enhancing?nutrient?
exchange.?
Muscle?perfusion?and?nutrient?flux?with?exercise?and?insulin?
Perfusion? delivers? oxygen,? free? fatty? acids? (FFA),? glucose,? triglycerides,? and? amino?
acids? to? and? removes? metabolites? (amino? acids,? lactate,? carbon? dioxide,? and?
ammonia)? from? muscle.?Muscle? is? a? major? site? of? carbohydrate,? protein,? and? fat?
storage?during?feeding?and?a?major?supplier?of?nutrients?during?periods?of?deprivation.?
The?regulation?of?fuel?fluxes?in?and?out?of?muscle?has?been?studied?intensely?in?vivo?in?
animals?and?humans?using?the?limb?balance?method,?which?is?at?times?supplemented?
with? metabolite? tracer? measurements.? Here,? we? will? consider? the? relationship?
between?muscle?blood?flow?and?nutrient?supply?to?muscle?in?response?to?exercise?or?
insulin? stimulation,? which? has? been? studied? intensively.? In? particular,? we? will?
emphasize?data? from? in? vivo? studies? in?humans.?We?will? consider?both? intense?and?
very? modest? stimulation? to? provide? the? reader? with? a? sense? of? the? hierarchical?
relationship?between?muscle?perfusion?and?metabolic?function.?
?
Total? limb? flow? can? be? assessed? in? different? ways? (e.g.,? plethysmography,? dye? or?
thermal?dilution,? and?Doppler?ultrasound).?The? advantages? and? limitations?of? these?
methods? have? been? reviewed? elsewhere.10? Although? flow? measurement? methods?
have? been? compared? with? one? another,? none? can? be? considered? to? be? the? gold?
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standard? to?measure? skeletal?muscle?blood? flow.10?12?Of?note? is? that?each?measures?
blood? flow? directed? to? all? tissues? of? the? limb,? not? just?muscle.? In? overnight?fasted?
humans,?resting? limb?blood?flow?averages?~2–5?ml?min?1?100?ml?1?of? limb13?15? in?both?
men?and?women,16?using?the?arm?or? leg.17?19?Because?resting?skin?and?subcutaneous?
adipose?blood?flow?(on?a?per?100?ml?of?tissue?basis)?are?similar?to?that?of?muscle,20?22?
these?resting? limb? flow?values?are?assumed?to?reflect?average?blood? flow?to?muscle,?
i.e.,?the?methods?treat?the?limb?as?a?homogenous?tissue?represented?by?muscle.?
?
Vasomotion,?the?rhythmic?vessel?diameter?oscillations?first?described?by?Jones23?in?the?
bat?wing? in?1852,? is?more?prevalent? in? small?arteries?and?arterioles? than? in? conduit?
arteries.24?These?oscillations?modify?blood? flow?and?are?one?contribution? to?periodic?
flow? fluctuations? known? as? flowmotion.24,25? In? addition? to? vasomotion,? heart? rate,?
respiration,?and?autonomic?factors? influence?flowmotion.?The?several?components?of?
flowmotion? are? distinguished? by? their? frequencies;? heart? rate? and? respiratory?
contributions? arise? at? 1? and? 0.3? Hz,? respectively,? whereas? low?frequency? signals?
associated? with? vasomotion? arise? at? 0.1? Hz? for? myogenic? activity,? 0.04? Hz? for?
neurogenic?activity,?and?0.01?Hz?for?endothelial?activity.26?28?
?
Vasomotion?originates? from?an?oscillator?component? in? the?SMCs?and?synchronizing?
mechanisms,?which?are?modified?by?ECs.24?Upon? increased?metabolic?needs,? signals?
originating? from? the? microvasculature? travel? upstream? to? larger? arterioles? and?
arteries,?possibly?via?gap?junctions?in?the?SMCs,29?thereby?influencing?vessel?diameter.?
In? addition,? vasomotor? responses? in? arterioles? can? be? triggered? by? stimulation? of?
individual?capillaries,?and?changes?in?membrane?potential?appear?to?be?responsible?for?
these? observations.29?31? Moreover,? NO? can? regulate? EC?to?SMC? signaling? at?
myoendothelial? junctions,? and? reduced? NO? production? attenuates? the? duration? of?
conducted? vasodilation.29,32? These? findings? suggest? that? muscle? microcirculation?
modulates?upstream?vasodilation?and?vasomotion.?
?
In?vivo,?vasomotion?may?regulate?microvascular?flow?distribution?to?optimize?delivery?
of?nutrients?and?regulate? local?hydraulic?resistance.33? In?addition?to?regulating?blood?
flow? distribution,? vasomotion? of? terminal? arterioles? also? affects? lymph? flow,? thus?
influencing? water? transport? in? muscle? interstitium? and? tissue? homeostasis.6?
Vasomotion,?by?continuously?altering?flow?delivery?to?vessels?over?time,?increases?the?
number?of?ECs?exposed?to?plasma?for?nutrient?or?hormone?exchange34?without?total?
flow?or?cardiac?output?being?changed.?When?perfusion?demand?exceeds?flowmotion’s?
compensatory?capacity,?blood?flow?control?shifts?upstream,?enabling?increases?in?total?
flow.24,35?
?
Studying?muscle?vasomotion? requires? invasive?direct?blood?vessel?visualization? (e.g.,?
intravital? microscopy),36?39? and? it? is? affected? by? anesthetic? agents? and? a? host? of?
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experimental?variables.37?Its?invasive?nature?limits?the?study?of?vasomotion?in?humans.?
By? contrast,? cutaneous? flowmotion? can? be? studied? using? laser?Doppler? flowmetry?
(LDF)?and?has?become?popular?in?clinical?studies.40?43?To?quantify?flowmotion,?Fourier?
or?wavelet?analyses?methods?are?used?to?determine?the?relative?contribution?of?each?
frequency?to?the?observed?LDF?signal.26,37,42?A?drawback?of?LDF?measurements?is?that?
they?are?affected?by?nearby?vessels?and?blood?pressure? fluctuations,?and? therefore,?
they? may? not? necessarily? reflect? only? the? rhythmic? activities? of? blood? vessels?
themselves.24,44,45? Several? disorders? influence? vasomotion? and? flowmotion;?
hemorrhage?increases?vasomotion,?whereas?obesity?and?diabetes?reduce?flowmotion?
and? vasomotion.24,42? Taken? together,? vasomotion? provides? a? local? mechanism? for?
vascular? adaptation? to? altered?metabolic? needs,? and? its? regulation? impacts?muscle?
perfusion.?
Exercise?and?muscle?perfusion?
Myocyte?and?related?whole?body?metabolic?changes?with?acute?and?chronic?exercise?
were? reviewed? recently.46? Oxygen? and? nutrient? delivery? to?muscle? during? intense?
exercise? and? the? accompanying?blood? flow? changes?have?been? studied? extensively.?
The? increased? bulk? blood? flow? during? exercise? arises? both? from? local? factors? [e.g.,?
potassium,? adenosine,? phosphate,? lactate,? hydrogen? ion,? nitric? oxide? (NO),? and?
prostaglandins]? released? by? the? muscle? and? by? neurovascular? changes? that? relax?
muscle?vasculature.?With?very? intense?whole?body?exercise,?blood? flow?and?oxygen?
delivery? to? the? tissue? become? limiting? secondary? to? limitations? of? respiratory? and?
cardiac? function.47,48? By? contrast,? with? intense? exercise? of? isolated?muscle? groups,?
neither? cardiorespiratory? function? nor? hemodynamic? factors? limit? muscle?
performance.?Thus,?blood?flow?to?the?human?quadriceps?can?increase?>50?fold?during?
brief,? intense? exercise.47? Increasing? the? arterial? oxygen? content? does? not? further?
increase?quadriceps?O2?extraction?or?peak?work? rate?by?either? trained?or?untrained?
muscle.49? Muscle’s? remarkable? flow? reserve? can? meet? even? extreme? muscle? O2?
demands.? In?addition? to?oxygen,? glucose? and? fatty? acids?are? important? fuels?during?
exercise.? Carbohydrates? (both? circulating? glucose? and? muscle? glycogen)? are? the?
preferred? fuel? for? intense,? brief?duration? muscle? exercise.? With? intense? muscle?
exercise,?glucose?extraction?can?increase?more?than?sixfold?and?leg?blood?flow?10?fold,?
whereas? plasma? glucose? changes? little.50? Interestingly,? whereas? glucose?
concentrations? in? resting? muscle? cytosol? are? extremely? low,? intense? exercise?
dramatically?increases?glucose?both?in?muscle?interstitium51?and?within?muscle?cells?in?
humans50? and? rodents.52? The? >? 30?fold? increase? in? leg? glucose? uptake? seen? with?
intense? exercise? indicates? that? both? the? delivery? of? glucose? to? muscle?
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microvasculature?and?transcapillary?glucose?transfer?have?capacity?sufficient?to?meet?
glucose?metabolic?needs.?
?
Vascular?responses?to?light?exercise?(operationally,?we?consider???25%?max?as?“light”)?
have? been? studied?much? less,? and? their? link? to?muscle? performance? is? less? clear.?
However,? studies?of? light?exercise?provide? insight? into? the?hierarchical? regulation?of?
muscle? perfusion.? With? light? exercise,? vasomotion? within? the? terminal? arterioles?
appears?to?cease,?and?the?number?of?perfused?capillary? increases?without?significant?
changes? in? total? muscle? blood? flow.34,53,54? Honig? et? al.,34? by? flash?freezing? and?
sectioning?muscle,? showed? that? low?frequency? electrical? stimulation?was? nearly? as?
effective?as?near?tetanic?stimulation? for?recruiting?hypoperfused?microvasculature? in?
canine? gracilis?muscle.? Further? increasing? contractile? activity? increases? total? blood?
flow,?as?regulation?shifts?upstream?to?progressively?larger?arterioles.35?Factors?driving?
microvascular?perfusion?changes?include?venous?PO2,?which,?by?enhancing?venular?EC?
NO? production? and? erythrocyte? NO? release,35,55?57? promotes? dilation? of? nearby?
arterioles.? Hemodynamic? forces,? i.e.,? shear? stress?induced? NO? production,? further?
modulate? hyperemic? responses.35? These? are? aided? by? prostaglandins? and?
endothelium?derived?hyperpolarizing? factors? to? increase?perfusion?with?exercise.48? It?
appears?that?inhibition?of?one?system?(e.g.,?NO?synthase)?can?be?compensated?by?the?
remaining? factors,? since? skeletal? muscle? blood? flow? is? preserved? in? such?
circumstances.58?If,?however,?two?pathways?are?inhibited?simultaneously,?the?increase?
in?skeletal?muscle?blood?flow?is?reduced.48,59?These?effectors?act?as?sympatholytics?to?
counteract?the?exercise?induced?vasoconstriction?of?distal?arterioles?and?feed?arteries?
by?sympathetic?nerves.48?
Insulin?and?muscle?perfusion??
The?effects?of? insulin?on? limb?metabolism?have?been? studied?extensively?using? limb?
balance? methods? combined? with? euglycemic? insulin? infusion.? Andres? et? al.60? first?
reported? insulin?stimulated? forearm? glucose? uptake? and? noted? an? accompanying?
increase?in?forearm?blood?flow.?Baron61?and?Laakso?et?al.62?first?reported?that?insulin?
induced?muscle?glucose?uptake?paralleled? insulin’s?ability? to? increase? total? leg?blood?
flow.?In?subsequent?work,?obesity,?type?1?and?type?2?diabetes,?and? increased?plasma?
free? fatty? acid? concentrations62?65? each? impaired? insulin?stimulated? limb? blood? flow?
and?glucose?uptake?in?parallel.?These?studies?suggested?that?1)?insulin?stimulates?limb?
blood?flow?in?both?humans?and?animals;?2)?during?a?high?dose?insulin?clamp,?increased?
limb? flow? correlates? with?muscle? glucose? uptake;? 3)? acute? and? chronic?metabolic?
insulin? resistance? is? associated? with? impaired? insulin?stimulated? increases? of? limb?
blood? flow;? and? 4)? insulin? enhances? limb? blood? flow? by? increasing? nitric? oxide?
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production.62,65?67?This? led? investigators?to?suggest?that? impaired?arteriolar?relaxation?
in? response? to? insulin? contributes? significantly? to?metabolic? dysfunction? in? insulin?
resistant?muscle.?
?
Insulin’s?vasodilatory?effects?arise?from?its?binding?to?the?insulin?receptor?on?ECs.?This?
stimulates? the?phosphatidylinositol?3?kinase/Akt?pathway? to?activate?endothelial?NO?
synthase? (eNOS)68,69?and? induces?NO?mediated?vasodilation.70? Insulin?also?stimulates?
the? MAPK? pathway? and? enhances? production? of? the? vasoconstrictor? endothelin?
1.66,67,71? In? health,? insulin’s? vasodilatory? effect? dominates.? With? endothelial?
dysfunction,?as?occurs?with?obesity?and?type?2?diabetes,?the?PI3K?pathway?appears?to?
be?selectively?inhibited?by?low?grade?inflammation,?FFA,?oxidative?stress,?and?reduced?
perivascular?adiponectin? release.72?76? In? these? circumstances,?a? reduced?vasodilatory?
response?or?even?paradoxical?vasoconstriction?can?be?seen?with?hyperinsulinemia.72,77?
?
Insulin?at?high?physiological?concentrations?relaxes?resistance?arterioles?and?increases?
limb?blood?flow?in?humans.?In?addition,?there?is?convincing?evidence?that?this?response?
is? blunted? in? insulin?resistant? individuals? with? obesity78? and? type? 179? or? type? 2?
diabetes.80?This?effect?of?insulin?on?blood?flow?is?most?evident?when?insulin?is?infused?
continuously? at? a? rate? of? 3? mU?kg?1?min?1? to? achieve? marked? steady?state?
hyperinsulinemia?for???2?h.?It?has?been?more?difficult?to?reproduce?this?effect?infusing?
insulin? at? a? lower? rate?or? for? shorter?duration.81? This?has? led? to?questioning?of? the?
physiological? importance? of? this? response.? In? addition,? in? insulin?resistant? subjects,?
pharmacologically? increasing?blood? flow?often?does?not? improve? insulin’s?metabolic?
action?measured? as? limb? glucose? uptake.82? However,? in? the? latter? circumstance,? it?
remains? likely? that? while? perfusion? is? improved? insulin? resistance? in? the? myocyte?
persists,? and? short?term? correction? of? perfusion? is? insufficient? to? overcome? that?
metabolic?defect.?
?
Over? the? last?15? years,? research?on? insulin’s? action?on?muscle?perfusion?has? added?
focus? on? the? microvasculature.? There,? analogous? to? the? effect? of? low?frequency?
stimulation?reported?by?Honig?et?al.,34,53?relaxation?of?terminal?arterioles?could?recruit?
hypoperfused?capillaries?and?expand?the?EC?surface?available?for?nutrient?exchange83?
without?changing?total?flow.?However,?there?were?no?noninvasive?methods?available?
to?quantify?the?microvascular?volume?perfused?in?intact?muscle?in?animals?or?humans.?
In?1997,?a?technique?was?introduced?to?estimate?the?endothelial?surface?available?for?
nutrient?exchange?based?on?the?single?pass?conversion?of?1?methylxanthine?(1?MX)?to?
1?methylurate?(1?MU)?by?xanthine?oxidase,?which?is?present?on?capillary?endothelium.?
Increased? endothelial? exposure? to? substrate? (i.e.,? capillary? recruitment)? would?
increase? 1?MX? to? 1?MU? conversion.84,85? Later,? contrast?enhanced?ultrasound? (CEUS)?
was?used? to? investigate?microvascular?perfused? volume? regulation.86,87?Using? either?
method,?we?found?that?in?healthy?animals?and?humans,?physiological?doses?of?insulin?
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and? carbohydrate?containing?meals? each? increased?microvascular? perfusion? volume?
even?in?the?absence?of?increases?in?total?limb?blood?flow.77,86,88?Using?CEUS,?we?found?
that,? from? the? start? of? an? euglycemic? insulin? clamp,? microvascular? blood? volume?
increases?within?15?–?30?min,?and?this?microvascular?change?precedes?and?correlates?
with?the?rise? in?forearm?glucose?uptake.89?91?Moreover,?chronic? (obesity)?and?acutely?
induced? (lipid? infusion)? insulin? resistance? are? associated? with? an? impaired?
microvascular? response? to? insulin? or?meal? ingestion.77,92?94?Using? CEUS,54,88?we? also?
confirmed? the? original? finding? by? Honig? et? al.53? that? light? exercise? increased?
microvascular?perfused?volume?~3?fold?with?minimal?increases?in?total?limb?blood?flow?
(Figure?2.2).?However,?with?more? intense?exercise,?both?microvascular?blood?volume?
and? total? limb? blood? flow? increase.54,88,95? Interestingly,? cardiac? muscle? behaves?
similarly?to?skeletal?muscle?during?hyperinsulinemia96?and?feeding,97?and?its?increases?
in?microvascular?blood?volume?are?blunted?by?insulin?resistance?as?well.98?
?
?
?
?
?
?
?
?
?
?
?
?
?
?
?
?
?
?
Figure?2.2.?Top:?contrast?enhanced?ultrasound?images?of?rat?thigh?muscle?as?a?function?of?time?after?a?high?
energy? ultrasound? pulse?with? the?muscle? at? rest? or? given? a? 1?Hz? electrical? stimulation.?Bottom:? greater?
plateau?video?intensity?(red)?corresponding?to?a?larger?number?of?microbubbles?in?the?imaged?volume?of?the?
stimulated?muscle.?
?
?
Insulin? is? not? the? only? hormone? that? can? “recruit”?muscle?microvasculature.? Both?
glucagon?like? peptide?1? (GLP?1)99,100? and? adiponectin,101? like? insulin,? increase?
microvascular? volume,? albeit? each? acting? by? different? biochemical? pathways.? By?
contrast,? epinephrine? can? increase?muscle? blood? flow?without? increasing? perfused?
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microvascular? volume.102? The? responses? to? physiological? hyperinsulinemia? and? low?
intensity? exercise? suggest? a? hierarchical? response? by? muscle? vasculature? whereby?
microvascular?units?respond?to?these?stimuli,?whereas?with?more? intense?stimulation?
(high? physiological? insulin? concentrations?or? heavy? exercise)?more? proximal? arterial?
elements?also?respond,?leading?to?the?flow?increases?seen?in?those?settings.?Whether?
this? graded? response? involves? antidromic? signals? through? the? vascular? network? or?
again?is?a?response?to?multiple?locally?generated?metabolic?signals?is?not?known.?
Nutrient?and?hormone?transfer?across?the?endothelium?
Here?we?very?briefly?review?evolving?evidence?that?the?vascular?endothelium?in?tissues?
like?muscle?and?adipose?may?actively?mediate?the?transendothelial?transport?(TET)?of?
substrates? (e.g.,? glucose? or? FFA)? and? hormones,? including? insulin.? As? would? be?
expected,?such?a?role?for?the?endothelium?is?of?consequence?principally?in?tissues?with?
a?continuous?endothelium,?like?muscle?and?adipose,?but?less?consequential?in?liver?and?
other?splanchnic?tissues.103??
?
We?consider?first?the?endothelium’s?role?in?FFA?transport,?as?FFAs?are?a?major?muscle?
fuel.? It? has? long? been? known? that? lipoprotein? lipase? (LPL)? is? secreted? by? skeletal?
myocytes? and? adipocytes? but? resides? on? the? luminal? surface? of? the? vascular? EC? in?
muscle? and? fat,?where? it? cleaves? fatty? acid?monomers? from? triglycerides? bound? to?
circulating? lipoproteins.104?This?process? can?be? regulated?by? insulin,?which? increases?
LPL? expression.? Recently,? it? was? found? that? the? EC? possesses? a? receptor? for? LPL?
[glycosylphosphotidylinositol?anchored? high?density? lipoprotein? binding? protein?1?
(GPIHBP1)]105? and? that? when? LPL? binds? to? GPIHBP1? a? vesicular? transport? system?
mediates? LPL’s? TET? to? the? luminal? membrane,? where? it? encounters? circulating?
triglycerides.106?Mutations? in?either?GPIHBP1?or?LPL? that? interfere?with? this?pathway?
can?cause?severe?hypertriglyceridemia?in?humans.107?
?
In?addition? to? this?pathway? for?LPL? transport? that?provides? triglyceride?derived? fatty?
acids?to?the?EC,?the?EC?possesses?membrane?associated?fatty?acid?transport?proteins?
(FATPs)?as?well?as?fatty?acid?binding?proteins?(FABPs).?The?former?take?up?FFA?derived?
either? from? triglyceride? hydrolysis? or? circulating? as? FFA? associated?with? albumin? or?
other? plasma? proteins.? FATP3? and? FATP4? are? expressed? by? ECs? along? with? the?
scavenger? receptor? CD36.? Each? appears? to? be? involved? in?movement? of? fatty? acids?
across? the? EC? luminal? plasma?membrane.? Expression? of? both? FATP3? and? FATP4? is?
increased?by?VEGF??secreted?by?myocytes?and?adipocytes?acting?via?VEGFR1.?Muscle?
expression?of?VEGF??is?increased?by?the?transcriptional?coactivator?PGC?1?,?which?is?a?
central? player? in? the? regulation? of?mitochondrial? oxidative?metabolism? within? the?
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myocyte.? In? the?context?of? increasing?muscle?oxidative?capacity,?muscle? signaling? to?
adjacent?ECs?to?enhance?FFA?uptake?may?be?part?of?an?adaptive?response.?Expression?
of?CD36?by?ECs?is?upregulated?by?peroxisome?proliferator?activated?receptor??,?which?
enhances? fat?mass? and? adipogenesis.? Interestingly,? inhibition? of? VEGF?? in? diabetic?
animal?models?decreases?muscle?ectopic?fat?and? improves?glucose?metabolism.108?By?
contrast,?VEGFA?knockout? in?muscle? increases?susceptibility? to?high?fat?diet? induced?
insulin? resistance,? which? is? due? at? least? in? part? to? decreased? microvascular?
perfusion.109? The? transport? of? FFA? across? the? ECs? is? presumably? bidirectional,?
particularly?in?adipose?tissue,?although?this?has?not?been?clarified?in?detail.?
?
In?contrast?to?the?complex?regulatory?system?involved?in?the?movement?of?FFA?across?
the?EC,?glucose?transport?from?the?vascular?lumen?into?and?across?the?endothelium?is?
mediated?by?the?constitutive?activity?of?the?GLUT1?transporter.?The?system?has?a?high?
capacity?in?the?absence?of?exogenous?insulin,?as?indicated?by?the?marked?increases?in?
glucose? transport? that? occur? with? exercise? (see? above).? The? GLUT1? transporter? is?
expressed? in?both? vascular? smooth?muscle?and?endothelial? cells.? In? the? former,? the?
transporter?activity?is?downregulated?by?high?ambient?glucose?concentrations.110?This?
adaptive?response?is?absent?in?aortic?ECs.?The?function?of?this?transporter?is?important?
to?the?metabolic?activity?of?the?EC,?which?receives?a?significant?fraction?of? its?energy?
from? glycolytic? ATP? production.111? The? specific? transport? capacity? in? brain?
microvascular?ECs?has?been?studied?extensively,?as?ECs?perform?a?critical? function? in?
assuring? adequate? glucose? delivery? to? the? central? nervous? system.? Cardiac?muscle?
microvascular?glucose?transport?capacity?has?been? investigated?and?utilizes?the?same?
high?capacity?GLUT1?transporter?reported?for?other?endothelia.111?To?our?knowledge,?
GLUT1?transporter?function?specific?to?skeletal?muscle?microvasculature?has?not?been?
studied.? As? noted? previously,? the? observation? that?muscle? interstitial? and?myocyte?
glucose? concentrations? rise? during? intense? exercise? suggests? that? glucose? transport?
through? the? vascular? endothelium? is? not? limiting? even? under? conditions? of? high?
substrate?demand.?Indeed,?the?high?capacity?of?the?system?may?in?part?be?responsible?
for?damage?that?occurs?to?the?microvascular?endothelium?as?a?result?of?hyperglycemia?
in? the?diabetic? state.112?The?EC?does?not?appear? to?defend? itself? from?high? levels?of?
intracellular? glucose,? which? via? several? pathways? can? generate? reactive? oxygen?
species.112,113?When? this? is?unchecked,? as?occurs? in?persistent?hyperglycemic? states,?
vascular?injury?occurs.?
?
The?EC? in?tissues?with?a?continuous?endothelium?also?constitutes?a?barrier?to? insulin?
movement? into? the? tissue.? Indeed,? estimates? of? muscle? interstitial? insulin?
concentrations? using? either? lymphatic? sampling114? or? microdialysis115? suggest? that?
insulin?TET?could?be?rate?limiting?for?insulin’s?action?on?muscle.?This?led?us?to?examine?
the? cellular? pathway? of? insulin? TET.? Most? ECs? express? insulin,? IGF?I,? and? the?
insulin/IGF?I?hybrid?receptor.116?In?aortic?ECs?and?preadipocytes,117?the?insulin?receptor?
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associates? with? a? specialized? lipid? raft? domain,? i.e.,? caveolae.? Caveolae? can? be?
internalized? and?mediate? TET? of? a? variety? of? proteins? (e.g.,? albumin? in? pulmonary?
microvascular?ECs).118?In?a?series?of?experiments,?we?found?that?caveolae?are?required?
for?insulin?uptake?by?and?transport?across?aortic?ECs.119?In?these?ECs,?preserved?insulin?
signaling? through? phosphatidylinositol? 3?kinase? to? Akt? and? eNOS? is? necessary? for?
insulin? TET.120? Interestingly,? inflammatory? cytokines? or? several? days? of?high?fat? diet?
diminish? EC? insulin? transport.120? If?muscle?microvascular? ECs? behave? similarly,? then?
impaired?EC?insulin?signaling?and?TET?could?contribute?to?the?impaired?muscle?insulin?
action?of?insulin?resistance.?As?we?had?seen?for?microvascular?recruitment,?for?insulin?
TET,?NO?appears?to?be?a?critical?regulatory?factor.?When?phosphatidylinositol?3?kinase?
or?NO? synthase? is? inhibited,? insulin? transport? declines.?Giving? sodium? nitroprusside?
(3?30??M)?can?restore?insulin?uptake121?in?aortic?ECs.?Surprisingly,?an?EC?specific?insulin?
receptor?knockout?mouse?(with?Cre?recombinase?driven?by?Tie?2)?did?not?display?any?
metabolic?phenotype.122?However,?more?recently,?another?EC?specific?insulin?receptor?
knockout?(with?Cre?recombinase?driven?by?a?vascular?endothelial?cadherin?promoter)?
displayed? glucose? intolerance? and? delayed? insulin? action? on? insulin? target? tissues?
(Konishi? M,? Sakaguchi? M,? Cai? W,? Rask?Madsen? C,? and? Kahn? CR,? unpublished?
observations).? Likewise,? the? EC?specific? IRS?2? knockout?mouse? is? glucose? intolerant?
and? has? impaired? insulin?induced? microvascular? perfusion? and? diminished? muscle?
insulin?delivery.123?These?genetic?models?underscore?the?role?of?EC?insulin?signaling?to?
whole?body?metabolic?functioning.?
?
Recent?work?using?adipose?microvascular?ECs?has?suggested?a?similar?vesicle?mediated?
insulin? TET? process,? and? initial? studies? implicate? clathrin?coated? vesicles,? not?
caveolae.124?However,?there? is?a? lack?of?data?clarifying?whether? insulin?regulates?that?
transport?or?whether?a? transendothelial? insulin? concentration?gradient? is?present? in?
adipose?tissue?and?whether?insulin?TET?limits?insulin?action?in?adipose?tissue.125?
Conclusion?
In? summary,? a? hierarchical,? graded? control? of? muscle? perfusion? arises? from?
cooperative?interactions?among?the?factors?released?locally?by?myocytes,?by?SMCs,?or?
by?ECs?along?with?systemically?and?neurally?delivered?signals.?Very?modest?contractile?
activity?or?physiological?hyperinsulinemia?promptly?increases?microvascular?perfusion?
volume?even?in?the?absence?of?changes?in?limb?blood?flow.?In?both?cases,?EC?exchange?
surface?for?nutrient?or?hormone?delivery?expands?without?requiring?increased?cardiac?
work.?Greater?contractile?activity?or?hyperinsulinemia?triggers?signals?that?may?ascend?
the?vascular?network?and?provoke?relaxation?of?progressively?larger?vessels,?increasing?
total?flow?to?the?expanded?microvascular?network.?Beyond?insulin?and?exercise,?other?
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humoral?factors?(e.g.,?GLP?1,?angiotensin?II,?and?adiponectin)?similarly?enhance?muscle?
microvascular? perfusion.? However,? the? role? of? these? factors? in? normal? muscle?
physiology?is?still?being?unraveled.?Evolving?evidence?indicates?that?(at?least?for?insulin?
and? triglycerides/FFA),? beyond? altered? perfusion,? the?microvasculature,? particularly?
the?EC,?actively?regulates?the?delivery?of?insulin?and?FFA?to?the?muscle?via?regulation?
of? specialized? transport? mechanisms.? Thus,? the? EC? of? muscle? vasculature? is?
increasingly?recognized?as?a?key?regulator?of?normal?muscle?physiology?and?metabolic?
health.?Much?remains?to?be?learned?regarding?the?normal?regulation?of?the?integrated?
functioning? of? the? skeletal? muscle? myocytes? and? its? vasculature? and? how? this?
regulation?is?altered?by?disease?or?dysfunction.?
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Appendix?2.1?
Capillary?recruitment:?lessons?from?skin?microvasculature?
Yvo?H.A.M.?Kusters,?Coen?D.A.?Stehouwer?
Crosstalk?Series:?De?novo? capillary? recruitment? in?healthy?muscle? is/is?
not?necessary?to?explain?physiological?outcomes?
J?Physiol?2015.?
?
?
In? this? crosstalk? both? discussants? raise? important? issues? regarding? current?
methodological? limitations?while? assessing? the? concept?of? capillary? recruitment.?On?
the? one? hand,? contrast?enhanced? ultrasound? is? unable? to? visualize? individual?
capillaries,1?whereas? intravital?microscopy? in? surgically? prepared? skeletal? ?muscle? is?
likely?to?disturb?baseline?observations.2?Because?of?these?limitations,?it?is?not?possible?
to?disprove?either?one?of?the?models.?
?
We?do,?however,?believe?that?earlier?observations? in?skin?can?add?to?this?discussion.?
Although? skin?as?a?model? for?muscle?also?has? limitations,? the?human?data?with? skin?
videomicroscopy?show? that? insulin?can? in? fact?cause?capillary?recruitment? in?at? least?
one?organ?system.?Our?skin?data?show?that?the?cutaneous?microvascular?response?to?
insulin? (i.e.?capillary?recruitment)?behaves,?and?can?be?manipulated,? in?a?way?that? is?
entirely? consistent? with? the? model? described? by? Dr.? Barrett? et? al.,? in? which?
microcirculation? and? muscle? behave? as? a? functional? unit? with? respect? to? insulin?
sensitivity?and?muscle?glucose?uptake.1?5??
?
Hence,? we? do? not? concur? with? Dr.? Poole? that? the? Kroghian? model? of? capillary?
recruitment? can? be? dismissed.? Yet,? progress? with? regard? to? the? validity? of? these?
models?requires?that?the?methodological?issues?discussed?above?be?resolved.??
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Abstract?
Background?
The? measurement? of? variables? is? a? vital? part? of? clinical? practice? and? biomedical?
research.? However,? the? reliability? of? measurements? is? frequently? misused,?
incompletely? considered,? or? not? at? all? assessed? in? biomedical? research.? We?
investigated? the? reliability,?which? relates? the? random?error?variance? to? the?variance?
among? subjects? in? a? population,? and?measurement? error,? which? is? related? to? the?
concept? agreement,?of? several? commonly?used? anthropometric,? vascular,?metabolic?
and?inflammatory?variables.?
?
Methods?
We?evaluated?visceral?(VAT)?and?subcutaneous?adipose?tissue?(SAT),?intrahepatic?(IHL)?
and? intrapancreatic? lipid? (IPL),? muscle? microvascular? recruitment? (MVR),? capillary?
microscopy? (CM),? flowmotion,? sublingual? microvascular? glycocalyx,? flow?mediated?
dilation? (FMD),? reactive?hyperemia? index? (RHI),? carotid?femoral?pulse?wave? velocity?
(cfPWV),?augmentation?index?(Aix),?carotid?distensibility,?distensibility?coefficient?(DC),?
compliance?coefficient?(CC)?and?intima?media?thickness?of?the?common?carotid?artery?
(cIMT),?whole?body?glucose?disposal?(WBGD),?beta?cell?glucose?sensitivity?(b?GS),?beta?
cell?rate?sensitivity?(b?RS),?potentiation?factor?ratio?(PFR),?CD11B?surface?expression?of?
circulating? NK? cells? (NK?CD11B),? and? a? z?score? of? plasma? biomarkers? of? low?grade?
inflammation? (z?LGI).?We?evaluated? reliability?and?measurement?error? for? intra??and?
inter?observer? comparisons? as? well? as? over? time? for? the? execution? of? the?
measurements.? Similar? comparisons? were? made? for? the? analyses? of? the?
measurements.?When? available,?measurements? were? also? compared? to? their? gold?
standard.?
?
Results?
Most?measurements?were?highly?reliable?and?had?acceptable?measurement?error,?yet?
sublingual? microvascular? glycocalyx? and? some? indices? derived? from? CM? and?
flowmotion?were?not?reliable?and?had?a?considerable?measurement?error.?Analyses?of?
all?measurements?was?reliable?and?had?acceptable?measurement?error.?VAT,?SAT?and?
IHL?were?compared?to?their?gold?standard?and?considered?valid.??
?
Conclusion?
Here,? we? established? the? reliability? and? measurement? error? of? commonly? used?
anthropometric,? vascular,? metabolic? and? inflammatory? variables.? This? detailed?
understanding?of? sources?of?measurement?error?and? the? reliability?of? variables? in?a?
certain?study?population?allows?for?the?adequate?selection?of?outcome?measurements?
in?observational?and? intervention?studies,?as?well?as?provide?data? for?more?accurate?
sample?size?calculations?for?such?studies.?
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Introduction?
The? measurement? of? variables? is? a? vital? part? of? clinical? practice? and? biomedical?
research.?Measurements?are,?however,?seldom?perfect.1?To?assess?the?quality?of?the?
measurement?of?a?variable,?the?COSMIN?statement?is?generally?used;?it?defines?a?good?
measurement?as?reliable,?responsive,?valid,?and? interpretable? (Supplementary?Figure?
3.1).2?However,? the? reliability?of?measurements? is? frequently?misused,? incompletely?
considered,? or? not? at? all? assessed? in? biomedical? research.3,4? Nonetheless,? an?
appropriate?assessment?and? interpretation?of?reliability? is?essential? for?correct?study?
designs?and?power?calculations,?as?well?as?to?develop?strategies?to?improve?reliability?
in?the?measurement?of?variables.??
?
Potentially?confusingly,?the?domain?reliability?in?the?COSMIN?taxonomy?is?divided?into?
the?measurement?properties?measurement?error?and,?again,?reliability?(also?known?as?
reproducibility,? repeatability,? or? test?retest? performance;? Supplementary? Figure?
3.1).1,2?It?is?important?to?understand?the?difference?between?measurement?error?and?
reliability.?Parameters?of?measurement? error? relate? to? the? concept? agreement,? i.e.,?
the?absolute?difference?between?repeated?measurements.?Two?commonly?reported,?
and? related,? parameters? of? measurement? error? are? the? standard? error? of? the?
measurement? (SEM)? and? the? limits? of? agreement? (Bland? and?Altman?method).? The?
SEM?can?be?interpreted?as?the?standard?deviation?around?a?single?measurement?(e.g.,?
when? waist? circumference? is? assessed? 100? consecutive? times,? the? SD? of? these?
measurements?equals?the?SEM).1?A?different?parameter?of?measurement?error?are?the?
limits? of? agreement.5? In? Bland?Altman? plots,? the? difference? between? repeated?
measurements?is?plotted?against?the?average?of?those?measurements.?This?allows?for?
the?visualization?of?systematic?differences,?as?well?as?the? limits?of?agreement.? If?one?
assumes?a?normal?distribution?of?difference?scores,?95%?of?the?difference?scores?will?
fall?between?the?limits?of?agreement.1,5?
?
Reliability?parameters?on?the?other?hand,?like?intraclass?correlation?coefficients?(ICC),?
which? range? in? value? from? 0? (totally?unreliable)? to? 1? (perfect? reliability),? relate? the?
random? error? variance? to? the? variance? among? subjects? in? a? population.1,6,7?
Consequently,? a?parameter?of? reliability? is? in? fact?only? valid? for? the?population? it? is?
measured?in?and?the?observers?it?is?measured?by.?If,?for?example,?reliability?were?to?be?
determined? in? a? population? where? variance? between? subjects? is? very? high? (e.g.,?
determining? insulin? sensitivity? in? a? population?with? trained? athletes? and? individuals?
with?type?2?diabetes?are?included),?reliability?is?generally?high.?When?this?reliability?is?
then? assumed? for? the?measurement? itself,? regardless?of? the?population? (e.g.,?when?
studying? only? obese? individuals? without? type? 2? diabetes),? the? reliability? of? that?
measurement?is?grossly?overestimated.??
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Although? the? COSMIN? Statement? was? primarily? designed? for? patient? reported?
outcomes,2?most?of? its?criteria?can?be?applied?to?observer?derived?measurements?as?
well.? As? observers? are? then,? possibly,? involved? twice? in? the? process,? i.e.,? the?
conduction? of? the?measurement? as?well? as? the? (offline)? analyses? of? the? data,? the?
measured?variable?can?entail?measurement?error?derived?from?both.?
?
In? this? thesis,?a?multitude?of?anthropometric,?vascular,?metabolic?and? inflammatory??
measurements? have? been? used.? Nevertheless,? the? reliability? of? some,? like?muscle?
microvascular?recruitment?(MVR)?by?means?of?contrast?enhanced?ultrasound?(CEUS),?
has?never?been?reported?at?all.?Other?measurements,?like?nailfold?capillary?microscopy?
for?example,?are?known?for?their?relatively?high? inter?observer?variance.8?As?a?result,?
researchers?are?commonly?subjected?to?an?extensive?training?program?before?they?are?
deemed?capable?to?perform?or?analyze?such?measurements.?Moreover,?it?is?important?
to? identify?where? sources?of? error? arise,? as? strategies? to? improve? a?measurement’s?
reliability?can?be?developed?and?deployed?from?this?insight.??
?
It? is,? therefore,? important? to? 1)? determine? whether? measurement? error? arises?
predominantly?from?the?acquisition?of?data?or?its?analyses;?2)?to?assess?to?what?extent?
measurements? differ? within? one? observer,? as? well? as? between? observers;? and?
3)?determine?to?what?extent?a?measurement?varies?over?time.?To?our?knowledge,?this?
is?the?first?study?to?evaluate?the?sources?of?measurement?error?for?the?measurements?
in? this? thesis? and? provide? substantiated? recommendations? on? the? improvement? of?
reliability.??
?
We? assessed? reliability? and? measurement? error? several? ways.? First,? we? evaluated?
reliability? and? measurement? error? for? intra?? and? inter?observer? reliability? and?
reliability?over?time,?for?the?execution?of?the?measurements.?Then,?we?evaluated?the?
reliability? and? measurement? error? for? intra?? and? inter?observer? reliability? for? the?
(offline)?analyses?of?the?measurements.?Finally,?we?compared?measurements?to?their?
gold? standard,?when?available.?For?each?of? these?assessments?we?provided? the? ICC,?
SEM,?and?Bland?Altman?plot?with?limits?of?agreement.?
Materials?and?methods?
Study?designs?
In? this?manuscript?on? reliability,?data? from? several? separate? studies?are? reported? in?
order? to? provide? as? much? information? on? reliability? and? measurement? error? as?
possible?in?a?single?report.?Reliability?data?of?MVR?were?collected?in?a?dedicated?CEUS?
Reproducibility?Study?in?which?individuals?were?measured?on?two?occasions?one?week?
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apart?with? handgrip? exercises? as? stimulus? for?MVR.?On? each? study? day,? CEUS?was?
performed?twice?with?60?minutes?in?between.?CEUS?measurements?were?conducted?in?
a?temperature?controlled?room?(T?=?24°C?±?0.5°C)?after?a?12?hour?overnight?fast?and?
with? the? individuals? in? the? supine? position? for? at? least? 30? minutes? prior? to? the?
measurements.? Individuals?were? instructed?to?refrain? from?alcoholic?beverages? for?a?
period?of?72?hours?prior?to?each?study?day?and?strenuous?physical?exercise?24?hours?
prior?to?each?study?day.??
?
From? a? weight? loss? intervention? (WLI)? trial,? which? is? described? in? more? detail?
elsewhere,9,10?we?derived?data?on?1)? the? reliability?over? time?of? abdominal? visceral?
adipose? tissue? volume? (VAT),? abdominal? subcutaneous? tissue? volume? (SAT),?
intrahepatic? lipid? content? (IHL),? intrapancreatic? lipid? content? (IPL),?MVR,? sublingual?
microvascular? perfused? boundary? region? (PBR),? capillary? microscopy,? vasomotion,?
flow?mediated?dilation?(FMD),?reactive?hyperemia?index?(RHI)?and?whole?body?glucose?
disposal? (WBGD);?2)?the?reliability?of?VAT,?SAT,? IHL,? IPL,?MVR,?vasomotion,?and?FMD?
analyses;? and? 3)? the? comparison? of? VAT,? SAT? and? IHL? measurements? to? their?
respective? gold? standard.? The? data? on? reliability? over? time? was? derived? from? the?
weight?stable?control?group?that?did?not?alter?their?diet?or?exercise?pattern?for?eight?
weeks.?The?comparison?of?our?VAT,?SAT,?and?IHL?measurements?to?their?gold?standard?
were?performed?in?a?random?subsample?of?lean?and?abdominally?obese?individuals.??
?
The? reliability? data? of? carotid?femoral? pulse? wave? velocity? (cfPWV),? augmentation?
index?(AIx),?carotid?distensibility,?distensibility?coefficient?(DC)?of?the?common?carotid?
artery? (CCA),? compliance? coefficient? (CC)? of? the? CCA,? and? carotid? IMT? (cIMT)?
measurements?were? investigated? in? a? subsample? of? the?Maastricht? Study.11? In? this?
subset? of? 12? individuals,? two? investigators? performed? these? measurements?
consecutively? on? the? first? day.? One? week? later,? one? investigator? repeated? these?
measurements.? In? this? study,? participants?were? asked? to? refrain? from? smoking? and?
drinking?coffee,? tea?or?alcoholic?beverages???3?hours?prior? to? the?study.?Participants?
were?allowed?to?have?a? light?meal? (breakfast?and/or? lunch).?All?measurements?were?
performed?after?10?minutes?of?rest?and?talking?or?sleeping?was?not?allowed?during?the?
examination.12?The?reliability?of?VAT?and?SAT?analyses?were?determined? in?a?random?
subset? of? 29? participants? in? the? Maastricht? study.? Two? observers? (YK? and? an?
experienced? abdominal? radiologist? (StH))? analyzed? all? images? in? parallel? and? in? a?
masked?fashion,?unaware?of?each?other’s?analyses.?
?
The? reliability? of? capillary? microscopy? analyses? were? assessed? in? a? standardized?
training?set?of?representative?images?chosen?from?several?studies.11,13?This?training?set?
has?been?used?by?previous? and? current? researchers? in?order? to? standardize? scoring?
criteria? for? (continuously)? perfused? capillaries.? Observers? were? unaware? of? each?
other’s?analyses.?
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Data?on? the? reliability?of?FMD?measurements?have?been?published?before,14?yet?are?
included?in?this?manuscript?to?illustrate?the?difference?in?reliability?of?several?common?
vascular?function?measurements?as?well?as?their?analyses.?In?this?Acute?Hyperglycemia?
Study,?which? aimed? to? normalize? FMD? to? local?wall? shear? stress,? participants?were?
studied?on?two?separate?days?with?a?week?in?between.?On?each?study?day,?participants?
underwent?repeated?FMD?measurements?with?ten?minutes? in?between;?assessors?of?
FMD? videos?were?not?masked.? Individuals?were? instructed? to? refrain? from?exercise,?
smoking,? vitamin? supplement?use,? caffeine? consumption,? and? alcohol? consumption.?
Measurements?were?performed?after?a?12?hour?overnight?fast?in?supine?position?in?a?
climate?controlled?room.?
Study?populations?
In? the? CEUS? Reproducibility? study,? 5? women? and? 3? men? were? recruited? by?
advertisements? and? enrolled? at? the? Maastricht? University? Medical? Center,? The?
Netherlands,? from? September,? 2012? to? April,? 2013.? Participants? were? aged? 18??
?55?years,?non?smokers,?free?of?cardiovascular?disease,?and?had?a?BMI?below?25?kg/m2.?
Individuals?were? excluded?when? office? blood? pressure?was? >?140/90?mmHg,?when?
they?used?medication?affecting?blood?pressure,? serum? lipids?or?glucose?metabolism,?
when?they?were?pregnant?or?lactating,?when?they?were?allergic?to?the?contrast?agent?
used,?and/or?when?they?had?known?cardiac?dysrhythmias?or?a?family?history?of?sudden?
cardiac?death.?The?study?was?approved?by? the?Maastricht?University?Medical?Center?
ethics? committee,? performed? in? accordance? with? the? Declaration? of? Helsinki,? and?
registered? at? the? Dutch? research? database? ToetsingOnline? (NL37229.068.11).? All?
participants?gave?written?informed?consent.?
?
The?details?on?the? individuals?enrolled? in?the?randomized?controlled?weight? loss?trial?
with?blinded?analyses?are?described?elsewhere.9,10?Briefly,?53?abdominally?obese?and?
25? lean? men? were? recruited? by? advertisements? and? enrolled? at? the? Maastricht?
University?Medical?Center?in?Maastricht,?The?Netherlands,?from?August,?2012?to?May,?
2014.?Participants?were? aged?18???65? years,?non?smokers,?nondiabetic,? free?of?CVD,?
had?a?waist?circumference?below?94?cm?(lean)?or?between?102???110?cm?(abdominally?
obese),? and? a? stable?body?weight? for? at? least?3?months.?Men?were?excluded?when?
fasting?plasma?glucose?was?>?7.0?mmol/l,?when?HbA1c?was?>?6.5%,?when?serum?total?
cholesterol?was? >?8.0?mmol/l,?when? serum? triacylglycerol?was? >?4.5?mmol/l,?when?
they?had?a?contra?indication?for?magnetic?resonance?imaging?(MRI),?and/or?when?they?
used?medication? affecting? blood? pressure,? serum? lipid? or? glucose?metabolism.? The?
study?was?approved?by? the?Maastricht?University?Medical?Center?ethics? committee,?
performed? in? accordance? with? the? Declaration? of? Helsinki,? and? registered? at?
clinicaltrials.gov?(NCT01675401).?All?participants?gave?written?informed?consent.?
?
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The? rationale? and?methodology? of? the?Maastricht? Study,? as?well? as? its? population?
characteristics,? have? been? described? previously.11,12? To? reiterate? from,12? the? study?
focuses?on? the?etiology,?pathophysiology,?complications?and?comorbidities?of?T2DM?
and? is?characterized?by?an?extensive?phenotyping?approach.?Eligible?for?participation?
were?all? individuals?aged?between?40?and?75?years?and? living? in?the?southern?part?of?
the?Netherlands.?Individuals?were?recruited?through?mass?media?campaigns?and?from?
the? municipal? registries? and? the? regional? Diabetes? Patient? Registry? via? mailings.?
Recruitment?was?stratified?according?to?known?T2DM?status,?with?an?oversampling?of?
individuals? with? T2DM,? for? reasons? of? efficiency.? Clinical? characteristics? of? the?
individuals?included?in?the?Maastricht?Study?are?summarized?elsewhere.12,15?Reliability?
was? assessed? in? a? subset?of?12? individuals? (6?men;?60.8?±?6.8? years;?6? TDM2).? The?
study? is?registered?at?the?Dutch?research?database?ToetsingOnline?(NL31329.068.10),?
has?been?approved?by?the?Minister?of?Health,?Welfare?and?Sports?of?the?Netherlands,?
on? the? basis? of? the? Health? Council's? opinion? (Permit? 131088?105234?PG),? and?
performed?in?accordance?with?the?Declaration?of?Helsinki.?All?participants?gave?written?
informed?consent.?
?
As?described?previously,? the?Acute?Hyperglycemia?Study,? in?which? reliability?of?FMD?
measurements?is?already?mentioned,?consisted?of?22?men.14?All?individuals?were?non?
diabetic,? free?of? cardiovascular?disease,?and?did?not?use?any?medication.?The? study?
was? approved? by? the? Maastricht? University? Medical? Center? ethics? committee,?
performed?in?accordance?with?the?Declaration?of?Helsinki,?and?registered?at?the?Dutch?
research? database? ToetsingOnline? (NL33485.068.10).? All? participants? gave? written?
informed?consent.?
Anthropometric?measurements?
Visceral?and?subcutaneous?adipose?tissue?volumes?
In?the?WLI?trial,?VAT?and?SAT?volumes?were?obtained?by?MRI?through?two?dimensional?
(2D)?T1?weighted?turbo?spin?echo?(TSE)?imaging?on?a?3.0T?Philips?Achieva?MRI?scanner?
with? a? dedicated? sixteen?element? torso? coil? (XL? Torso? coil,? Philips? Healthcare,? The?
Netherlands)?as?described?previously.9?Nine?5?mm?thick?transverse?slices?with?10?mm?
gaps?centered?at?the?top?of?the?L4?vertebral?body?were?acquired?using?the?following?
scan?parameters:? repetition? time? (TR)?=?526?ms,?echo? time? (TE)?=?10?ms,? turbo?spin?
echo?factor?=?4,?number?of?signal?averages?(NSA)?=?1,?field?of?view?(FOV)?=?400?x?322?
mm,? acquired?matrix? size? =? 308x164,? acquired? in?plane? voxel? size? =? 1.3?x?1.96?mm,?
reconstructed?matrix?size?=?512?x?412,?and?a?reconstructed?voxel?size?of?0.78?x?0.78?
mm.? Images? were? analyzed? offline? after? completion? of? the? trial? with? dedicated?
software?(Hippo?Fat,?IFC?CNR,?Pisa,?Italy)?to?provide?VAT?and?SAT?volumes.16?
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In? the?Maastricht? Study,? VAT? and? SAT? area?were? acquired? using? a? 3T?MRI? system?
(MAGNETOM?Prismafit,?Siemens?Healthineers,?Erlangen,?Germany)?with?body?matrix?
and? supine? radiofrequency? coils.? Subjects? were? positioned? supine.? After? an? initial?
scout?view,?a?single?slice? transversal? image?at? the? top? level?of? the?L4?vertebral?body?
was? obtained? during? breath?hold? to? assess? areas? of? the? visceral? and? subcutaneous?
adipose? tissue? compartments? using? a? T1?weighted? TSE? pulse? sequence? with? the?
following?parameters:?acquired?and?reconstructed?in?plane?voxel?size?2?x?2?mm3,?slice?
thickness? 8?mm,? TR? 550?ms,?NSA? =? 1,? parallel? imaging? (GRAPPA)? factor? =? 2,? turbo?
factor?=?7.?Depending?on?the?size?of?the?patient,?the?FOV?was?384?x?312?mm2?with?a?TE?
of?36?ms?or?500?x?406?mm2?with?a?TE?of?38?ms.? Images?were?analyzed?offline?after?
completion? of? the? trial?with? dedicated? software? (Hippo? Fat,? IFC? CNR,? Pisa,? Italy)? to?
provide?VAT?and?SAT?volumes.16?
?
The?reliability?over?time?was?derived?from?the?weight?stable?control?group?of?the?WLI?
trial,?consisting?of?26?abdominally?obese?men.? Intra??and? inter?observer?reliability?of?
the?analyses?was?assessed?in?a?subset?of?29?scans?from?the?Maastricht?study.?For?intra?
observer?reliability?this?subset?was?analyzed?twice?with?two?weeks?in?between.?During?
that?same?period,?this?subset?was?analyzed?by?an?experienced?and?certified?abdominal?
radiologist? to? determine? the? inter?observer? reliability.? In? addition,? this? subset? of?
29?scans? was? also? analyzed? by? determining? SAT? and? VAT? pixel? by? pixel? (MRIcron?
version?6.6.2013,?Chris?Rorden,?CRNL,?USA),?which?could?be?considered?to?be?the?gold?
standard?for?VAT?and?SAT?analyses.16?
Intrahepatic?lipid?content?
With? the? same?MRI? scanner?and? coil,? IHL?was?assessed? through?mDixon? imaging?as?
described?before.9?Two?6?mm?thick?transverse?slices?through?the? liver?were?acquired?
using?a?2D?three?point?T1?fast?field?echo?(T1?FFE)?mDixon?pulse?sequence,?to?correct?
for?T2*?relaxation.?The?scan?parameters?were?as?follows:?TR?=?150?ms,?TE1?=?0.85?ms,?
?TE?=?0.7?ms,? flip?angle? (FA)?=?10°,?NSA?=?1,?FOV?=?375?x?310?mm,?acquired?matrix?
size?=?92?x?77,?acquired? in?plane? resolution?=?4.08?x?4.02?mm,? reconstructed?matrix?
size? =? 384? x? 320? mm,? and? a? reconstructed? voxel? size? of? 0.98? x? 0.97? mm.? The?
intrahepatic?fat?percentage?was?calculated?in?three?regions?of?interest?(ROI)?within?the?
liver?parenchyma,?carefully?avoiding?blood?vessels.?The?fat?content?was?expressed?as?
the?weighted?mean?fat?signal,?divided?by?the?sum?of?the?weighted?mean?water?and?fat?
signal.??
?
The?reliability?over?time?was?derived?from?the?weight?stable?control?group?of?the?WLI?
trial?consisting?of?26?abdominally?obese?men.?Intra?observer?reliability?of?the?analyses?
was?assessed?by?analyzing?a?random?subset?of?10?scans?derived?from?lean?and?obese?
individuals? from? the?WLI? trial? twice,?with?one? year? in?between.? In?parallel?with? the?
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second?analysis?by?the?first?observer?(YK),?another?subset?of?15?scans?was?analyzed?by?
an?experienced?and? certified?abdominal? radiologist? to?determine? the? inter?observer?
reliability.? In?addition,? intra?slice,? inter?slice?and? inter?ROI? reliability?was?assessed? in?
the?baseline?scans?of?the?WLI?trial?(n?=?74).?
?
Moreover,?we?compared?IHL?by?means?of?the?mDixon?sequence?to?proton?resonance?
spectroscopy? (1H?MRS),?the?gold?standard?for?non?invasive?quantification?of? IHL,? in?a?
random?subset?of?45?measurements?in?lean?and?abdominally?obese?individuals?in?the?
WLI?trial.?The?decision?whether?additional?1H?MRS?was?performed?was?dependent?on?
the?availability?of?trained?personnel.?The?1H?MRS?scan?was?performed?using?the?same?
MRI?scanner?and? torso?coil?and? the?spectra?were?obtained? from?a?30?x?30?x?30?mm?
voxel? placed? centrally? in? the? right? lobe? of? the? liver? by? using? point?resolved?
spectroscopy? volume? selection? (PRESS)? with? the? following? scan? parameters:?
TR?=?4000?ms,?TE?=?32.5?ms,?2048?sample?points.?A?total?of?32?spectra?with?NSA?of?2?
were?acquired.?A?water?signal?was?acquired?as?a?reference?(NSA?=?2?x?8).?To?keep?the?
TR? constant,? the? subject?was? instructed? to?breathe?exactly? at? the?4s?rhythm?of? the?
sequence.? Shimming? was? performed? by? using? second?order? FASTMAP?based?
shimming.?
Intrapancreatic?lipid?content?
Information?on?IPL?was?obtained?through?mDixon?imaging?with?the?same?MRI?scanner?
and?coil.?A?six?mm?thick?transverse?slice?through?the?pancreas?was?acquired?using?a?2D?
three?point?T1?fast? field?echo?mDixon?pulse?sequence,? to?correct? for?T2*? relaxation.?
The? scan?parameters?were? as? follows:? TR? =? 150?ms,? TE1? =? 0.85?ms,? ?TE? =? 0.7?ms,?
FA?=?10°,?NSA?=?1,?FOV?=?375?x?310?mm,?acquired?matrix?size?=?92?x?77,?acquired? in?
plane?resolution?=?4.08?x?4.02?mm,?reconstructed?matrix?size?=?384?x?320?mm,?and?a?
reconstructed?voxel?size?of?0.98?x?0.97?mm.?IPL?was?calculated? in?one?ROI?within?the?
pancreas?parenchyma,?preferably?encompassing?the?head?and?body?of?the?pancreas.?
In?the?WLI?trial,?the?ROI?was?matched?between?baseline?and?follow?up?measurements.?
IPL?was?expressed?as?the?mean?fat?signal?divided?by?the?sum?of?the?mean?water?and?
fat?signal.?The?reliability?over?time?was?derived?from?the?weight?stable?control?group?
of?the?WLI?trial?consisting?of?26?abdominally?obese?men.? Intra?observer?reliability?of?
the?analyses?was?assessed?by?analyzing?a?random?subset?of?15?scans?derived?from?lean?
and?obese? individuals?from?the?WLI?trial?twice,?with?one?year? in?between.? In?parallel?
with? the? second? analysis?by? the? first?observer? (YK),? the? subset?was? analyzed?by? an?
experienced? and? certified? abdominal? radiologist? to? determine? the? inter?observer?
reliability.? In?contrast?to? IHL,?1H?MRS? is?not?considered?to?be?superior?to?mDixon?for?
IPL?quantification,?as?mDixon?allows?for?image?based?determination?of?the?volume?of?
interest,?which? reduces? the? risk?of? erroneously? including?non?pancreatic? tissue? into?
the?volume?of?interest.17,18?
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Microvascular?measurements?
Muscle?microvascular?recruitment??
CEUS?was? used? to? assess?MVR? in? skeletal?muscle.? For? these?measurements,? flexor?
muscles?of?the?right?arm?were?visualized?with?a?Toshiba?Aplio?XG?ultrasound?system?
(Supplementary? Figure? 3.2A;? Toshiba,? Japan).?On? a? transparent? overhead? projector?
sheet?covering?the?display,?characteristic?morphological?features?were?copied?in?order?
to? visualize? the? exact? same? ROI?with? each?measurement.? The?microvascular? blood?
volume? (MBV)? of? forearm? skeletal?muscle?was? determined?with? contrast? harmonic?
imaging.?Meanwhile,? sulfur? hexafluoride? gas?filled? microbubbles? (SonoVue,? Bracco?
diagnostics,? The? Netherlands)?were? intravenously? and? continuously? infused.? In? the?
CEUS?Reproducibility?Study,?microbubbles?were?infused?during?10?minutes.?After?three?
minutes,?when?steady?state?microbubble?concentration?is?typically?achieved,?five?real?
time?replenishment?curves?of?25?seconds?were?obtained?after?microbubble?disruption?
by?a?high?mechanical?index?ultrasound?pulse.?Individuals?were?then?asked?to?perform?
dynamic?handgrip?exercises?at?80%?of? their?maximal?hand?grip? strength.?During? the?
first? two? minutes? individuals? contracted? once? every? 5? seconds,? followed? by? one?
contraction?every?30?seconds? for?another?2.5?minutes,?adding?up? to?a? total?exercise?
time? of? 4.5? minutes.? During? the? last? 2.5? minutes,? five? replenishment? curves? of?
25?seconds? each?were? acquired? in? between?muscle? contractions.? In? the?WLI? study,?
microbubbles?were? infused? for? 6?minutes? both? in? a? fasted? state,? as?well? as? during?
hyperinsulinemia.? After? three? minutes,? five? real?time? replenishment? curves? of?
25?seconds?were? acquired? after?microbubble?disruption?by? a?high?mechanical? index?
ultrasound? pulse.? Replenishment? curves? were? stored? and? analyzed? offline? upon?
completion? of? the? study? using? the? CHI?Q? software? (Toshiba,? Japan).?One? region? of?
interest?was?drawn? in?the?deep? flexor?muscles,?carefully?avoiding?blood?vessels,?and?
was?matched?between?all?measurements.?The?replenishment?curves?were?fitted?to?the?
exponential?function?y?=?A(1???e?ßt)?and?averaged?as?described?before.9,19?Briefly,?MBV?
was?calculated?by?subtracting?the?value?of?the?fitted?curve?after?one?second?(y1)?from?
the?plateau?phase?(A?value);?herewith,?signal?from?rapid?filling?arterioles?and?venules?
are?discarded.?MVR?was?calculated?as?the?increase?in?MBV?induced?by?either?dynamic?
handgrip?exercises?or?hyperinsulinemia.?
?
Intra?observer? reliability? of? the? measurements? were? determined? in? the? CEUS?
Reproducibility?Study?by?measuring?microvascular? recruitment? induced?by?hand?grip?
exercises?twice?on?each?study?day?(n?=?8).?The?reliability?over?time?was?determined?in?
two?study?populations.?First,?in?the?CEUS?Reproducibility?Study?where?MVR?induced?by?
hand? grip? exercises? was? assessed? on? two? separate? days,? one? week? apart? (n?=?7).?
Second,? from?the?weight?stable?control?group?of?the?WLI?trial?where? insulin?induced?
MVR?was?assessed? in?26?abdominally?obese?men?on?two?separate?days,?eight?weeks?
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apart.?Intra?observer?reliability?of?the?analyses?was?assessed?by?analyzing?a?subset?of?
21?CEUS?recordings?in?lean?and?abdominally?obese?individuals?that?participated?in?the?
WLI?trial.?The?subset?consisted?of?10?random?recordings?and?11?recordings?of?relatively?
poor? image?quality.?The?second?assessment?took?place?one?week?after?the?first?MVR?
analyses?were?completed.??
Capillary?microscopy?
Nailfold? capillaries? were? visualized? by? means? of? intravital? videomicroscopy,? which?
allowed?for?direct?visualization?of?nutritive?skin?capillaries?(Capiscope,?KK?Technology,?
Devon,?England).?Nailfold?capillaries?of?the?dorsal?skin?of?the?third?and?fourth?finger?of?
the?right?hand?were?visualized?with?a?total?system?magnification?of?100?x?and?recorded?
at?25?frames?per?second.?Each?frame?measures?640?x?480?pixels?with?256?grey? levels?
per? pixel.? During? the?measurements,? the? investigated? finger?was? immobilized? in? a?
mass?of?clay?and?paraffin?oil?was?applied?to?the?imaged?area?of?the?nailfold?to?improve?
skin?translucency?and?reduce?skin?reflections?as?described?previously?(Supplementary?
Figure?3.2B).20?Capillaries?3?to?5?mm?proximal?to?the?terminal?row?of?capillaries?in?the?
middle?of? the?nailfold,?with? the?exact? location?dependent?of? the? image?quality? and?
perpendicularity?of?the?visualized?capillaries,?were?analyzed.?The?ROI?size?was?1?mm2.?
On? a? transparent? overhead? projector? sheet? covering? the? monitor,? characteristic?
morphological? features?were?copied? in?order? to?visualize? the?exact?same?ROI?during?
each?measurement,?as?well?as?between?study?days.?In?case?a?specific?ROI?could?not?be?
retrieved?on?the?second?study?day,?a?different?ROI?that?met?the?quality?standards?was?
recorded.? Yet,? only? ROIs? that? could? be?matched? between? both? visits?were? used? to?
assess? the?data?on? reliability?over? time? reported? in? this?manuscript.?For?each? finger,?
continuously? (??15? seconds)? perfused? capillaries? in? the? rested? state,? perfused?
capillaries?during?hyperemia,?capillary?recruitment?by?hyperemia?and?capillary?density?
during?venous?occlusion?were?recorded?in?a?fasted?state?and?during?an?insulin?clamp.?
Hyperemia?was? induced? by? inflation? of? a?miniature? cuff? (Digit? cuff,?Hokanson? Inc.,?
Bellevue,? USA)? that?was? positioned? around? the? base? of? the? finger? to? suprasystolic?
pressure? (240?mmHg)? for? four?minutes,? after?which? the? cuff?was? rapidly? deflated.?
During? the? period? of? post?occlusive? reactive? hyperemia,? all? capillaries? that? were?
perfused? at? any? moment? during? a? 15?second? period? were? counted.? Capillary?
recruitment? during? post?occlusive? hyperemia? (?HE)? was? defined? as? the? difference?
between? number? of? perfused? capillaries? during? hyperemia? and? the? number? of?
continuously? perfused? capillaries? in? the? rested? condition? and? is? considered? a?
functional?capillary?reserve?capacity.?Five?minutes?after?the?suprasystolic?pressure?was?
released? from? the? cuff,? the? cuff? was? re?inflated? to? 50? mmHg? (i.e.,? subdiastolic?
pressure)? for? two?minutes? in?order? to? induce?venous? congestion.?After?one?minute,?
the? number? of? capillaries? that? were? erythrocyte?filled? at? any? moment? during? a?
15?second?period?were?counted;? this?method? is?considered? to?visualize? the?maximal?
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number? of? skin? capillaries.? Capillary? recruitment? by? hyperinsulinemia? (?Ins)? was?
defined? as? difference? in? terms? of? percentage? between? continuously? perfused?
capillaries?during?hyperinsulinemia?and?continuously?perfused?capillaries?in?the?fasted?
condition.?All?recorded?videos?were?stored,?masked?and?subsequently?analyzed?offline?
by? a? single? investigator? (PN).? For? these? offline? analyses,? a? semi?automatic? image?
analysis? application? (CapiAna,? Ed?Gronenschild? and?Alfons?Houben,?Maastricht,? The?
Netherlands)? was? used? as? described? into? more? detail? elsewhere.8? To? exclude? a?
learning? effect? or? a? shift? in? judgment? during? the? analyses? of? the? WLI? trial,? the?
recordings?were?divided?into?three?batches?and?between?group?effects?and?treatment?
effects? were? determined? for? each? batch;? nonetheless,? no? difference? in? either?
comparison?was?found?between?batches.?
?
The?reliability?over?time?was?derived?from?the?weight?stable?control?group?of?the?WLI?
trial,?which?consists?of?26?abdominally?obese?men,?of?whom?24?men?had?at?least?one?
ROI? that? was? identical? between? both? visits.? The? intra?observer? reliability? was?
determined?in?a?training?set?of?six?individuals?selected?from?the?Maastricht?Study?and?
the? inter?observer?reliability?of?the?analyses?was?determined? in?a?second?training?set?
of? five? individuals? selected? from? several? previous? studies11,13? and? analyzed? by? two?
investigators?more?than?one?year?apart.??
Flowmotion?
The?periodic?blood?flow?fluctuations,?known?as?flowmotion,?which? in?part?arise?from?
rhythmic? vessel? diameter? oscillations? known? as? vasomotion,21? were? non?invasively?
assessed? in? skin?by?means?of? laser?Doppler? flowmetry? (LDF;?PeriFlux?5000,?PeriMed?
AB,? Järfälla,? Sweden)? as? described? previously.20? In? summary,? LDF? is? based? on? the?
emission?of?a?beam?of?780?nm?wavelength?laser?light?carried?by?a?fiber?optic?probe.?As?
the? laser? light?penetrates?the?skin,?a?fraction?of?the? light? is?backscattered?by?moving?
erythrocytes,? which? leads? to? a? shift? in? frequency? proportional? to? the? velocity? of?
erythrocyte?movement? (i.e.,? the? Doppler? principle).? The?magnitude? and? frequency?
distribution?of? these?changes? in?wavelength?are?directly?related? to? the?number? (i.e.,?
volume)? and? velocity?of? the?blood? cells? in? the? sampled? volume.? This? information? is?
detected?and?transported?by?a?returning?optical?fiber?and?converted?to?an?electronic?
signal.?Typically,? the?measuring?depth? is?0.5?1?mm,? yet? as? the?exact? volume? that? is?
measured? is?unknown,? the?blood? flow? is?expressed? in?arbitrary?units.?Subsequently,?
flowmotion?can?be?analyzed?by?either?Fourier?or?wavelet?analyses,?which?quantifies?
the?relative?contribution?of?each?frequency?to?the?observed?LDF?signal.?Low?frequency?
signals? associated? with? vasomotion? arise? from? endothelial? (~0.01? Hz),? neurogenic?
(~0.04?Hz),?and?myogenic?activity?(~0.1?Hz).21?27?The?LDF?probe?was?positioned?at?the?
level? of? the? left?wrist? (Supplementary? Figure? 3.2C),?which? renders? less?movement?
artifacts? than? the? fingers.?All? recordings?were? stored,?masked,?and?analyzed?offline.?
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Here,?we?used?Fast?Fourier?transformation?of?the?LDF?signal?with?the?build?in?software?
(PSW?2.5.5,?PeriMed?AB,?Järfälla,?Sweden)?as?it?is?the?method?used?in?previous?papers?
by?our?research?group.??
?
The? reliability? over? time?was? derived? from? a? subset? of? 14? abdominally? obese?men?
randomized?to?the?weight?stable?control?group?of?the?WLI?trial.?The?subset?was?based?
on?the?enrollment?date,?i.e.,?the?14?individuals?included?in?these?analyses?are?the?first?
weight?stable?controls?that?participated.?The? intra?observer?reliability?of?the?analyses?
was?determined?in?a?training?set?of?six?individuals?selected?from?the?Maastricht?Study?
and? analyzed? more? than? four? months? apart.? The? inter?observer? reliability? of? the?
analyses?was?determined? in?a?random?subset?of?35? lean?and?abdominally?obese?men?
that?participated?in?the?WLI?trial.?
Sublingual?microvascular?perfused?boundary?region?(Glycocalyx)?
The? glycocalyx? was? assessed? in? terms? of? the? sublingual? microvascular? perfused?
boundary? region? (PBR),? which? reflects? the? part? of? the? glycocalyx? that? can? be?
penetrated?by?moving?erythrocytes,?and?measured?with?a?dedicated?and?automated?
on?line? quantification? system? (GlycoCheck™,? Maastricht,? The? Netherlands).28? The?
sublingual?microcirculation?was? visualized? by? placement? of? a? sidestream? dark? field?
handheld?imaging?device?under?the?tongue.?Here,?the?imaging?software?automatically?
controlled? the? quality? of? the? videorecordings? and? only? those? of? sufficient? quality?
(1???2?minutes? in? total)? were? recorded.? Upon? completion? of? the? recordings,? the?
automated?software?recognizes?the?microvessels,?divides?them? in?over?3000?vascular?
segments,? and? calculates? in? them? the? PBR? as? a? measure? of? glycocalyx? barrier?
properties.28? The? PBR? is? reported? for?microvessels? from? 5? to? 25? ?m,?where? lower?
PBR?values?reflect?a?healthier?glycocalyx?barrier?function.?The?reliability?over?time?was?
derived? from? the? weight? stable? control? group? of? the? WLI? trial? consisting? of?
26?abdominally?obese?men.?In?contrast?to?the?measurements,?the?analyses?of?PBR?are?
automated?and?therefore?observer?independent.?
Macrovascular?measurements?
Flow?mediated?dilation?
Details?on?flow?mediated?dilation?(FMD)?measurements?and?part?of?its?reliability?have?
been?published?elsewhere.14?Briefly,?with?the?individual?in?supine?position?for?at?least?
20?minutes,?the?right?shoulder?and?arm?were?positioned?on?soft?supports?for?optimal?
comfort?and?stability.?A?well?accessible?segment?of?the?brachial?artery?was?visualized?
with? a? 7.5? MHz,? 40? mm? linear? array? ultrasound? system? (MyLab™? 70,? Esaote,?
Maastricht,? The? Netherlands)? in? Duplex?mode? to? record? simultaneously? artery?
diameter? and? center?line? blood? flow? sonogram.? The? transducer? position?was? fixed?
539883-L-sub01-bw-Kusters
Processed on: 13-1-2020 PDF page: 81
? Reliability,?measurement?error?and?methodology?
81?
3?
using? a? custom?made? stereotactic? probe? holder.? The? electronically? steered? pulsed?
Doppler?beam?was?set?at?an?angle?of?65???70?degrees?with?respect?to?the?vessel? long?
axis.?The? length?of?the?pulsed?Doppler?sample?volume?was?set?at?approximately?half?
the? vessel? diameter? to? ensure? consistent? registration? of? the? center?line? velocity?
despite?possible?movements?over? the? recording?period.?A? sphygmomanometer? cuff?
(Hokanson? TD? 312,?D.E.?Hokanson? Inc.,?Bellevue,?USA)?was?positioned?on? the? right?
lower?arm?and? rapidly? inflated? to?at? least?200?mmHg? (or?higher?when?simultaneous?
EndoPAT™?measurements? indicated? incomplete? arterial?occlusion)? for?5?minutes? to?
elicit?upon?release?the?hyperemic?response?required?for?brachial?artery?flow?mediated?
dilation?measurement.? For? each? FMD?measurement,? duplex? images?were? recorded?
continuously?on?DVD?over?a? total?of?15?minutes:?a?5?minutes? reference?period? (i.e.,?
before?cuff?inflation),?5?minutes?during?lower?arm?cuff?inflation,?and?5?minutes?during?
hyperemia? following?rapid?cuff?release.?Recorded?videos?were?analyzed?offline?using?
proprietary?wall?detection?and?Doppler?velocity? tracing?software? (MyFMD;?Prof.?A.P.?
Hoeks,?Department?of?Biomedical?Engineering,?MUMC+,?Maastricht,?The?Netherlands)?
implemented? in? Matlab? (The? Mathworks,? Natick,? USA).? In? the? weight? loss? study,?
recordings?were?masked?prior?to?analysis.??
?
Intra?observer?reliability?and?reliability?over?time?were?assessed? in?the?FMD? in?Acute?
Hyperglycemia?Study.14?For?intra?observer?reliability,?individuals?were?measured?twice?
in?a? fasted?state?with? ten?minutes? in?between?on?each?study?day.?The?second?study?
day?was? repeated?one?week? later,? from?which? reliability?over? time?was?obtained.? In?
addition,?reliability?over?time?was?also?derived?from?the?weight?stable?control?group?of?
the?WLI?trial,?where?23?FMD?measurements?were?available?for?analysis.10?Both? intra??
and?inter?observer?reliability?of?the?offline?analyses?were?assessed?in?a?random?subset?
of? 25?masked? FMD?measurements? in? lean? and? abdominally? obese? individuals.?One?
observer?(JoR)?repeated?the?analyses?three?days?apart.?In?that?same?period,?a?second?
observer?(PJ)?analyzed?the?same?subset?of?FMD?measurements.??
Reactive?hyperemia?index??
The?reactive?hyperemia?index?(RHI)?was?measured?during?FMD?measurements?with?a?
dedicated?device? (EndoPAT?2000,? Itamar?Medical? Ltd,?Caesarea,? Israel)?as?described?
previously.10? Briefly,? on? the? index? finger? of? both? hands? a? pneumatic? probe? that?
measures?arterial?pulsatile?volume?changes?(dubbed?peripheral?arterial?tone?(PAT)?by?
the? manufacturer)? is? placed.? The? RHI? was? quantified? as? the? postocclusion? to?
preocclusion?PAT?signal?in?the?occluded?hand,?normalized?to?the?values?in?the?control?
hand,? then? further? corrected? for?baseline? vascular? tone.29?Reliability?over? time?was?
determined?in?a?subset?of?14?individuals?in?the?weight?stable?control?group?of?the?WLI?
Trial.?The?first?14?individuals?to?complete?the?study?were?included?in?this?subset.?
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Carotid?femoral?pulse?wave?velocity?and?augmentation?index?
Carotid?femoral?pulse?wave?velocity?(cfPWV),?the?ratio?of?travelled?distance?divided?by?
transit? time,? was? determined? according? to? recent? guidelines? with? applanation?
tonometry?(SphygmoCor,?Atcor?Medical,?Australia)?as?described?previously.12,30?Briefly,?
pressure?waveforms?were?determined?at?the?right?common?carotid?and?right?common?
femoral? arteries.? Difference? in? the? time? of? pulse? arrival? from? the? R?wave? of? the?
electrocardiogram? between? the? two? sites? (transit? time)? was? determined? with? the?
maximum?upstroke?algorithm.?The?pulse?wave? travel?distance?was?calculated?as? the?
total? direct? straight? distance? (measured? with? an? infantometer)? between? the? two?
arterial? sites.? The? augmentation? index? (Aix)?was? determined? by? radial? applanation?
tonometry?and?computed?by?built?in?software?(SphygmoCor?v9,?Atcor?Medical,?Sidney,?
Australia).31,32? Intra?? and? inter?observer? reliability,? and? reliability? over? time? were?
assessed? in? 12? individuals? that?participated? in? the?Maastricht? study? and? visited? the?
research?facility? for?a?second?time?one?week?after?their?first?visit.?On?their? first?visit,?
one? observer? repeated? cfPWV? and?Aix?measurements,? directly? thereafter? a? second?
observer?repeated?the?measurements.???
Distensibility,?distensibility?coefficient,?compliance?coefficient,?and?carotid?intima?
media?thickness?
After? completion?of? cfPWV? and?Aix?measurements,? the? left? common? carotid? artery?
(CCA)?was?visualized?directly?proximal?from?the?bulbus?(0???10?mm)? in?fast?brightness?
mode?with? a?7.5?MHz,?40?mm? linear? array?ultrasound? system? (MyLab™?70,?Esaote,?
Maastricht,?The?Netherlands)?equipped?with?an?ARTLAB?system? (Esaote,?Maastricht,?
The? Netherlands).? Ultrasound? data? and? 3?lead? ECG? signal? were? simultaneously?
recorded?during?3?consecutive?6?seconds?measurements.?Herewith,?measurements?of?
diameter,? distensibility,? and? carotid? intima?media? thickness? (cIMT)? were?
simultaneously? acquired.? The? cumulative? radiofrequency? signals?were? digitized? and?
stored? and? analyzed? offline? by? custom?build? software? (Dist13;? Prof.? A.P.? Hoeks,?
Department? of? Biomedical? Engineering,? MUMC+,? Maastricht,? The? Netherlands).?
Herewith,?the?change?in?diameter?as?a?function?of?time?(distensibility)?was?estimated,?
diastolic?diameter?was?calculated?as? the?difference? in?position?between? the?anterior?
and?posterior?wall?markers,? and? the? cIMT?was? calculated? as? the? distance? from? the?
leading? edge? interface? between? lumen? and? intima? to? the? leading? edge? interface?
between? media? and? adventitia? of? the? posterior? wall.? Subsequently,? distensibility?
coefficient?(DC),?which?represents?arterial?stiffness,?and?compliance?coefficient,?which?
represents? arterial? buffering? capacity,? were? calculated? using? the? following?
formulas33?35:?
?
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DC?=?(2?D?x?D?+??D2)?/?(PP?x?D2)?(in?10?3/kPa)?
?
CC?=???x?(2D?x??D?+??D2)?/?(4?x?P)P?(in?mm2/kPa)?
?
Intra?? and? inter?observer? reliability? and? reliability? over? time? were? assessed? in?
10?individuals? that? participated? in? the? Maastricht? study? and? visited? the? research?
facility? for? a? second? time? one? week? after? their? first? visit.? On? their? first? visit,? one?
observer? repeatedly?measured? cIMT? and? distensibility,? directly? thereafter? a? second?
observer?repeated?the?measurements.?
Metabolic?measurements?
Whole?body?glucose?disposal?
It? is?generally?accepted?that?a?euglycemic? insulin?clamp,?as?developed?by?Dr.?Andres’?
group? in?the?70’s,36,37? is?the?best?available?method?to?determine?peripheral?or?whole?
body? glucose? disposal? (WBGD).38?41? With? this? technique,? exogenous? insulin? is?
administered? to? achieve? and?maintain? high? physiological? insulin? levels,? usually? for?
2?hours?or? longer.?Here,? insulin?was? infused? in? a?primed? continuous?matter;? insulin?
(Novorapid,?Novo?Nordisk,?Bagsvaerd,?Denmark)?was?first? infused?at?120?mU/kg/min?
for? 10? minutes,? after? which? its? infusion? rate? was? lowered? to? 60? mU/kg/min? for?
170?minutes.? As? insulin? adsorbs? to? infusion? equipment,? 3?ml? of? whole? blood? was?
added?per?60?ml?syringe? to?reduce?adsorption.42? In?order? to?maintain? isoglycemia,?a?
variable?rate?20%?glucose?infusion?is?administered?throughout?the?clamp.?Ideally,?one?
aims? to?maintain?arterial?glucose?at?a?constant? level,?yet?cannulation?of? the?brachial?
artery? is?considered?a? rather? invasive?procedure.? Instead,?a?hand? is?often?heated? to?
“arterialize”?venous?blood.37,43,44?This,?however,?alters?blood? flow? in? the?heated?and?
contralateral? arms,? as?well? as? increase?norepinephrine? levels? and? thereby? influence?
(micro)vascular? and?metabolic?measurements.43?Therefore,?we?used? the?method?by?
Clerk?et?al.,?which?recognizes? that?when?arterial?glucose? is?maintained?at?a?constant?
level? during? an? insulin? clamp,? venous? glucose? concentrations? decline? progressively?
with?time,?and?the?arteriovenous?glucose?difference?increases?in?proportion?to?insulin?
sensitivity.19?In?this?model,?the?target?for?venous?glucose?to?decline?is?0.27?mmol/l?for?
every?1?mg/kg/min? increase? in?glucose? infusion?rate?above?the?basal?hepatic?glucose?
production?(estimated?at?2?mg/kg/min),?the?rationale?for?which? is?based?on?previous?
studies?and?provided?into?more?detail?elsewhere.19?Whole?body?glucose?disposal?was?
estimated? from? the? steady?state? glucose? infusion? rate? (90???150?min? of? the? clamp).?
Plasma?glucose?concentrations?during?the?clamp?were?measured?by?first?centrifuging?
0.5?ml?of?whole?blood?at?13,000?x?g?for?30?seconds?and?then?analyzed?with?an?on?site?
YSI2300?glucose?analyzer?(YSI,?Yellow?Springs,?USA).??
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Beta?cell?function?
As?beta?cell? function? (BCF)?cannot?be?described?by?a?single?measure,?we?used? three?
dynamic? BCF? measures? derived? from? mathematically? modeling? mixed? meal? test?
(MMT)?data,? i.e.,?beta?cell?glucose? sensitivity? (??GS),?beta?cell? rate? sensitivity? (??RS)?
and? potentiation? factor? ratio? (PFR).45?47? The? parameter? ??GS? is? the? slope? of? the?
glucose?insulin? secretion?dose?response? function,?which? reflects? the?dependence?of?
insulin?secretion?on?absolute?glucose?concentration?at?any?time?during?the?MMT.45?47?
The? dose?response? relationship? is? modulated? by? beta?cell? potentiation,? which?
accounts? for?higher? insulin? secretion?during? the?descending?phase?of?hyperglycemia?
than? during? the? ascending? phase? of? an? OGTT? or? MMT? for? the? same? glucose?
concentration.? Beta?cell? potentiation? is? set? as? a? positive? function? of? time? and?
averages?1?during?the?MMT.?Therefore,? it?represents?the?relative?potentiation?of?the?
insulin? secretion? response? to? glucose.?The?beta?cell?potentiation?parameter?used? in?
the?present?analysis?represents?the?ratio?of?the?beta?cell?potentiation?factor?at?the?end?
of? the?MMT? relative? to? the?beta?cell?potentiation? factor? at? the? start.?Beta?cell? rate?
sensitivity? is? a?marker? of? early? phase? insulin? release,? and? represents? the? dynamic?
dependence?of? insulin?secretion?on? the? rate?of?change? in?glucose?concentration.45?47?
The?test?meal?of?the?MMT?consisted?of?two?muffins?(containing?56.6?g?fat)?and?300?ml?
low?fat?milk?(0%?fat?milk;?Friesland?Campina,?Woerden,?The?Netherlands).?The?mixed?
meal?had?an?energy?content?of?4598?kJ?(fat?/?carbohydrate?/?protein:?28?En%?/?59?En%?
/?13?En%)?and?provided?26.5?g?protein,?121.0?g?carbohydrates?and?56.6?g?fat?(fatty?acid?
composition:? 33.9? g? saturated? fatty? acids,? 2.2? g? trans? fatty? acids,? 14.5? g?
monounsaturated? fatty? acids,? and? 2.7? g? polyunsaturated? fatty? acids).?One? batch? of?
muffins?was?prepared?for?the?entire?study?by?a?research?nurse;?muffins?were?baked?at?
180°C? in? a? fan?assisted? oven? for? 20?minutes,? packaged? per? portion,? and? frozen? at?
?20°C.?Reliability?of?BCF?measurements?over?time?was?determined?in?26?individuals?in?
the?weight?stable?control?group?of?the?WLI?Trial.??
Inflammatory?measurements?
CD11B?surface?expression?
In?chapter? five?of? this? thesis,?we? found? that?CD11B?surface?expression,?measured?as?
mean?fluorescence?intensity?on?total?circulating?NK?cells?(from?here?on?referred?to?as?
NK?CD11B),?was?closely?associated?with?NK?cell?accumulation?in?VAT.?CD11B?has?been?
described? as? a? maturation? marker? of? NK? cells.48,49? This? integrin? can? mediate? cell?
adhesion,?but?is?also?part?of?the?complement?receptor?3?complex,?which?is?involved?in?
cytotoxic?activation?of?NK?cells.50?Reliability?and?measurement?error?of?NK?CD11B?was?
determined? in?a? subset?of? individuals? in? the?weight? stable?control?group?of? the?WLI?
Trial;?the?last?22?individuals?to?complete?the?study?were?included?in?this?subset.?Blood?
was?drawn?after?an?overnight?fast?and?a?30?minute?acclimatization?period?and?frozen?
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for?flow?cytometry.?Upon?completion?of?the?WLI?trial,?blood?was?thawed?and?stained?
for?flow?cytometry?using?CD3?fitc?(BD?561807),?CD19?fitc?(BD?555412),?CD66b?fitc?(BD?
555724),? CD56?PE? (BD? 345810),? HLA?DR?V500? (BD? 561224),? CD14?APC?H7? (BD?
641394),? CD16?PerCP? (BD? 560717),? CD11B?BV421? (BD? 562632),? CD11c?PE?Cy7? (BD?
561356),? and? CX3CR1?APC? (Biolegend? 341609).? The? gating? strategy? (Supplementary?
Figure? 3.3)?was? as? follows.? From? single? blood? cells,? live? cells?were? gated? based? on?
forward? and? side? scatters.? From? live? cells,?NK? cells?were? gated? as?negative? for?CD3?
(T?cells),?CD19?(B?cells),?CD66b?(granulocytes),?HLA?DR?(monocytes,?dendritic?cells)?and?
positive?for?CD56.?Singlets?were?gated?based?on?both?forward?and?side?scatters.?Live?
cells?were?defined?as?negative?for?live?death?staining.?NK?cells?were?CD3??and?CD56+,?
which?were? subdivided?according? to?CD56?and?CD16? surface?expression.?Each?panel?
was? optimized? using? fluorescence?minus? one? (FMO)? controls? and? isotype? controls,?
yielding?similar?measures?as?auto?fluorescent?samples.?For?each?experiment,?an?auto?
fluorescence? control?was?performed.? Samples?were?measured?with? a? FACS?Canto? II?
(BD?Biosciences,? San? Jose,?CA,?USA).?Results?were?analyzed?with? FACSdiva? software?
(BD?Biosciences,?San?Jose,?CA,?USA).?
Plasma?biomarkers?of?low?grade?inflammation?
Biomarkers? of? low?grade? inflammation? (C?reactive? protein,? serum? amyloid? A,?
interleukin?6,? interleukin?8,? soluble? intercellular? adhesion? molecule?1,? and? tumor?
necrosis? factor)?were? assessed? by? a?multiarray? detection? system? based? on? electro?
chemiluminescence? technology? (SECTOR? Imager? 2400,? MesoScaleDiscovery,?
Gaithersburg,?Maryland,?USA)?as?described?previously.51?This?system?uses?multi?array?
plates? fitted?with?multielectrodes?per?well?with?each?electrode?being? coated?with?a?
different? catching? antibody.? The? assay? procedure? then? follows? that? of? a? classic?
sandwich? ELISA? with? any? of? the? analytes? of? interest? captured? on? the? relevant?
electrode.? These? captured? analytes? were? then? in? turn? detected? by? a? secondary?
analyte?specific? ruthenium?conjugated? antibody,? which? is? capable? of? emitting? light?
after?electrochemical?stimulation.?A?particular?advantage?of?this?system? is?the?ability?
to? measure? different? biomarkers? of? low?grade? inflammation? and/or? endothelial?
dysfunction? simultaneously? in? relatively? small? (25? or? 50? ?l)? serum? samples.? For?
reasons?of?statistical?efficiency?and?to?reduce?the? influence?of?biological?variability,52?
overall?biomarker? scores?were? calculated? for?endothelial?dysfunction?and? low?grade?
inflammation? as? follows.53? First,? each? individual? biomarker? was? log?transformed? if?
warranted.?Then,?a?z?score?was?calculated?according?to?the?formula?(individual?value?–?
population?mean)/population? standard?deviation? (SD);? the?population?mean?and?SD?
were? determined? from? the? baseline? samples? only.? Finally,? the? resulting? individual?
biomarker? z?scores? were? averaged? into? an? overall? biomarker? score? of? low?grade?
inflammation.?
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Statistical?analyses?
Intraclass?correlation?coefficients?
All? variables? in? this? paper? are? continuous,? hence,? intraclass? correlation? coefficients?
(ICC)?were?calculated?to?provide?a?parameter?of?reliability.?For?all?reliability?analyses,?
i.e.,? inter?? and? intra?observer? reliability? and? reliability? over? time,? ICCagreement? was?
chosen? as? systematic? differences? between? observers? are? included? in? the? error?
variance,? in?contrast? to? ICCconsistency.1,6,7?For?all?reliability?analyses,?except?comparison?
with?a?gold?standard,?a?two?way?mixed?model,?where?people?effects?are?random?and?
the?item?effects?are?fixed,?was?used.?This?model?is?chosen?when?each?measurement?is?
rated? by? the? same? observers,? who? are? the? only? observers? of? interest.6? For? the?
comparisons?with?a?gold?standard,?a?one?way?random?model?was?used.1?
Limits?of?agreement?and?Bland?Altman?plots?
Measurement?error?can?be? found? in? the? limits?of?agreement,?and?Bland?and?Altman?
have? designed? a? plot? in? which? systematic? errors? and? limits? of? agreement? are?
presented.5? In? these?plots,? the?mean?of? two?measurements? is?plotted?on? the?x?axis,?
whereas? the? difference? between? the?measurements? is? plotted? on? the? y?axis.? Every?
comparison?in?measurement?is?added?as?a?dot?and,?typically,?four?(horizontal)?lines?are?
added.?One? represents? the? line? of? perfect? agreement? (y? =? 0),? one? line? is? added? to?
represent? the?mean? difference? between?measurements? (or? observers? when? inter?
observer?variance?is?assessed),?and?two?lines?to?represent?the?upper?and?lower?limit?of?
agreement.? The? limits? of? agreement? are? calculated? as? mean? difference? ±? 1.96? x?
SDdifference?and,?hence,?95%?of?the?dots?will?fall?between?these?lines.?When?differences?
between? repeated? measurements? or? between? observers? are? large,? the? lines?
representing?the? limits?of?agreement?will?be?further?away?from?the?mean?difference.?
Paired?T?tests?were? conducted? to?assess? statistical? significance?of?mean?differences.?
These?Bland?Altman?plots?were?made?for?each?comparison.?
Standard?error?of?the?measurement?
The?SEM?is?a?parameter?of?measurement?error.?It?shows?how?far?apart?the?outcomes?
of? repeated? measures? are,? i.e.,? it? is? the? standard? deviation? around? a? single?
measurement.1? A? SEM? may? (SEMagreement)? or? may? not? (SEMconsistency)? include? the?
systematic?error?(e.g.,?between?observers).?SEMconsistency?equals? ??????????,?where?residual?
error? can? be? found? in?ANOVA? or? variance? component? analyses.? Yet,? it? can? also? be?
calculated? from? the? limits?of?agreement?as?SEMconsistency?=?SDdifference?/? ? ? ? .?Of?note,? in?
case? no? systemic? error? is? present,? SEMagreement? equals? SEMconsistency.? Here,? we? have?
reported?only?SEMconsistency?unless?noted?otherwise.1?
2
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Linear?regression?
To?analyze?the?association?between? IHL?measured?by?means?of?mDixon?and?1H?MRS,?
linear? regression?was? used.? As? two? techniques?were? compared,?with? subjects? and?
observers?being?identical,?no?confounders?were?added?to?the?model.??
Software?and?data?expression?
Analyses? were? performed? using? SPSS? version? 20.? Where? appropriate,? data? are?
expressed?as? ICC,?SEM,?means?±?SD,?median? [IQR],?or? count.?Two?tailed?p?values?of?
<0.05?were?considered?statistically?significant.?
Results?
Anthropometric?measurements?
For?reliability?over?time?of?VAT,?SAT,?IHL?and?IPL?measurements,?data?on?26?individuals?
from?the?weight?stable?control?group?were?used.?The?ICCtime?of?each?was?>?0.89?(Table?
3.1;?p?<?0.001)?and?the?SEMtime?was?0.17?L?for?VAT,?0.12?L?for?SAT,?1.10%?point?for?IHL?
(by? means? of? mDixon),? and? 1.14%?point? for? IPL.? The? Bland?Altman? plots? of? the?
reliability?over?time?with?the? limits?of?agreement?are?presented?below?(Figures?3.1A,?
3.2A,?3.3A?and?3.4A).?
?
For? intra?observer?reliability?of?analyses,?data?of?29? (VAT,?SAT)?or?10? (IHL,? IPL)?scans?
were?used.?The?ICCintra?for?each?was?>?0.95?(Table?3.2;?p?<?0.001)?and?the?SEMintra?was?
7.9?cm2?per?slice? for?VAT,?4.4?cm2?per?slice? for?SAT,?0.56%?point? for? IHL,?and?0.66%?
point? for? IPL.?The?Bland?Altman?plots?of?the? intra?observer?reliability?of?the?analyses?
with?the?limits?of?agreement?are?presented?below?(Figures?3.1B,?3.2B,?3.3B?and?3.4B).?
In? addition,? we? assessed? for? IHL? the? ICC? for? intra?slice? (0.976;? n?=?74),? inter?slice?
(0.968;?n?=?73)?and?overall? inter?ROI? reliability? (0.966;?p?<?0.001? for?each;?n?=?73),?as?
well?as?the?SEMintra?slice?(0.79%?point)?and?SEMinter?slice?(0.84%?point).?
?
Inter?observer? reliability? of? analyses? was? assessed? in? 29? (VAT,? SAT),? 15? (IHL)? or?
14?scans? (IPL;?one? excluded?due? to? technical?difficulties).? The? ICCinter?was? >?0.97? for?
VAT,?SAT?and?IHL,?and?0.88?for?IPL?(p?<?0.001?for?each).?The?SEMinter?was?11.4?cm2?per?
slice?for?VAT,?6.8?cm2?per?slice?for?SAT,?0.33%?for? IHL,?and?1.72%?for? IPL.?The?Bland?
Altman? plots? of? the? inter?observer? reliability? of? the? analyses? with? the? limits? of?
agreement?are?presented?below?(Figures?3.1C,?3.2C,?3.3C?and?3.4C).?
?
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Table?3.1?–?Intraclass?correlation?coefficients?for?measurements.?
? Intra?observer? Inter?observer? Over?Time?
Anthropometric?variables? ? ? ?
???Visceral?Adipose?Tissue? N/A? N/A? ? 0.974?***a?
???Subcutaneous?Adipose?Tissue? N/A? N/A? ? 0.988?***a?
???Intrahepatic?Lipid? N/A? N/A? ? 0.972?***a?
???Intrapancreatic?Lipid? N/A? N/A? ? 0.897?***a?
Microvascular?variables? ? ? ?
???Muscle?Microvascular?Recruitment? ? 0.886?*b? N/A? ? 0.828?*c,?
? 0.613?*a?
???Capillary?Microscopy?(continuously?perfused)? N/A? N/A? ? 0.660?**d?
???Capillary?Microscopy?(??Insulin)? N/A? N/A? ? 0.049?d?
???Capillary?Microscopy?(HE)? N/A? N/A? ? 0.815?***d?
???Capillary?Microscopy?(??HE)? N/A? N/A? ? 0.670?**d?
???Capillary?Microscopy?(VO)? N/A? N/A? ? 0.811?***d?
???Flowmotion?(endothelial?component)? N/A? N/A? ? 0.628?e?
???Flowmotion?(neurogenic?component)? N/A? N/A? ? 0.696?*e?
???Flowmotion?(myogenic?component)? N/A? N/A? ? 0.000?e§?
???Sublingual?microvascular?perfused?boundary?region?? N/A? N/A? ? 0.000?a§?
Macrovascular?variables? ? ? ?
???Flow?mediated?Dilation? ? 0.677?*f? N/A? ? 0.526?*f,?
? 0.533?**g?
???Reactive?Hyperemia?Index?(EndoPAT™)? N/A? N/A? ? 0.579?*h?
???Carotid?Femoral?Pulse?Wave?Velocity? ? 0.984?***i? ? 0.815?**i? ? 0.931?***j?
???Augmentation?Index?(@75bpm)? ? 0.610?**i? ? 0.597?*i? ? 0.853?**j?
???Carotid?Distensibility? ? 0.906?***i? ? 0.750?*i? ? 0.902?***k?
???Distensibility?coefficient?CCA?? N/A? ? 0.846?**i? ? 0.916?***l?
???Compliance?coefficient?CCA?? N/A? ? 0.840?**i? ? 0.974?***l?
???Intima?Media?Thickness?CCA? ? 0.840?***k? ? 0.265?i? ? 0.867?**k?
Metabolic?variables? ? ? ?
???Whole?Body?Glucose?Disposal? N/A? N/A? ? 0.881?***a?
???Beta?cell?Glucose?Sensitivity? N/A? N/A? ? 0.461?*a?
???Beta?cell?Rate?Sensitivity? N/A? N/A? ? 0.447?*a?
???Potentiation?Factor?Ratio? N/A? N/A? ? 0.418?*a?
Inflammatory?variables? ? ? ?
???CD11B?Expression?on?Circulating?Natural?Killer?Cells? N/A? N/A? ? 0.738?**m?
???Z?Score?Low?Grade?Inflammation?Plasma?Biomarkers? N/A? N/A? ? 0.949?***a?
Data? presented? as? intraclass? correlation? coefficient? (ICC)?with? absolute? agreement? in? a? two?way?mixed?
effects?model.?Intra?observer,?inter?observer?ICCs?and?ICC?over?time?are?presented.?*?p?<?0.05,?**?p?<?0.01,?
***?p?<?0.001.?Analyzed?in?a?n?=?26;?b?n?=?7;?c?n?=?6;?d?n?=?24;?e?n?=?13;?f?n?=?22,?as?reported?in?Van?Bussel?et?al.?
–?with?permission14;?g?n?=?23;?h?n?=?14;? i?n?=?12;? j?n?=?11;?k?n?=?10;? l?n?=?9;?m?n?=?22.?§?Negative?ICC?values?were?
reported? as? zero,? as? described? before.? ?? Insulin? =? capillary? recruitment? by? hyperinsulinemia,? HE? =?
hyperemia,? ??HE? =? capillary? recruitment?by?hyperemia,?VO? =? venous?occlusion,? ?CCA? =? common? carotid?
artery,?N/A?was?noted?when?data?was?not?available?or?not?applicable.?
?
?
For?VAT?and?SAT?analyses,?pixel?by?pixel?quantification?had?been?considered?the?gold?
standard.16? Hence,? the? VAT? and? SAT? surface? per? slice? obtained? by? the? Hippo? Fat?
software?was?compared?to?pixel?by?pixel?analyses.?The?ICC?for?both?was?>?0.96?(Table?
3.3;?p?<?0.001?for?each;?n?=?29)?and?the?SEM?was?7.9?cm2?per?slice?for?VAT?and?4.4?cm2?
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per? slice? for? SAT.? Both? VAT? and? SAT? tended? to? be? slightly? underestimated? when?
analyzed? with? the? Hippo? Fat? software.? The? companion? Bland?Altman? plots? are?
presented?below?(Figures?3.1D?and?3.2D).??
?
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Figure?3.1?–?Bland?Altman?plots?of?abdominal?visceral?adipose?tissue?(VAT)?measurements?and?analyses.?The?
green?line?represents?perfect?agreement,?the?orange?line?represents?the?mean?difference,?and?the?red?lines?
represent?the?limits?of?agreement.?A.?Agreement?over?time?between?two?VAT?volume?measurements?with?
8?weeks? in?between;? the?mean?difference?was?not? statistically? significant.?B.? Intra?observer?agreement? in?
analyses?of?VAT?area?in?a?single?slice;?the?mean?difference?was?not?statistically?significant.?C.?Inter?observer?
agreement? in? analyses? of? VAT? area? in? a? single? slice;? the? mean? difference? was? statistically? significant?
(?12.5?cm2;?p?<?0.05).?D.?Agreement?between?pixel?by?pixel?quantification?and?Hippo?Fat? software?of?VAT?
area,?the?mean?difference?was?statistically?significant?(13.8?cm2;?p?<?0.05).?Visually,?a?trend?towards?greater?
increase?in?measurement?error?with?increasing?mean?VAT?area?was?seen,?yet?was?not?statistically?significant?
(??=?0.005;?p?=?0.86)?Nonetheless,?these?limits?of?agreement?should?be?interpreted?with?care.?
?
?
As? for? IHL?analyses,? the?mDixon? sequence?was? compared? to? 1H?MRS?with? the? latter?
considered? to? be? the? gold? standard.? The? ICC? between? both? techniques? was? 0.82?
(p?<?0.001;? n?=?45),? whereas? the? SEM? was? not? calculated? due? to? structural?
overestimation? in? individuals?with? low? IHL? and? underestimation? in? individuals?with?
high? IHL,? as? illustrated? by? the? Bland?Altman? plot? (Figure? 3.3D).? By?means? of? linear?
regression,?we?found?that?IHL?by?means?of?mDixon?was?associated?with?IHL?by?means?
of?1H?MRS?(Figure?3.3E;???=?0.432;?p?<?0.001).?Moreover,?the?presence?of?NAFLD?could?
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be?differentiated?nearly?as?well?with?mDixon?as?compared?to?1H?MRS?(Cohen’s?kappa?
0.90).?
?
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Figure? 3.2? –? Bland?Altman? plots? of? abdominal? subcutaneous? adipose? tissue? (SAT)? measurements? and?
analyses.?The?green?line?represents?perfect?agreement,?the?orange?line?represents?the?mean?difference,?and?
the? red? lines? represent? the? limits? of? agreement.? A.? Agreement? over? time? between? two? SAT? volume?
measurements?with? 8?weeks? in? between;? the?mean? difference?was? not? statistically? significant.? B.? Intra?
observer? agreement? in? analyses? of? SAT? area? in? a? single? slice;? the?mean? difference?was? not? statistically?
significant.?C.? Inter?observer?agreement? in?analyses?of?SAT?area? in?a?single?slice;?the?mean?difference?was?
statistically?significant? (?5.2?cm2;?p?<?0.05).?D.?Agreement?between?pixel?by?pixel?quantification?and?Hippo?
Fat?software?of?SAT?area;?the?mean?difference?was?statistically?significant?(16.1?cm2;?p?<?0.05).?
?
539883-L-sub01-bw-Kusters
Processed on: 13-1-2020 PDF page: 91
? Reliability,?measurement?error?and?methodology?
91?
3?
?????A???????????????????????????????????????????????????????????????????????????B?
?
?
?
?
?
?
?
?
?
?????C???????????????????????????????????????????????????????????????????????????D?
?
?
?
?
?
?
?
?
?
?
?????E????
?
?
?
?
?
?
?
?
?
?
Figure? 3.3? –? In?panel?A?D,?Bland?Altman?plots?of? intrahepatic? lipid? (IHL;? in?%?points)?measurements? and?
analyses?are?presented,?where?the?green?line?represents?perfect?agreement,?the?orange?line?represents?the?
mean?difference,?and?the?red?lines?represent?the?limits?of?agreement.?A.?Agreement?over?time?between?two?
IHL?measurements?with?8?weeks?in?between;?the?mean?difference?was?not?statistically?significant.?B.?Intra?
observer? agreement? in? analyses? of? IHL;? the? mean? difference? was? not? statistically? significant.? C.? Inter?
observer?agreement?in?analyses?of?IHL;?the?mean?difference?was?not?statistically?significant.?D.?Agreement?
between? IHL? quantification? by?means? of?mDixon? and? 1H?MRS.? As? the? assumptions? of? the? Bland?Altman?
analyses?are?violated,?the?mean?difference?and?limits?of?agreement?are?useless.?E.?Scatterplot?between?IHL?
by?means?of? 1H?MRS?and?mDixon.?The?green? line? represents?perfect?agreement,?whereas? the?orange? line?
represents?the?regression?equation?fitted?to?the?data.?
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Figure?3.4?–?Bland?Altman?plots?of?intrapancreatic?lipid?(IPL;?in?%?points)?measurements?and?analyses.?The?
green?line?represents?perfect?agreement,?the?orange?line?represents?the?mean?difference,?and?the?red?lines?
represent?the?limits?of?agreement.?A.?Agreement?over?time?between?two?IPL?measurements?with?8?weeks?in?
between;?the?mean?difference?was?not?statistically?significant.?B.? Intra?observer?agreement? in?analyses?of?
IPL;?the?mean?difference?was?not?statistically?significant.?C.?Inter?observer?agreement?in?analyses?of?IPL;?the?
mean?difference?was?not?statistically?significant.?
?
Table?3.2?–?Intraclass?correlation?coefficients?for?analyses.?
? Intra?observer? Inter?observer?
Anthropometric?variables? ? ?
Subcutaneous?Adipose?Tissue? ? 0.998?***a? ? 0.996?***a?
Visceral?Adipose?Tissue? ? 0.992?***a? ? 0.971?***a?
Intrahepatic?Lipid? ? 0.995?***b? ? 0.992?***c?
Intrapancreatic?Lipid? ? 0.955?***b? ? 0.882?***d?
Microvascular?variables? ? ?
Muscle?Microvascular?Recruitment? ? 0.977?***e? N/A?
Capillary?Microscopy?(baseline)? ? 0.940?**f? ? 0.989?***g?
Capillary?Microscopy?(HE)? ? 0.995?**f? ? 0.967?***g?
Capillary?Microscopy?(?HE)? ? 0.881?**f? ? 0.492?*g?
Capillary?Microscopy?(VO)? ? 0.956?**f? ? 0.987?***g?
Flowmotion?(endothelial?component)? ? 1.000?***g? ? 0.882?***h?
Flowmotion?(neurogenic?component)? ? 0.987?***g? ? 0.957?***h?
Flowmotion?(myogenic?component)? ? 0.988?***g? ? 0.847?***h?
Macrovascular?variables? ? ?
Flow?mediated?Dilation? ? 0.881?***i? ? 0.836?***i?
Data?presented?as?intraclass?correlation?coefficient?(ICC)?with?absolute?agreement?in?a?two?way?mixed?effects?
model.?Intra??and?inter?observer?ICCs?are?presented.?*?p?<?0.05,?**?p?<?0.01,?***?p?<?0.001.?Analyzed?in?a?n?=?29;?b?
n?=?10;?c?n?=?15;?d?n?=?14;?e?n?=?21;?f?n?=?6;?g?n?=?5;?h?n?=?35;?i?n?=?25.?N/A?is?noted?when?data?was?not?available.?
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Table?3.3?–?Intraclass?correlation?coefficients?between?current?method?and?gold?standard.?
Visceral?Adipose?Tissue? 0.967?***?a?
Subcutaneous?Adipose?Tissue?? 0.987?***?a?
Intrahepatic?Lipid? 0.823?***?b?
Data?presented?as?one?way?intraclass?correlation?coefficient?(ICC).?ICC?SAT?and?VAT?compares?analyses?with?
Hippo? Fat? software? to? pixel?by?pixel? analyses.? ICC? IHL? compares? mDixon? sequence? to? 1H?MRS.?
***?p?<?0.001.?Analyzed?in?a?n?=?29,?b?n?=?45.?
?
Microvascular?measurements?
Muscle?microvascular?recruitment??
In?the?CEUS?Reproducibility?Study,?the?intra?observer?reliability?of?MVR?measurement?
by?means? of? CEUS? was? assessed? in? 7? individuals? (one? individual? lacked? one?MVR?
measurement?due?to?technical? issues)?and? in?6? individuals?over?time?(two? individuals?
dropped? out? because? of? personal? issues).? ICCintra? and? ICCtime? were? 0.89? and? 0.83,?
respectively?(Table?3.1;?p?<?0.05?for?each),?whereas?SEMintra?was?0.17?and?SEMtime?was?
0.43? (videointensity).? The? companion? Bland?Altman? plots? are? presented? below?
(Figures?3.5A?and?3.5B).?The?overall? intra?observer? reliability?of?MVR?measurements?
was?0.86? (ICCoverall;?p?<?0.001).? In?addition,?the?reliability?of?MVR?measurements?over?
time?was?also?assessed? in? the?weight? stable? control?group?of? the?WLI? trial? (n?=?26),?
where? the? ICCtime?was?0.61? (p?<?0.05),?SEMtime?was?20%,?and? its?Bland?Altman?plot? is?
depicted?below?(Figure?3.5C).??
?
As?for?the?analyses?of?MVR,?ICCintra?was?0.98?(p?<?0.001)?and?SEMintra?was?9.0%?(n?=?21).?
The?Bland?Altman?plot?of?the? intra?observer?reliability?of?the?analyses?with?the? limits?
of?agreement?is?presented?below?(Figure?3.5D).?Of?note,?no?adverse?events?related?to?
CEUS?were?observed?in?143?measurements?in?82?unique?individuals.??
Capillary?microscopy?
For?reliability?over?time?of?capillary?microscopy?measurements,?data?on?24?individuals?
from? the? weight? stable? control? group? of? the?WLI? Trial? were? used? as? two? of? the?
26?controls? (i.e.,? 8%)? had? no? matching? ROI? between? baseline? and? follow?up?
measurements.? The? ICCtime? of? continuously? perfused? capillaries,? insulin?induced?
capillary? recruitment,?perfused? capillaries?during?post?occlusive?hyperemia,? capillary?
recruitment?by?hyperemia? and?erythrocyte?filled? capillaries?during? venous?occlusion?
were?0.66,?0.05,?0.82,?0.67,?and?0.81? respectively? (Table?3.1).?The?SEMtime?was?11.3?
continuously? perfused? capillaries,? 18%?point? insulin?induced? capillary? recruitment,?
9.6?capillaries? during? hyperemia,? 8.5? recruited? capillaries,? and? 9.8? capillaries? during?
venous? occlusion.? The? respective? Bland?Altman? plots? are? presented? below? (Figures?
3.6A,?3.7,?3.8A,?3.9A?and?3.10A).?The? intra??and? inter?observer? reliability?of?capillary?
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microscopy? analyses?were? assessed? in? 6? and? 5? individuals,? respectively.? ICCintra? for?
analyses? of? continuously? perfused? capillaries,? perfused? capillaries? during? post?
occlusive? hyperemia,? capillary? recruitment? by? hyperemia? and? erythrocyte?filled?
capillaries? during? venous? occlusion? were? all? >?0.88? (p?<?0.01? for? each),? as? their?
respective? SEMintra? was? 2.9,? 1.2,? 3.9? and? 4.4? capillaries.? ICCinter? was? >?0.96? for?
continuously? perfused? capillaries,? perfused? capillaries? during? post?occlusive?
hyperemia?and?erythrocyte?filled?capillaries?during?venous?occlusion,?yet?for?capillary?
recruitment?by?hyperemia?was?markedly?lower?(0.49;?p?<?0.01?for?each?ICC;?Table?3.2).?
SEMinter?was?1.4?continuously?perfused?capillaries,?3.4?capillaries?during?hyperemia,?3.2?
recruited? capillaries,? and? 3.5? capillaries? during? venous? occlusion.? The? Bland?Altman?
plots? of? intra?observer? (Figures? 3.6B,? 3.8B? and? 3.9B)? and? inter?observer? agreement?
(Figures?3.6C,?3.8C,?3.9C?and?3.10C)?are?presented?below.??
?
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Figure? 3.5? –? Bland?Altman? plots? of?measurements? and? analyses? of?microvascular? recruitment? (MVR;? in?
%?points)? in? forearm? skeletal? muscle.? The? green? line? represents? perfect? agreement,? the? orange? line?
represents? the?mean? difference,? and? the? red? lines? represent? the? limits? of? agreement.?A.? Intra?observer?
agreement?between?two?MVR?measurements?performed?on?the?same?day?(1?hour? in?between);?the?mean?
difference?was?not?statistically?significant.?B.?Agreement?over?time?between?two?MVR?measurements?with?
1?week?in?between;?the?mean?difference?was?not?statistically?significant.?C.?Agreement?over?time?between?
two?MVR?measurements?with?8?weeks? in?between;? the?mean?difference?was?not? statistically? significant.?
D.?Intra?observer?agreement?in?analyses?of?MVR;?the?mean?difference?was?not?statistically?significant.?
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Figure?3.6?–?Bland?Altman?plots?of?continuously?perfused?nailfold?capillaries?at?baseline?(BL;?i.e.,?fasted)?by?means?
of?nailfold?capillary?videomicroscopy?measurements?and?analyses.?The?green? line?represents?perfect?agreement,?
the?orange?line?represents?the?mean?difference,?and?the?red?lines?represent?the?limits?of?agreement.?A.?Agreement?
over?time?between?two?capillary?videomicroscopy?measurements?with?8?weeks?in?between;?the?mean?difference?
was?not?statistically?significant.?B.? Intra?observer?agreement? in?analyses?of?capillary?videomicroscopy;?the?mean?
difference?was?not?statistically?significant.?C.? Inter?observer?agreement? in?analyses?of?capillary?videomicroscopy;?
the?mean?difference?was?statistically?significant?(?3.2?capillaries;?p?<?0.05).?
Flowmotion?
Data?from?13? individuals?from?the?weight?stable?control?group?of?the?WLI?Trial?were?
used? to? assess? the? reliability?of? flowmotion? analyses?over? time.? For? the?endothelial?
(ICCtime? 0.63;? p?=?0.06)? and? neurogenic? component? of? flowmotion? (ICCtime? 0.70;?
p?<?0.05)? appeared? to?be? reliable?over? time? to? some?extent,?whereas? the?myogenic?
component?was?not?(Table?3.1;?ICCtime??0.03?and?thus?converted?to?0.00;?p?=?0.52).54,55?
The?latter?could,?however,?be?attributed?to?one?measurement?that?contained?several?
artifacts;?when?this?measurement?was?excluded,?the?reliability?increased?substantially?
(ICCtime? 0.67;? p?<?0.05;? n?=?12).? The? SEMtime? was? 0.55? arbitrary? units? (AU)? for? the?
endothelial,?0.88?AU?for?the?neurogenic,?and?1.57?AU?for?the?myogenic?component.?If?
the?measurement?with?artifacts?was?excluded,?SEMtime? for? the?myogenic?component?
dropped?to?0.77?AU.?The?companion?Bland?Altman?plots?are?presented?below?(Figures?
3.11A,?3.12A,?3.13A?and?3.13B).?
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Figure?3.7?–?Bland?Altman?plot?of?agreement?over?time?in?insulin?induced?increase?in?continuously?perfused?
nailfold? capillaries? (?Ins;? in?%?points)?by?means?of?nailfold? capillary? videomicroscopy?measurements;? the?
mean?difference?was?not?statistically?significant.?The?green? line?represents?perfect?agreement,?the?orange?
line?represents?the?mean?difference,?and?the?red?lines?represent?the?limits?of?agreement.?
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Figure?3.8?–?Bland?Altman?plots?of?perfused?nailfold?capillaries?during?post?occlusive?hyperemia?(HE)?by?means?
of? nailfold? capillary? videomicroscopy? measurements? and? analyses.? The? green? line? represents? perfect?
agreement,? the? orange? line? represents? the? mean? difference,? and? the? red? lines? represent? the? limits? of?
agreement.?A.?Agreement?over?time?between?two?capillary?videomicroscopy?measurements?with?8?weeks? in?
between;?the?mean?difference?was?statistically?significant?(?7.4?capillaries;?p<0.05).?B.?Intra?observer?agreement?
in?analyses?of?capillary?videomicroscopy;?the?mean?difference?was?not?statistically?significant.?C.?Inter?observer?
agreement?in?analyses?of?capillary?videomicroscopy;?the?mean?difference?was?not?statistically?significant.?
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Figure?3.9?–?Bland?Altman?plots?of?capillary?recruitment?by?hyperemia?(?HE)?by?means?of?nailfold?capillary?
videomicroscopy?measurements?and?analyses.?The?green?line?represents?perfect?agreement,?the?orange?line?
represents? the?mean?difference,?and? the? red? lines? represent? the? limits?of?agreement.?A.?Agreement?over?
time?between?two?capillary?videomicroscopy?measurements?with?8?weeks?in?between;?the?mean?difference?
was?not?statistically?significant.?B.? Intra?observer?agreement? in?analyses?of?capillary?videomicroscopy;? the?
mean? difference? was? not? statistically? significant.? C.? Inter?observer? agreement? in? analyses? of? capillary?
videomicroscopy;?the?mean?difference?was?statistically?significant?(7.4?capillaries;?p?<?0.05).?
?
?
Intra?observer? reliability? of? flowmotion? analyses? was? assessed? in? a? subset? of?
participants? of? the?Maastricht? Study? (n?=?5),? whereas? the? inter?observer? reliability?
(n?=?35)?of? flowmotion?analyses?was?evaluated? in?a?masked? subset?of? the?WLI? trial.?
ICCintra?was?1.00?for?the?endothelial,?0.99?for?the?neurogenic?and?0.99?for?the?myogenic?
component? (Table? 3.2;? p?<?0.001? for? each),? as? the? SEMintra? of? the? respective?
components?were?0.02,?0.26?and?0.27?AU.?The? ICCinter?was? lower?for?all?components,?
yet?was?still?>?0.84?(Table?3.2;?p?<?0.001)?for?each.?The?SEMinter?was?0.30?arbitrary?units?
(AU)? for? the?endothelial,?0.32?AU? for? the?neurogenic,?and?0.62?AU? for?the?myogenic?
component.? The? Bland?Altman? plots? of? intra?observer? (Figures? 3.11B,? 3.12B? and?
3.13C)?and?inter?observer?agreement?(Figures?3.11C,?3.12C?and?3.13D)?are?presented?
below.??
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Figure?3.10?–?Bland?Altman?plots?of?erythrocyte?filled?capillaries?during?venous?occlusion?(VO)?by?means?of?
nailfold? capillary? videomicroscopy? measurements? and? analyses.? The? green? line? represents? perfect?
agreement,? the? orange? line? represents? the?mean? difference,? and? the? red? lines? represent? the? limits? of?
agreement.?A.?Agreement?over?time?between?two?capillary?videomicroscopy?measurements?with?8?weeks?in?
between;? the?mean? difference? was? statistically? significant? (?6.7? capillaries;? p? <? 0.05).? B.? Intra?observer?
agreement? in?analyses?of? capillary?videomicroscopy;? the?mean?difference?was?not? statistically? significant.?
C.?Inter?observer? agreement? in? analyses? of? capillary? videomicroscopy;? the? mean? difference? was? not?
statistically?significant.?
?
Sublingual?microvascular?perfused?boundary?region?(Glycocalyx)?
Reliability? over? time? of? PBR?was? assessed? in? 26? individuals? from? the?weight? stable?
control? group? of? the?WLI? Trial.? ICCtime? was? ?0.15? and?was? thus? converted? to? 0.00?
(p?=?0.76;54)? and? SEMtime? was? 0.20? ?m.? The? Bland?Altman? plot? is? presented? below?
(Figure?3.14).??
?
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Figure?3.11?–?Bland?Altman?plots?of?the?endothelial?derived?flowmotion?spectrum?(FMEC)?by?means?of?laser?
Doppler? flowmetry? (LDF)?measurements?and?analyses.?The? green? line? represents?perfect? agreement,? the?
orange? line? represents? the? mean? difference,? and? the? red? lines? represent? the? limits? of? agreement.?
A.?Agreement?over?time?between?two?LDF?measurements?with?8?weeks? in?between;?the?mean?difference?
was?not?statistically?significant.?B.?Intra?observer?agreement? in?analyses?of?FMEC;?the?mean?difference?was?
not?statistically?significant.?C.? Inter?observer?agreement? in?analyses?of?FMEC;?the?mean?difference?was?not?
statistically?significant.?
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Figure?3.12?–?Bland?Altman?plots?of?the?neurogenic?flowmotion?spectrum?(FMNC)?by?means?of?laser?Doppler?
flowmetry?(LDF)?measurements?and?analyses.?The?green?line?represents?perfect?agreement,?the?orange?line?
represents? the?mean?difference,?and? the? red? lines? represent? the? limits?of?agreement.?A.?Agreement?over?
time?between?two?LDF?measurements?with?8?weeks? in?between;?the?mean?difference?was?not?statistically?
significant.? B.? Intra?observer? agreement? in? analyses? of? FMNC;? the?mean? difference? was? not? statistically?
significant.? C.? Inter?observer? agreement? in? analyses? of? FMNC;? the?mean? difference? was? not? statistically?
significant.?
?
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Figure?3.13?–?Bland?Altman?plots?of?the?myogenic?flowmotion?spectrum?(FMMC)?by?means?of?laser?Doppler?
flowmetry?(LDF)?measurements?and?analyses.?The?green?line?represents?perfect?agreement,?the?orange?line?
represents? the?mean?difference,?and? the? red? lines? represent? the? limits?of?agreement.?A.?Agreement?over?
time?between?two?LDF?measurements?with?8?weeks? in?between;?the?mean?difference?was?not?statistically?
significant.?B.?Agreement?over?time?between?two?LDF?measurements?with?8?weeks?in?between,?one?outlier?
was? excluded? to? illustrate? its? effect? on? agreement;? the?mean? difference?was? not? statistically? significant.?
C.?Intra?observer?agreement? in?analyses?of?FMMC;? the?mean?difference?was?not? statistically? significant.?D.?
Inter?observer?agreement?in?analyses?of?FMMC;?the?mean?difference?was?not?statistically?significant.?
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Figure? 3.14? –?Bland?Altman?plot?of? agreement?over? time? in? sublingual?microvascular?perfused?boundary?
region?(PBR)?measurements?with?8?weeks?in?between;?the?mean?difference?was?not?statistically?significant.?
The?green?line?represents?perfect?agreement,?the?orange?line?represents?the?mean?difference,?and?the?red?
lines?represent?the?limits?of?agreement.?
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Macrovascular?measurements?
Flow?mediated?dilation?
As? published? before,? intra?observer? reliability? and? reliability? over? time? of? FMD?
measurements? was? determined? in? a? group? of? 22? individuals? from? the? Acute?
Hyperglycemia? Study.14? In? this? study,? ICCintra?was? 0.68,? ICCtime?was? 0.53? (Table? 3.1;?
p?<?0.05? for? each),? SEMintra?was? 1.3%?point? and? SEMtime?was? 1.9%?point;? the? Bland?
Altman? plots? are? presented? below? (Figures? 3.15A? and? 3.15B).?Additionally,?we? also?
evaluated?reliability?over?time? in?23? individuals?from?the?weight?stable?control?group?
of?the?WLI?Trial?(3?of?26?controls?were?excluded?due?to?technical?issue),?which?yielded?
similar?results?for?ICCtime?(0.53;?p?<?0.01;?Table?3.1)?and?SEMtime?(1.8%?point).?
Intra?? and? inter?observer? reliability? of? FMD? analyses?were? assessed? in? a? subset? of?
25?lean? and? abdominally?obese? individuals? that?participated? in? the?WLI? trial.? ICCintra?
was?0.88,?ICCinter?was?0.84?(Table?3.2;?p?<?0.001?for?each),?SEMintra?was?0.3%?point,?and?
SEMinter?was?0.7%?point.?The?Bland?Altman?plots?of? intra?observer?and? inter?observer?
agreement?of?the?analyses?are?presented?below?(Figures?3.15C?and?3.15D).?
Reactive?Hyperemia?Index??
Reliability?of?RHI?measurements?over?time?was?assessed? in?a?subset?of?14? individuals?
from? the?weight? stable?control?group?of? the?WLI? trial? (i.e.,? the?control? subjects? that?
were?enrolled?when?60%?of?the?trial?was?completed).? In?this?subset,? ICCtime?was?0.58?
(Table? 3.1;? p?<?0.001)? and? SEMtime? was? 0.32%?point;? the? Bland?Altman? plot? is?
presented?below?(Figure?3.16).?
Carotid?femoral?pulse?wave?velocity?and?augmentation?index??
The? intra?? and? inter?observer? reliability? (n?=?12),? as?well? as? the? reliability? over? time? of?
cfPWV?and?Aix?measurements?(n?=?11)?were?determined?in?a?subset?of?individuals?from?the?
Maastricht?Study.?For?cfPWV?all?ICCs?were?>?0.81?(Table?3.1;?p?<?0.01?for?each),?whereas?for?
Aix? ICCintra?(0.61)?and? ICCinter?(0.60;?Table?3.1;?p?<?0.05?for?each)?were?considerably? lower.?
For?cfPWV,?SEMintra?was?0.3?m/s,?SEMinter?was?1.0?m/s?and?SEMtime?was?0.9?m/s.?As?for?Aix,?
SEMintra,?SEMinter?and?SEMtime?were?1.8,?4.3?and?3.1%?point,?respectively.?The?companion?
Bland?Altman?plots?are?presented?below?(Figures?3.17A?C?and?3.18A?C).?
?
?
?
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Figure?3.15?–?Bland?Altman?plots?of?Flow?mediated?Dilation? (FMD;? in?%?points)?measurements?and?analyses.?
The?green?line?represents?perfect?agreement,?the?orange?line?represents?the?mean?difference,?and?the?red?lines?
represent?the? limits?of?agreement.?A.?Intra?observer?agreement?of?FMD?measurements;?the?mean?difference?
was?not? statistically? significant.?B.?Agreement?over? time?between? two? FMD?measurements?with?1?week? in?
between;?the?mean?difference?was?not?statistically?significant.?C.?Intra?observer?agreement?over?time?between?
two? FMD?measurements? with? 8? weeks? in? between;? the?mean? difference? was? not? statistically? significant.?
D.?Intra?observer?agreement? in?FMD?analyses;? the?mean?difference?was? statistically? significant? (?0.2%?point;?
p?<?0.05).?E.?Inter?observer?agreement?in?FMD?analyses;?the?mean?difference?was?not?statistically?significant.?
?
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Figure?3.16?–?Bland?Altman?plot?of?agreement?over?time?in?Reactive?Hyperemia?Index?(RHI)?measurements?
with?8?weeks? in?between;? the?mean?difference?was?not?statistically?significant.?The?green? line? represents?
perfect?agreement,?the?orange?line?represents?the?mean?difference,?and?the?red?lines?represent?the?limits?of?
agreement.?
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Figure?3.17?–?Bland?Altman?plots?of?carotid?femoral?pulse?wave?velocity?(cfPWV)?measurements.?The?green?
line? represents? perfect? agreement,? the? orange? line? represents? the?mean? difference,? and? the? red? lines?
represent? the? limits? of? agreement.? A.? Intra?observer? agreement? of? cfPWV? measurements;? the? mean?
difference?was?not?statistically?significant.?B.?Inter?observer?agreement?of?cfPWV?measurements;?the?mean?
difference?was?not?statistically?significant.?C.?Agreement?over?time?between?two?cfPWV?measurements?with?
1?week?in?between;?the?mean?difference?was?not?statistically?significant.??
?
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Figure? 3.18? –?Bland?Altman?plots?of? augmentation? index? (at?75?heartbeats?per?minute;?Aix?@75bpm;? in?
%?points)? measurements? and? analyses.? The? green? line? represents? perfect? agreement,? the? orange? line?
represents? the?mean? difference,? and? the? red? lines? represent? the? limits? of? agreement.?A.? Intra?observer?
agreement?of?Aix?@75bpm?measurements;? the?mean?difference?was?not? statistically? significant.?B.? Inter?
observer?agreement?of?Aix?@75bpm?measurements;? the?mean?difference?was?not?statistically?significant.?
C.?Agreement? over? time? between? two? Aix?@75bpm?measurements?with? 1?week? in? between;? the?mean?
difference?was?not?statistically?significant.??
?
Carotid?distensibility,?distensibility?coefficient,?compliance?coefficient,?and?intima?
media?thickness?
The? intra?observer? reliability? of? carotid? distensibility? (n?=?12)? and? cIMT? (n?=?11),? the?
inter?observer? reliability?of? carotid?distensibility,?DC,?CC?and? cIMT? (n?=?12? for?each),?
and? reliability? over? time? of? carotid? distensibility? (n?=?11),?DC? (n?=?9),? CC? (n?=?9)? and?
cIMT? (n?=?11)?were?determined? in?a?subset?of? individuals?from?the?Maastricht?Study.?
For?carotid?distensibility,?all?ICCs?were?>?0.75?(Table?3.1;?p?<?0.05?for?each)?as?SEMintra,?
SEMinter?and?SEMtime?were?0.4,?0.8?and?0.5%?point,?respectively.?For?both?DC?and?CC,?
ICCinter? and? ICCtime?were? >? 0.84? (Table? 3.1;? p?<?0.01? for? each).? For? DC? SEMinter? and?
SEMtime?were?1.1?and?2.5?10?3/kPa,?respectively,?whereas?for?CC,?SEMinter?was?0.14?and?
SEMtime?was?0.06?mm2/kPa.?As?for?cIMT,?both?ICCintra?and?ICCtime?were?>?0.84?(p?<?0.01?
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for?each),?whereas?ICCinter?was?remarkably?low?(0.27;?Table?3.1);?SEMintra,?SEMinter?and?
SEMtime?were? estimated? at? 31,? 93? and? 49? ?m,? respectively.? The? companion? Bland?
Altman?plots?are?presented?below?(Figures?3.19?22).?
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Figure?3.19?–?Bland?Altman?plots?of?carotid?distensibility?(Dist.;?in?%?points)?measurements.?The?green?line?
represents?perfect?agreement,?the?orange?line?represents?the?mean?difference,?and?the?red?lines?represent?
the? limits? of? agreement.?A.? Intra?observer? agreement? of? carotid? distensibility?measurements;? the?mean?
difference? was? not? statistically? significant.? B.? Inter?observer? agreement? of? carotid? distensibility?
measurements;?the?mean?difference?was?not?statistically?significant.?C.?Agreement?over?time?between?two?
carotid? distensibility?measurements?with? 1?week? in? between;? the?mean? difference?was? not? statistically?
significant.???
?
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Figure? 3.20? –?Bland?Altman?plots?of? carotid?distensibility? coefficient? (DC)?measurements.? The? green? line?
represents?perfect?agreement,?the?orange?line?represents?the?mean?difference,?and?the?red?lines?represent?
the? limits? of? agreement.? A.? Inter?observer? agreement? DC?measurements;? the?mean? difference?was? not?
statistically?significant.?B.?Agreement?over?time?between?two?DC?measurements?with?1?week? in?between;?
the?mean?difference?was?statistically?significant?(?2.2?/MPa;?p?<?0.05).??
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Figure? 3.21? –? Bland?Altman? plots? of? carotid? compliance? coefficient? (CC)?measurements.? The? green? line?
represents?perfect?agreement,?the?orange?line?represents?the?mean?difference,?and?the?red?lines?represent?
the? limits? of? agreement.? A.? Inter?observer? agreement? CC?measurements;? the?mean? difference?was? not?
statistically?significant.?B.?Agreement?over?time?between?two?CC?measurements?with?1?week? in?between;?
the?mean?difference?was?statistically?significant?(?0.08?mm2/kPa;?p?<?0.05).??
?
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Figure?3.22?–?Bland?Altman?plots?of?carotid? intima?media? thickness? (cIMT)?measurements.?The?green? line?
represents?perfect?agreement,?the?orange?line?represents?the?mean?difference,?and?the?red?lines?represent?
the? limits? of? agreement.?A.? Intra?observer? agreement? of? cIMT?measurements;? the?mean? difference?was?
statistically? significant? (42? ?m;?p?<?0.05).?B.? Inter?observer? agreement?of? cIMT?measurements;? the?mean?
difference?was?not?statistically?significant.?C.?Agreement?over?time?between?two?cIMT?measurements?with?
1?week?in?between;?the?mean?difference?was?not?statistically?significant.??
?
Metabolic?measurements?
Whole?body?glucose?disposal?
The? reliability? over? time? of?WBGD?measurement? by?means? of? a? euglycemic? insulin?
clamp?was?assessed?in?the?weight?stable?control?group?of?the?WLI?trial?(n?=?26).?In?this?
study? population,? ICCtime? was? 0.88? (Table? 3.1;? p?<?0.001)? and? SEMtime? was?
0.61?mg/kg/min;?the?Bland?Altman?plot? is?presented?below?(Figure?3.23).?No?adverse?
events?(e.g.,?hypoglycemia)?occurred?in?129?clamps?in?79?unique?individuals.??
Beta?cell?function?
The? reliability? over? time? of? BCF?measurements?were? assessed? in? the?weight? stable?
control?group?of?the?WLI?trial? (n?=?26).?The? ICCtime?for???GS,???RS?and?PFR?were?0.46,?
0.45,?and?0.42?respectively?(p?<?0.05?for?each).?The?SEMtime?was?11.9?pmol/min/m2/mM?
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for???GS,?203?pmol/m2/mM?for???RS,?and?0.16?for?PFR.?The?respective?Bland?Altman?
plots?are?presented?below?(Figures?3.24?26).?
?
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?
Figure? 3.23? –? Bland?Altman? plot? of? agreement? over? time? in? whole? body? glucose? disposal? (WBGD)?
measurements?by?means?of?a?euglycemic?insulin?clamp?with?8?weeks?in?between;?the?mean?difference?was?
not? statistically? significant.? The? green? line? represents?perfect? agreement,? the?orange? line? represents? the?
mean?difference,?and?the?red?lines?represent?the?limits?of?agreement.?
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Figure? 3.24? –? Bland?Altman? plot? of? agreement? over? time? in? beta?cell? glucose? sensitivity? (??GS)?
measurements?by?means?of?mathematically?modeling?mixed?meal?test?data?with?8?weeks? in?between;?the?
mean?difference?was?not?statistically?significant.?The?green? line?represents?perfect?agreement,?the?orange?
line?represents?the?mean?difference,?and?the?red?lines?represent?the?limits?of?agreement.?
?
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Figure?3.25?–?Bland?Altman?plot?of?agreement?over?time?in?beta?cell?rate?sensitivity?(??RS)?measurements?by?
means?of?mathematically?modeling?mixed?meal? test?data?with?8?weeks? in?between;? the?mean?difference?
was?not?statistically?significant.?The?green?line?represents?perfect?agreement,?the?orange?line?represents?the?
mean?difference,?and?the?red?lines?represent?the?limits?of?agreement.?
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Figure?3.26?–?Bland?Altman?plot?of?agreement?over?time?in?potentiation?factor?ratio?(PFR)?measurements?by?
means?of?mathematically?modeling?mixed?meal? test?data?with?8?weeks? in?between;? the?mean?difference?
was?not?statistically?significant.?The?green?line?represents?perfect?agreement,?the?orange?line?represents?the?
mean?difference,?and?the?red?lines?represent?the?limits?of?agreement.?
?
Inflammatory?measurements?
CD11B?surface?expression?
Data?from?22? individuals?from?the?weight?stable?control?group?of?the?WLI?Trial?were?
used? to?assess? the? reliability?of?NK?CD11B?over? time.? ICCtime?was?0.74? (p?<?0.01)?and?
SEMtime?was?2231?arbitrary?units.?The?respective?Bland?Altman?plot?is?presented?below?
(Figure?3.27).?
?
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Plasma?biomarkers?of?low?grade?inflammation?
The? reliability?over? time?of?z?LGI?was?assessed? in? the?weight?stable?control?group?of?
the?WLI? trial? (n?=?26);? ICCtime?was?0.949? (p?<?0.001).? Since? z?LGI? is?dependent?of? the?
population?it?is?measured?in,?neither?SEMtime?was?calculated,?nor?was?a?Bland?Altman?
plot?created.?
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Figure? 3.27? –? Bland?Altman? plot? of? agreement? over? time? CD11B? expression? on? circulating?NK? cells? (NK?
CD11B)?measurements?by?means?of?flow?cytometry?with?8?weeks?in?between;?the?mean?difference?was?not?
statistically?significant.?The?green? line?represents?perfect?agreement,?the?orange? line?represents?the?mean?
difference,?and?the?red?lines?represent?the?limits?of?agreement.?
?
Discussion?
In? this? report? we? established? the? reliability? and? measurement? error? of? the?
measurement? and? analyses? of? several? anthropometric,? vascular,? metabolic,? and?
inflammatory?variables.?To?our? knowledge,? it? is? the? first? study? that?A)? reported? the?
reliability?and?measurement?error?on? these?variables?within?a?single?research?group,?
B)?reported? the? reliability?and?measurement?error?of? the?measurement?and? (offline)?
analyses?of? these?variables? separately,?and?C)? reported? reliability?and?measurement?
error? of?MVR?by?means? of?CEUS.?We?will? address? the? reliability? and?measurement?
error?of?the?gamut?of?variables?below.?
Anthropometric?variables?
The?measurements?and?the?analyses?of?both?VAT?and?SAT?volumes?were?very?reliable?
and?had? little?measurement?error.?The?reliability?presented?here? is? in? line?with? intra??
and? inter?observer? reliability?of?VAT? and? SAT?quantification?by?means?of? computed?
539883-L-sub01-bw-Kusters
Processed on: 13-1-2020 PDF page: 112
Chapter?3?
112?
tomography? (CT)? analyses? in? the? Framingham? Study? (ICC?=?0.99? for? each).56,57?Only?
when?we? compare? VAT? quantification?methods,?was? there? a? non?significant? trend?
towards? increasing?differences?between?both?methods?with? increasing?VAT?volume.?
This? difference?may? have? arisen? from? the? limitations? of? pixel?by?pixel? analyses,? in?
which?an?observer?often?either?does?or?does?not?count?a?pixel?at?the?edges?between?
VAT?and?surrounding?tissue,?whereas?software?like?Hippo?Fat?uses?thresholding?of?grey?
scales? to?quantify?VAT.?Hence,?although?pixel?by?pixel?analyses?are?often?considered?
to?be?the?gold?standard,?this?may?be?open?for?debate.?As?both?VAT?and?SAT?volumes?
are? very? reliable?within? and?between? trained?observers,? there? are?no?objections? to?
letting?multiple?observers?analyze?such?data,? though? it?would?be?advisable? to?adjust?
for?systematic?differences?between?observers.??
?
As?for?IHL?and?IPL,?measurements?and?analyses?were?reliable,?although?both?tended?to?
have?a?considerable?measurement?error?over?a?time?course?of?8?weeks.?This?may,?at?
least? in?part,?be?due? to?the?expected?biological?variance? in?a?control?group?of?a?WLI?
Trial? in?which? some? controls?are? likely? to?better? their? life? style?whereas?others?may?
loosen?the?reins.?In?many?weight?loss?intervention?studies?a?control?group?is,?however,?
lacking;?as?a?result?data?on?biological?variance?of?IHL?and?IPL?are?scarce.?As?the?SEMtime?
of?IHL?and?IPL?were?comparable,?this? indicates?more?variance?over?time? in?IPL?values?
than? IHL.? In?addition,?since?regional?differences? in?the? lipid?content?of?both? liver?and?
pancreas? are? common,? it? would? be? recommended? to? standardize? the? location? of?
measurement,? in?particular? in? repeated?measurements,?as?well?as? to?determine? IHL?
and?IPL?in?multiple?volume?of?interest,?if?possible.17,58?
?
With?regard?to?the?comparison?of?mDixon?to?1H?MRS?to?assess? IHL,?there?was?a?high?
level? of? agreement? and? NAFLD? could? be? differentiated?well.? Yet,? there? was? some?
overestimation?of?IHL?at?low?levels?and?an?underestimation?at?higher?IHL?levels,?which?
would?make?mDixon?prone? to? type?2?errors.?As? the?signal? intensity? in?water?and? fat?
images?of?mDixon?can?only?adopt?positive?values,?noise?is?erroneously?counted?as?IHL,?
particularly? at? low? IHL? levels.? Thus,? this? appears? to? be? intrinsic? to? the? mDixon?
sequence.? In? a? recent? study? comparing?mDixon? to? 1H?MRS,? the? ICC? between? both?
methods? was? substantially? higher? (0.98)? and? the? SEM?was? very? low? (0.01%?point,?
calculated? from58).? This?difference?might?be?due? to? incorporation?of?bile?ducts? and?
blood?vessels?in?the?volume?of?interest,?which?1H?MRS?does?as?well,?as?well?as?due?to?
different?scan?parameters.?Therefore,?we?chose?not?to?recalculate?IHL?values?based?on?
the?available?data.? It? is?worthwhile?to?compare?our?current?mDixon?settings?to?those?
used? in?different?studies? to?evaluate?whether? reliability?and?measurement?error?can?
be?further?improved?and?type?2?errors?avoided.??
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Microvascular?variables?
Here,?we? first? present? the? reliability? and?measurement? error? of?MVR? by?means? of?
CEUS.?We?consider?the?CEUS?based?measurements?of?MVR?to?be?safe,?reliable,?and?to?
have? a? low? intra?observer? measurement? error? (i.e.,? within?day)? and? a? moderate?
measurement?error?over?time?(20%?point?MVR?by?hyperinsulinemia,?8?weeks?between?
visits).?When? the? time? interval? was? shorter? and? handgrip? exercises? were? used? to?
induce? MVR? instead? of? hyperinsulinemia,? the? reliability? of? MVR? measurements?
obviously?increase.?Nonetheless,?the?overall?reliability?and?measurement?error?of?MVR?
measurements,? either? induced? by? exercise? or? hyperinsulinemia,?would? endorse? the?
use?of?CEUS?even? in? relatively?small?study?populations.?Of?note,?when? the?expected?
effect?of?an?intervention?is?estimated?to?be?lower?than?the?measurement?error?of?this?
technique,? the? sample? size? needed? to? demonstrate? an? effect? on?MVR?will? increase?
considerably.1?
?
With? regard? to?MVR? analyses,? the? intra?observer? reliability?of? a? single,?well?trained?
observer? is? considered? to? be? excellent,? whereas? inter?observer? reliability? was? not?
assessed? at? this? time.? Likely,? the? intra?observer? reliability? reported? here? is? even?
underestimated,?as?measurements?of?substandard? image?quality?were?oversampled.?
Because?inter?observer?reliability?is?lacking?here,?we?cannot?advise?whether?MVR?can?
be? measured? or? analyzed? by? multiple? observers? without? introducing? considerable?
error.? Nonetheless,? no? benefit? is? to? be? expected? from? letting? multiple? observers?
analyze? the? same?data? to? improve? reliability.? Instead,? stakeholders? should? invest? in?
adequate? training?of?study?staff? to?minimize?error? in? the?acquisition?and?analyses?of?
MVR?data,?as?well?as? limit?the?number?of?observers?trained?to?perform?CEUS?and? its?
analyses?to?ensure?sufficient?expertise.??
?
In?contrast? to?MVR?by?means?of?CEUS,?we? found? that?reliability?was? lower? for?other?
microvascular?variables.?Although? the? reliability?of?continuously?perfused?capillaries,?
perfused?capillaries?during?post?occlusive?hyperemia?and?erythrocyte?filled?capillaries?
during?venous?occlusion?for?both?measurements?as?well?as?analyses?were?reasonably?
good,? the? reliability?of? capillary? recruitment?by?hyperemia?or?hyperinsulinemia?was?
either? considerably? lower? or? absent.? This? allows? for? several? conclusions.? First,? this?
illustrates? the? importance? of? measurement? error,? as? measurement? error? was?
comparable? between? all? videomicroscopy?measures,?whereas?mainly? the? between?
subject? variance? differs? between? these? variables? and,? by? extension,? oft? provides? a?
false?sense?of?reliability?when?other?variables?than?capillary?recruitment?are?reported.?
Second,?the?reliability?of?nailfold?capillary?recruitment?by?hyperemia?is?comparable?to?
that? of? FMD,? a? generally? accepted? vascular? function?measurement.? Third,? insulin?
induced?capillary?recruitment?has?a?comparable?measurement?error?as?MVR,?yet?has?
substantially? less? between?subject? variance.? Finally,? inter?observer? variance? is?
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particularly? bothersome? in? nailfold? videomicroscopy.? As? capillary? videomicroscopy?
analyses? are? laborious,? we? advise? to? adjust? for? the? systematic? error? between?
observers?and? to? limit? the?number?of?observers;? to?analyze?data?by?more? than?one?
observer?to?increase?reliability?is?far?from?realistic?for?most?studies.??
?
As?for?flowmotion,?reliability?over?time?for?the?endothelial?and?neurogenic?component?
were? reasonable,? whereas? no? reliability? was? found? for? the? myogenic? component,?
although? the? latter? could? be? attributed? to? a?measurement? that? contained?multiple?
artifacts.? This? underscores? the? importance? of? efforts? to? reduce? the? influence? of?
recorded? artifacts,? either? by? using? different? analyses? (e.g.,? wavelet? analyses),? by?
improving? the? quality? of? the? recordings,? or? by? extending? the? duration? of? the?
measurements?to?allow?the?selection?of?an?artifact?free?time?frame.??
?
As?it?is?impossible?to?measure?flowmotion?at?the?exact?same?recording?site?twice,59,60?it?
could?be? considered? to?measure? flowmotion? at? several? standardized? sites? and? then?
average?the?results?of?those?recordings.?One?could?justify?the?latter?by?the?assumption?
that? the? microvascular? dysfunction? one? strives? to? quantify? would? affect? the? skin?
microvasculature? as? a?whole,? not? just? focally.? Although? inter?observer? reliability? of?
flowmotion?analyses?was?good,?the?difference?between?observers? is?most?obvious? in?
recordings?of?poor?quality.?Hence,?reliability?of?analyses?would?profit?by?using?different?
analyses? (e.g.,? wavelet? analyses),? by? improving? the? quality? and? number? of? the?
recordings,?by?limiting?the?number?of?observers?to?one?observer,?or?–?in?contrast?–?by?
increasing? the?number?of?observers.? To?differentiate?whether? just?one? experienced?
observer?or?multiple?observers?should?analyze?flowmotion?data,?one?should?study?the?
raw?data?to?identify?the?origin?of?error.?For?example,?does?one?observer?handle?data,?
perhaps? those? of? poor? quality,? in? a? wrong? way? or? just? differently?? Or? are? the?
differences?due? to? the? selection?of? the? analyzed? timeframe? in? the? recordings?? This?
should?be?further?investigated?in?future?reliability?studies.?
?
Lastly,?reliability?over?time?of?PBR?(i.e.,?glycocalyx)?in?the?sublingual?vascular?bed?was?
absent? in? this? study? population.? In? statistical? terms? this?means? that? the? between?
subject?variance?was?very? low,?whereas? the?measurement?error?was? large,?which? is?
visible? in?the?Bland?Altman?plot?and?the?SEM.?The?absence?of?reliability?is? in?contrast?
to? the? whitepaper? by? the? manufacturer,? which? states? that? PBR? is? “highly?
reproducible”,? although? data? on? reliability? was? not? provided,? nor? cited.28? We,?
therefore,?advise?against?the?use?of?this?technique?for?research?questions?where?the?
estimated?effect? size? is? low? (e.g.,?below? the?SEM),? like? in? the? subset?of?abdominally?
obese? individuals?without?T2DM?used? in?our?analyses.?Conversely,? in?situations?with?
large?between?subject?variance,?like?a?septic?shock,?PBR?might?be?more?reliable.?This?is?
illustrated? by? a? recent? study? that? assessed? inter?observer? reliability? of? PBR? in? a?
combined?population?of?patients?in?the?emergency?room?or?intensive?care?unit,?where?
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reliability? was? markedly? higher? (ICC?=?0.75)? as? a? result? of? larger? between?subject?
variance?(i.e.,?PBR?ranged?from?~1.8?to?~3.2.61?Interestingly,?the?SEM?was?comparable?
to?our?data?(SEM?0.18??m,?calculated?from61).?Hence,?as?we?stated?before,?reliability?
data?should?only?be?judged?in?the?population?and?clinical?setting?it?is?measured?in.??
Macrovascular?variables?
As?published?before,? the? intra?observer? reliability?of? FMD?measurements?as?well?as?
the? reliability? over? time,? were? reasonable.14? The? reliability? over? time? of? FMD?
measurements? in? obese? individuals? randomized? to? the?weight? stable? control? group?
was?comparable?to?data?from?our14?and?other?research?groups.62?66?As?for?the?analyses?
of?FMD,?intra?observer?reliability?was?excellent,?whereas?inter?observer?reliability?was?
slightly? lower,?mainly? in?measurements? of? substandard? image? quality.?We? should,?
however,? not? neglect? that? the? measurement? error? of? FMD? measurements? is?
substantial,? which? should? significantly? impact? power? calculations.? If? we,? however,?
compare? FMD? to? other? endothelial?dependent? and? nitric?oxide? mediated? vascular?
measurements? like? MVR,? nailfold? capillary? recruitment? and? the? endothelial?
component? of? flowmotion,? the? reliability? of? FMD? appeared? to? be? slightly? lower,?
although?not?statistically?significantly.?The?reliability?of?RHI?over?time?was?acceptable?
and? comparable? to? the? ICC? and? SEM? in? adult? volunteers? reported? elsewhere? (ICCs?
0.56?0.73;?SEMtime?0.38;67,68).?In?our?study?population,?reliability?of?RHI?and?FMD?were?
comparable,?whereas?often?FMD? is?considered? to?be?somewhat?more? reliable?when?
measured?simultaneously.67?As?FMD?and?RHI?measurements?had?a?SEM?comparable?to?
other?studies,14,62,65?67?either?FMD?had?less?between?subject?variance,?or?RHI?had?more?
between?subject?variance?than?expected.??
?
Our?data?on?the? inter?observer?and? intra?observer?reliability?and?measurement?error?
of?cfPWV?and?Aix?were?excellent?and?are?slightly?better? than?reported? in? individuals?
with? type? 2? diabetes.69? In? a? different? study,? where? both? healthy? individuals? and?
individuals? with? end?stage? renal? disease? were? included,? reliability? was? obviously?
higher,?yet?SEM?or?limits?of?agreement?were?not?presented.70?
?
As? for? carotid? distensibility,? DC? and? CC,? reliability? and? measurement? error? were?
excellent? and? were? comparable? to? those? reported? by? others.71?73? As? these?
measurements? are? already? usually? repeated? three? times,? little? improvement? in?
reliability? is? to? be? expected? from? increasing? the? number? of? measurements? or?
observers.? Unfortunately,? no? data? was? available? to? determine? the? reliability? and?
measurement? error? of? the? analyses? of? these? variables.? It? would? be? advisable? to?
determine?these?in?the?near?future,?though,?since?variables?like?these?are?used?in?large?
study? samples? (e.g.,? the? Maastricht? Study),? where? having? a? single? observer? for?
analyses?is?often?not?feasible.??
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The? intra?observer? reliability? and? reliability? over? time? of? cIMT,? as? well? as? their?
measurement?error?were?excellent?and?comparable?to?those?reported?by?others.71?The?
inter?observer?reliability?was,?however,?considerably? lower,?without?any?evidence?for?
a?structural?difference?between?the?two?observers.?Although?inter?observer?reliability?
was?poor? in? this? study?population,? its? SEM?was?actually? comparable? to? studies? that?
reported?good?inter?observer?reliability.71?Here,?again,?the?crux?is?the?lack?of?between?
subject?variance,?as?all?cIMT?measurements?in?our?population?were?between?0.75?and?
1? mm.? The? appreciation? of? cIMT? measurements? should? therefore,? as? with? every?
measurement,? be? related? on? the? population? and? situation? it? is? determined? in.? In?
addition,?it?is?known?that?cIMT?measurements?have?a?substantial?measurement?error?
that?depends,? for? example,?on? the? system?used,? the? anatomical? location?measured?
and? the? observer? that? performs? the?measurement.74? Thus,? standardization? of? cIMT?
measurements?is?essential?to?reduce?measurement?error.?From?our?data,?it?would?also?
be?sensible?to?either?have?each?individual?measured?by?multiple?observers?or?to?have?
one?observer?measure?all?individuals.??
Metabolic?variables?
The?reliability?of?WBGD?over?time? in?our?population?was?excellent.?We?can?compare?
the? reliability?and?measurement?error?of?WBGD? in?our?study?population? to? the? first?
study?on?the?euglycemic?insulin?clamp,?in?which?arterial?blood?glucose?was?drawn?and?
repeated?measures?were?available? in?four? individuals.? In?that?study,37?the? ICCtime?was?
0.97? and? the? SEMtime? was? 0.32?mg/kg/min.? That? study?most? likely? had? a? superior?
reliability?compared?to?ours?due?to?1)?the?use?of?arterial?blood?glucose? levels,?2)? less?
biological?variance?over?time,?because?there?was?less?time?in?between?measurements?
(1?week? vs.? 8?weeks),? and? 3)? a? greater? between?subject? variance? of?WBGD.?As? for?
dynamic?BCF?measurements?on? the?other?hand,? reliability?was?modest? and? SEMtime?
was?reasonable.?Since?obese?men?were?studied,?between?subject?variance?may?have?
been?relatively?small;?this?may?have?reduced?the?reliability?of?the?BCF?measurements.?
Inflammatory?measurements?
To? our? knowledge,? the? reliability? of? NK?CD11B? over? time? had? not? been? described?
previously,?yet?it?proved?to?be?very?good.?For?z?LGI,?reliability?over?time?was?downright?
excellent,?which? illustrates? the? statistical? effectiveness? of? this? approach,? as? argued?
before.51,52?
?
Our?study?has?several?strengths.?First,?we?simultaneously?presented?various?commonly?
used?anthropometric,?vascular,?metabolic?and?inflammatory?variables,?many?of?which?
are? reported? in? this? thesis.? In? addition,? we? assessed? not? only? reliability,? but? also?
measurement?error? in?order? to?gain?a?deeper?understanding?of? the?performance?of?
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each?technique?regardless?from?the?between?subject?variance?in?the?study?population.?
Moreover,?we?assessed?reliability?and?measurement?error?for?both?the?measurement?
of?a?variable?as?well?as?its?analyses,?which?allows?for?a?more?detailed?understanding?of?
sources?of?error.??
Several? limitations? of? this? reliability? study? should? also? be? noted.? First,? for? many?
variables?the?sample?size?was?relatively?small?to?obtain?a?robust?estimate?of?reliability.?
Second,? reliability? data? were? currently? not? available? for? all? possible? comparisons;?
future?studies?should? fill? in?the?gaps.?Third,?we?often?used?the?weight?stable?control?
group? of? the?WLI? trial?which? consisted? of? abdominally? obese?men? only? that?were?
partaking? in?a? life?style? trial.? It? is?known? that?participation? in?a? trial? in? itself? leads? to?
changes? in? behavior? that? influence? outcome? variables,?which? by? extension? reduces?
reliability.? As? this? held? true? for?many? variables,? their? reliability? can? be? effectively?
compared? to? one? another.? Fourth,? ICCs? are? only? relevant? in? the? population? it? is?
measured? in?and? (when?applicable)? to? the?stimulus?used? (e.g.,?handgrip?exercises?or?
hyperinsulinemia?for?MVR).?Finally,?reliability?and?measurement?error?are?dependent?
on? the?observer(s)?who?performed? the?measurements?or? analyses;? they?may?differ?
substantially?when?other?observers?are?evaluated.??
Conclusion?
Here,?we?established?the?reliability?and?measurement?error?of?MVR?by?means?of?CEUS?
for? the? first? time,? as?well? as? determine? reliability? and?measurement? error? of? other?
commonly?used?anthropometric,?vascular,?metabolic?and?inflammatory?variables.?This?
detailed? understanding? of? sources? of? measurement? error? and? the? reliability? of?
variables? in?a?certain?study?population?allows?for?the?adequate?selection?of?outcome?
measurements? in?observational?and? intervention?studies,?as?well?as?provide?data?for?
more?accurate?sample?size?calculations?for?such?studies.??
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Supplementary?material?
Table?S3.1?–?Study?population?characteristics?CEUS?Reproducibility?Study.?
Age?[Yr]? ? 26.4?[20.3???29.4]?
Sex?[M/F]? 3?/?5?
yWeight?[kg]? ? 68.3?[54.4???78.9]?
BMI?[kg/m2]? ? 20.9?[20.3???24.0]?
Office?Systolic?Blood?Pressure?[mmHg]? ? 118?[113???128]?
Office?Diastolic?Blood?Pressure?[mmHg]? ? 70?[66???78]?
Maximum?handgrip?power?[kg]? ? 21?[17???31]?
Data?presented?as?median?[IQR]?or?count.?
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Figure?S3.1?–?Domains?of?health?measurement? instruments?and? relationships?of?measurement?properties?
according? to? the? COSMIN? taxonomy.? The? domain? reliability? refers? to? the? extent? to? which? scores? for?
individuals?who?have?not?changed?are?the?same?for?repeated?measurement?under?several?conditions.?The?
domain? reliability? consists? of? three?measurement? properties.? Internal? consistency? is? specific? to? patient?
reported?outcomes?and? is?not?applicable?to?the?variables?we? investigated? in?this?paper.?The?measurement?
property?reliability?refers?to?the?proportion?of?the?total?variance?in?the?measurements?which?is?due?to?the?
“true”? differences? between? individuals,? as? described? in? the? classical? test? theory.2,75?Measurement? error?
refers?to?the?systematic?and?random?error?of?a?patients’?score?that?is?not?attributed?to?true?changes?in?the?
construct? to? be?measured.2? Both? reliability? and?measurement? error? can? be? further? subdivided? in? intra?
observer?(repeated?measurements?by?one?observer),?inter?observer?(repeated?measurements?on?the?same?
occasion?by?different?observers),?or?over? time? (test?retest?with? relevant?amount?of? time? in?between).?For?
further? explanation? of? the? orther? domains,? we? refer? to? the? original? COSMIN? statement.2? COSMIN,?
COnsensus?based?Standards?for?the?selection?of?health?Measurement?INstruments;?HR?PRO,?health?related?
patient?reported?outcome.?Reproduced?from:?Mokkink?et?al.?2010,?with?permission.2?
?
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Figure? S3.2? –? Position? of? individuals? during? several? microvascular? measurements.? A.? Position? of? the?
transducer? to? image? the? right? forearm? flexor? muscles? by? means? of? contrast? enhanced? ultrasound.?
B.?Capillary? videomicroscopy? of? the? right? middle? finger.? C.? Flowmotion? measurement? (laser? Doppler?
flowmetry)? located? at? the? left? hand,? just? distal? of? the?wrist.? Photography? by? Dr.? J.L.J.M.? Scheijen,?with?
permission.?
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Figure?S3.3?–?Gating?strategy?for?flow?cytometry?in?the?weight?loss?intervention?trial,?which?is?described?into?
more?detail?in?the?main?text.?
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Abstract?
Background?
Induction?of?insulin?resistance?is?a?key?pathway?through?which?obesity?increases?risk?of?
type?2?diabetes,?hypertension,?dyslipidemia,?and?cardiovascular?events.?Although?the?
detrimental? effects? of? obesity? on? insulin? sensitivity? are? incompletely? understood,?
accumulation? of? visceral,? subcutaneous? and? liver? fat,? and? impairment? of? insulin?
induced? muscle? microvascular? recruitment? (MVR)? may? be? involved.? As? these?
phenotypic? changes? often? coincide? in? obesity,?we? aimed? to? unravel?whether? they?
independently?contribute?to?insulin?resistance?and?thus?constitute?separate?targets?for?
intervention.??
?
Methods??
We?measured? visceral? (VAT)? and? subcutaneous? adipose? tissue? (SAT)? volumes? and?
intrahepatic?lipid?content?(IHL)?by?MRI,?and?whole?body?glucose?disposal?(WBGD)?and?
MVR?(using?contrast?enhanced?ultrasound)?responses?to?a?euglycemic?insulin?clamp?in?
lean? (n?=?25)? and? abdominally? obese? men? (n?=?52).? Abdominally? obese? men? were?
randomized?to?dietary?weight?loss?intervention?or?habitual?diet.??
?
Results??
Obesity?associated? increases? in?VAT,? SAT? and? IHL,? along?with? the?decrease? in?MVR,?
contributed? independently? to? insulin? resistance.? Moreover,? a? dietary? weight? loss?
intervention? reduced? insulin? resistance? and? mediation? analyses? showed? that?
decreased? IHL? and? insulin?induced?MVR,? but? not? decreased? VAT? or? SAT? volumes,?
independently?contributed?to?improved?insulin?resistance?seen?with?weight?loss.??
?
Conclusion?
Quantifying? the? mutually? independent? contributions? of? visceral? and? subcutaneous?
adipose? tissue,? intrahepatic? lipid,? and? insulin?induced? muscle? microvascular?
recruitment?reveals?distinct?targets?for?treating?obesity?associated?insulin?resistance.?
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Introduction?
Insulin?resistance,?i.e.?reduced?insulin?induced?whole?body?glucose?disposal?(WBGD),?is?
common? in? obesity? and? plays? a? key? role? in? obesity?associated? type? 2? diabetes,?
hypertension,? dyslipidemia? and? cardiovascular? disease.1,2? Several? tissue?specific?
pathways,? including? adipose? tissue,? liver? and?muscle,? have? been? proposed? to? link?
obesity?to?insulin?resistance;?however,?whether?these?pathways?act?independently?of?
each?other?has?not?been?elucidated.?
?
Excess? visceral? adipose? tissue? (VAT)? in? obesity? causes? insulin? resistance? through?
increased? lipolysis,? dysregulation? of? adipokine? release,? and? induction? of? low?grade?
inflammation.2?4? However,? additional?mechanisms? that? explain? insulin? resistance? in?
obesity?have?been?postulated,?notably?increased?subcutaneous?adipose?tissue?(SAT),2?
increased? intrahepatic? lipid? (IHL)? accumulation,5? and? impairment? of? insulin?induced?
microvascular?recruitment?(MVR)?in?muscle.6?
?
SAT’s?effect?on?insulin?resistance?is?controversial;?the?increased?lipolysis?and?adipokine?
dysregulation? in? SAT? is? considered? to? contribute? to? insulin? resistance,2? yet? a? fat?
distribution?pattern?with?high?SAT?and?low?VAT?volumes?is?considered?a?metabolically?
healthy?phenotype.7?The?involvement?of?IHL?on?the?other?hand?is?also?debated,?as?IHL?
has? been? postulated? as? both? a? cause? and? consequence? of? insulin? resistance.?
Lipotoxicity? of? IHL? rich? in? saturated? fatty? acids,? diacylglycerols? and? ceramides;?
secretion?of?inflammatory?cytokines;?and?increased?triglyceride?synthesis?by?the?fatty?
liver? are? suggestive? of? the? former,8?10? whereas? adipocyte? insulin? resistance? with?
increased? NEFA? fluxes? towards? the? liver? suggest? the? latter.11,12? In? turn,? skeletal?
muscle’s?vasculature? can?contribute? to? insulin? resistance?when?physiological? insulin?
induced,?nitric?oxide?mediated?MVR?is?impaired.13?
?
A? key? question? is?whether? VAT,? SAT,? IHL,? and?MVR? act? independently? to? increase?
insulin?resistance.? ?Mutual? independence,? in?contrast?to?mutual?dependence,? implies?
that?distinct?mechanisms?can?be?targeted?to?improve?insulin?resistance.??
?
We? addressed? this? issue? in? two? ways.? First,? we? determined? the? independent?
contributions? of? VAT,? SAT,? IHL,? and? MVR? to? insulin? resistance? in? 25? lean? and?
52?abdominally? obese? men? (flow? diagram? in? Figure? 4.1).? Next,? we? assessed? their?
contributions? to? weight? loss?induced? improvement? of? insulin? resistance? by?
randomizing? the? abdominally? obese?men? to? either? an? 8?week? dietary? weight? loss?
program?or?habitual?diet?(control?group).?
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Figure?4.1?–?A?flow?diagram?of?participants?throughout?the?study.?After?screening,?25?lean?men?were?eligible?
for? participation? and? all? completed? the? study.? Baseline?measurements?were? performed? in? 54? abdominally?
obese?men;? one? dropped? out? for? personal? reasons? before? completing? the?measurements.? For? the? cross?
sectional?analyses,?all?lean?men?and?52?abdominally?obese?men?were?included,?one?was?excluded?from?analyses?
due?to?protocol?violations? (use?of?anti?hypertensive?medication?during?participation).?One? lean? individual?did?
not?complete?the?MR?imaging?due?to?claustrophobia.?A?total?of?53?abdominally?obese?men?were?randomized?to?
weight?loss? intervention? or? weight?stable? control? groups.? One? individual? discontinued? control? treatment?
because?of?illness,?one?dropped?out?because?of?noncompliance?with?the?program?to?lose?weight?and?another?
individual?dropped?out? for?personal? reasons? after? assignment? to? the?weight?loss? treatment.?One? individual?
completed?the?trial?but?was?excluded?from?all?analyses?because?of?protocol?violations.?In?agreement?with?the?
protocol,? the? study?was? stopped? after? 50? completed? follow?up?measurements.? Few? harms?were? observed?
during?this?study;?one?individual?had?an?incidental?finding?on?MRI?which?required?further?analysis?and?another?
individual?developed?thrombophlebitis?after?the?follow?up?measurements.?
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Methods?
Study?population?
In? this? randomized?controlled? trial?with?blinded?analyses,?53?abdominally?obese?and?
25? lean? men? were? recruited? by? advertisements? and? enrolled? at? the? Maastricht?
University?Medical?Center?in?Maastricht,?The?Netherlands,?from?August,?2012?to?May,?
2014.?Participants?were? aged?18???65? years,?non?smokers,?nondiabetic,? free?of?CVD,?
had?a?waist?circumference?below?94?cm?(lean)?or?between?102???110?cm?(abdominally?
obese),? and? a? stable?body?weight? for? at? least?3?months.?Men?were?excluded?when?
fasting?plasma?glucose?was?>?7.0?mmol/l,?when?HbA1c?was?>?6.5%,?when?serum?total?
cholesterol?was? >?8.0?mmol/l,?when? serum? triacylglycerol?was? >?4.5?mmol/l,?when?
they? had? a? contra?indication? for?MR? imaging,? and/or? when? they? used?medication?
affecting?blood?pressure,?serum?lipid?or?glucose?metabolism.??
Study?design?
Abdominally?obese?men?were? randomly?assigned? in?a?1:1? ratio? to?either?an?8?week?
weight?loss?program?or?maintaining?their?habitual?diet?for?8?weeks.?Abdominally?obese?
men?were? studied? at?baseline? and? after? completion?of? their?8?week?program.? Lean?
men?were? studied? at? baseline? only? and? thus? not? randomized.? Randomization?was?
performed?by? an? independent? investigator? using? block? randomization?with? variable?
block? sizes? and? stratifying? for? ages? below? and? above? 50? years.? The? allocation?was?
revealed?by?the? independent? investigator?to?the?participant?and?research?team?upon?
completion?of? all?baseline?measurements.? Study?data?were?blinded? to? the? assessor?
prior? to?analysis?and?de?blinded?upon?completion?of?all?analyses?by?an? independent?
investigator.??
?
The?weight? loss?program?consisted?of?4?5?weeks?of?a?very? low?calorie?diet?providing?
2.1?MJ/day? (Modifast,? Novartis? Nutrition,? Breda,? The? Netherlands),? 1???2? weeks? of?
energy?restricted? diet? providing? 4.2?MJ/day,? a?weight? stable? phase? of? 2?weeks? to?
maintain? the? newly? achieved? weight,? and? weekly? dietary? counseling.? During? their?
8?week? habitual? diet,? the? control? group? was?monitored? as? well? in? order? to? avert?
fluctuations?in?weight.?Both?groups?were?instructed?not?to?alter?their?exercise?pattern?
throughout?the?study.?Three?individuals?dropped?out?and?one?individual?was?excluded?
from?analyses?due?to?protocol?violations?(Figure?4.1).?A?sample?size?of?25? individuals?
per?group?was?calculated?to?detect?a?mean?difference?in?MVR,?the?least?precise?of?the?
techniques?used,?of?20%?with?a?power?(1??)?of?0.80?with???=?0.95.?In?agreement?with?
our?protocol,?the?study?was?stopped?after?50?completed?follow?up?measurements.?
?
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Measurements?were?conducted? in?a?temperature?controlled?room?(T?=?24°C?±?0.5°C)?
after?a?12?hour?overnight?fast?with?the? individuals? in?the?supine?position.? Individuals?
were?instructed?to?refrain?from?alcohol?and?meals?rich?in?lipids?for?a?period?of?24?hours?
prior?to?each?study?day,?and?strenuous?physical?exercise?for?a?period?of?48?hours?prior?
to? each? study? day.? After? insertion? of? two? intravenous? catheters? and? a? 30?minute?
acclimatization?period,?baseline?vascular?measurements?were?performed.?
Hyperinsulinemic?euglycemic?clamp?
Metabolic?insulin?sensitivity?was?assessed?by?a?1?mU/kg/min?euglycemic?insulin?clamp?
as? described? previously.29? Briefly,? insulin? (Novorapid,? Novo? Nordisk,? Bagsvaerd,?
Denmark)?was? infused? in?a?primed?continuous?manner? for?180?minutes.?Meanwhile,?
isoglycemia? was?maintained? with? a? variable? rate? 20%? glucose? infusion.?Metabolic?
insulin? sensitivity? was? estimated? from? the? steady?state? glucose? infusion? rate?
(90???150?min?of?the?clamp).??
Contrast?enhanced?ultrasound?
Microvascular?blood?volume?of?forearm?skeletal?muscle?was?measured?with?a?Toshiba?
Aplio?XG?ultrasound?system? (Toshiba,?Otawara,? Japan)?during?continuous? infusion?of?
sulfur?hexafluoride?gas?filled?microbubbles?(SonoVue,?Bracco?diagnostics,?Amsterdam,?
The? Netherlands).? After? steady? state? microbubble? concentration? was? achieved?
(3?minutes),? five? real?time? replenishment? curves? of? 30”? were? obtained? after?
microbubble? disruption? by? a? high? mechanical? index? ultrasound? pulse.? These?
replenishment? curves?were? stored? and? analyzed? offline? in? a? blinded? fashion? upon?
completion? of? the? trial? using? the? CHI?Q? software? (Toshiba,? Otawara,? Japan).? The?
replenishment? curves? were? fitted? to? the? exponential? function? y? =? A(1? ?? e?ßt)? and?
averaged? as? described? before26? providing? reliable? estimations? of? MVR?
(ICCintra?observer?=?0.86;? p? <? 0.001).? MVR? was? calculated? as? the? relative? increase? in?
microvascular?blood?volume?induced?by?the?insulin?clamp.?
Visceral?and?subcutaneous?fat?volumes,?and?intrahepatic?lipid?
Information? on? visceral? and? subcutaneous? adipose? tissue? volumes? was? obtained?
through? two?dimensional? (2D)?T1?weighted? turbo?spin?echo? (TSE)? imaging?on?a?3.0T?
Philips?Achieva?MRI?scanner?with?a?dedicated?sixteen?element?torso?coil?(XL?Torso?coil,?
Philips? Healthcare,? Best,? The?Netherlands).?Nine? 5?mm? thick? transverse? slices?with?
10?mm? gaps? centered? at? the? top?of? the? L4? vertebral?body?were? acquired?using? the?
following? scan?parameters:? repetition? time? (TR)?=?526?ms,?echo? time? (TE)?=?10?ms,?
turbo? spin? echo? factor? =? 4,? number? of? signal? averages? (NSA)? =? 1,? field? of? view?
(FOV)?=?400? x? 322mm,? acquired? matrix? size? =? 308? x? 164,? acquired? in?plane? voxel?
size?=?1.3?x?1.96?mm,?reconstructed?matrix?size?=?512?x?412,?and?a?reconstructed?voxel?
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size?of?0.78?x?0.78?mm.?Images?were?analyzed?offline?after?completion?of?the?trial?with?
dedicated? software? (Hippo? Fat,? IFC? CNR,? Pisa,? Italy)? to? provide? subcutaneous? and?
visceral?fat?volumes.??
?
The?same?MRI?scanner?and?coil?were?used?to?assess?intrahepatic?lipid?content?through?
mDixon? imaging.?Two?6?mm? thick? transverse? slices? through? the? liver?were?acquired?
using?a?2D?three?point?T1?fast?field?echo?(T1?FFE)?mDixon?pulse?sequence,?to?correct?
for?T2*?relaxation.?The?scan?parameters?were?as?follows:?TR?=?150?ms,?TE1?=?0.85?ms,?
?TE?=?0.7?ms,? flip?angle? (FA)?=?10°,?NSA?=?1,?FOV?=?375?x?310?mm,?acquired?matrix?
size?=?92?x?77,?acquired? in?plane? resolution?=?4.08?x?4.02?mm,? reconstructed?matrix?
size?=? 384? x? 320? mm,? and? a? reconstructed? voxel? size? of? 0.98? x? 0.97? mm.? The?
intrahepatic?fat?percentage?was?calculated?in?three?regions?of?interest?within?the?liver?
parenchyma,?carefully?avoiding?blood?vessels.?The? fat?content?was?expressed?as? the?
weighted?mean? fat? signal,?divided?by? the? sum?of? the?weighted?mean?water?and? fat?
signal.? The?mDixon? sequence?was? validated? against? 1H?MRS? in? a? random? subset? of?
participants? and? yielded? comparable? results? (n? =? 45;? ICC? =? 0.82;? p? <? 0.001).? The?
1H?MRS? scan?was? performed? using? the? same?MRI? scanner? and? torso? coil? and? the?
spectra?were?obtained?from?a?30?x?30?x?30?mm?voxel?placed?centrally?in?the?right?lobe?
of? the? liver?by?using?point?resolved? spectroscopy?volume? selection? (PRESS)?with? the?
following?scan?parameters:?TR?=?4000?ms,?TE?=?32.5?ms,?2048?sample?points.?A?total?of?
32?spectra?with?NSA?of?2?were?acquired.?A?water?signal?was?acquired?as?a?reference?
(NSA?=?2?x?8).?To?keep?the?TR?constant,?the?subject?was?instructed?to?breathe?exactly?
at? the?4s?rhythm?of? the? sequence.?Shimming?was?performed?by?using? second?order?
FASTMAP?based?shimming.?
Plasma?measurements?
Plasma?glucose?was?determined?with?a?YSI2300?glucose?analyzer?(YSI,?Yellow?Springs,?
OH,?USA).? Samples?were? analyzed? for? total? cholesterol? (CHOD?PAP?method;? Roche?
Diagnostics,? Mannheim,? Germany),? HDL? cholesterol? (precipitation? method;? Roche?
Diagnostics,?Mannheim,? Germany),? triacylglycerol? with? correction? for? free? glycerol?
(GPO?Trinder;?Sigma?Aldrich,?St.?Louis,?MO,?USA),?HbA1c?(Bio?Rad,?Hercules,?CA,?USA),?
and?insulin?(RIA;?Millipore,?Billerica,?MA,?USA).?
Statistics?
Data? are? expressed? as? means? ±? SD? or? median? [25th???75th? percentile].? Two?tailed?
independent? Student’s? t?tests? or? Mann?Whitney? U? tests? were? used? to? assess?
differences? between? groups? at? baseline.? We? used? one?factor? ANCOVA? with? the?
baseline? value? as? a? covariate? to? detect? differences? between? groups? over? time.?
Analyses?were?performed?using? SPSS? version? 20.?Multiple?mediation? analyses?were?
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carried?out?with?the?PROGRESS?plug?in? for?SPSS?version?2.13? (A.F.?Hayes,?Ohio?State?
University,?OH,?USA).?In?the?cross?sectional?mediation?model,?complete?mediation?was?
found.? Therefore,? the? independent? variable? BMI? was? omitted? from? the? model? to?
estimate? the?contributions?of?each?mediator30?and?Monte?Carlo?confidence? intervals?
were?calculated?with?R?statistical?software?(version?3.2.2).?For?sensitivity?analyses?we?
also?used?multiple?mediation?analyses?with?a?repeated?measures?design,?which?were?
carried?out?with?the?MEMORE?plug?in?for?SPSS.?All?regression?and?mediation?models?
were?adjusted? for? the?potential? confounder?age.?Two?tailed?p?values?of?<0.05?were?
considered?statistically?significant.??
Study?approval?
The? study? was? approved? by? the? Maastricht? University? Medical? Center? ethics?
committee,?performed?in?accordance?with?the?Declaration?of?Helsinki,?and?registered?
at?clinicaltrials.gov?(NCT01675401).?All?participants?gave?written?informed?consent.?
Results?
Demographic?and?metabolic?features?of?the?study?population?
After? a? screening? procedure,? 25? lean? and? 52? abdominally? obese? individuals? were?
enrolled?in?this?study?(Figure?4.1).?Compared?with?lean?men,?abdominally?obese?men?
had?higher?BMI,?VAT,?SAT?and?IHL,?and?lower?MVR?and?WBGD?during?an?insulin?clamp?
(Figure? 4.2;? p? <? 0.001? for? each).? In? addition,? abdominally? obese?men? had? ? higher?
baseline?HOMA?IR,?fasting?plasma?glucose,?and?fasting?insulin?levels?compared?to?lean?
men? (Table? 4.1;? p? <? 0.001? for? each).? At? baseline,? abdominally? obese? individuals?
randomized? to? the?weight? loss?program? and? those? randomized? to? the?habitual?diet?
were?comparable?(Table?4.1).?
Contributors?to?obesity?associated?insulin?resistance?
We? observed? that? VAT? (r? =? ?0.615;? p? <? 0.001),? SAT? (r? =? ?0.564;? p? <? 0.001),? IHL?
(r?=??0.603;? p? <? 0.001),? and?MVR? (r? =? 0.567;? p? <? 0.001)?were? each? associated?with?
WBGD?(Figure?4.3).?As?expected,?VAT,?SAT,?IHL,?and?MVR?were?all?associated?with?one?
another,? which? can? be? inferred? from? the? attenuation? in? the? individual? regression?
coefficients?when? the? age?adjusted? associations?were? additionally? adjusted? for? the?
other?variables? (Table?4.2).?Yet,?a?multivariate? regression?model? including?VAT,?SAT,?
IHL,? and? MVR? as? determinants? of? WBGD? shows? that? each? was? independently?
associated? with?WBGD? (Table? 4.2).? Of? note,? no? statistically? significant? interaction?
between?VAT?and?SAT?was?found?(p?=?0.223).??
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Table?4.1?–?Study?population?characteristics.?
Parameter? Lean?
(n=25)?
Obese?
(n=52)?
Weight?Stable?
Baseline?
(n=26)?
Weight?Loss?
Baseline?
(n=23)?
Age?[Yr]? 53.7?[25.0?61.6]? 51.8?[45.7?60.7]? 52.0?[45.4?61.1]? 52.4?[46.8?61.7]?
Weight?[kg]? 74.9?±?8.3? 96.9?±?8.4?***? 95.9?±?8.9? 98.2?±?8.1?
Fat?Free?Mass?[kg]? 60.8?±?6.4? 69.6?±?6.1?***? 69.2?±?6.6? 69.7?±?5.9?
Fat?Mass?[kg]? 14.1?±?4.8? 27.2?±?4.6?***? 26.7?±?4.6? 28.5?±?4.2?
BMI?[kg/m2]? 23.3?±?1.8? 30.1?±?2.1?***? 29.9?±?2.5? 30.2?±?1.5?
Waist?Circumference?[cm]? 84.9?±?6.3? 106.5?±?3.6?***? 106.2?±?3.8? 106.8?±?3.4?
Hip?Circumference?[cm]? 96.6?±?4.3? 107.5?±?5.2?***? 107.2?±?6.0? 108.1?±?4.4?
Visceral?Fat?[L]a? 0.890?±?0.417? 2.341?±?0.720?***? 2.526?±?0.752? 2.167?±?0.643?
Subcutaneous?Fat?[L]a? 1.452?±?0.513? 3.089?±?0.780?***? 2.915?±?0.811? 3.226?±?0.642?
Intrahepatic?Lipid?[%]a? 3.43?[3.13?3.78]? 4.96?[3.90?7.86]?***? 5.34?[4.24?9.23]? 4.21?[3.59?6.63]?
Microvascular?Recruitment?[%]? 44.4?±?41.3? ?3.5?±?27.3?***? 0.7?±?27.6? ?5.0?±?26.6?
Whole?Body?Glucose?Disposal?
[mg/kg/min]?
6.76?±?1.79? 4.08?±?1.30?***? 4.03?±?1.38? 4.14?±?1.25?
HOMA?IR? 1.65?±?0.46? 2.84?±?1.38?***? 2.90?±?1.40? 2.64?±?1.21?
Fasting?Plasma?Glucose?[mmol/l]? 5.35?±?0.29? 5.64?±?0.48?**? 5.75?±?0.53? 5.49?±?0.37?
Fasting?Plasma?Insulin?[mIU/l]? 7.1?±?1.9? 11.6?±?5.4?***? 11.5?±?5.6? 11.2?±?5.0?
Clamped?Plasma?Insulin?[mIU/l]? 71.0?±?18.0? 100.0?±?33.3?***? 91.3?±?30.3? 112.3?±?34.7?
HbA1c?[%]? 5.18?±?0.37? 5.30?±?0.37? 5.33?±?0.39? 5.24?±?0.35?
Total?Cholesterol?[mmol/l]?? 4.55?±?0.78? 5.56?±?0.97?***? 5.63?±?0.86? 5.60?±?1.09?
LDL?Cholesterol?[mmol/l]b? 2.82?±?0.70? 3.68?±?0.89?***? 3.71?±?0.85? 3.70?±?0.96?
HDL?Cholesterol?[mmol/l]? 1.26?±?0.26? 1.11?±?0.21?**? 1.08?±?0.23? 1.15?±?0.17?
Triacylglycerol?[mmol/l]? 0.95?[0.67?1.11]? 1.66?[1.17?2.19]?***? 1.75?[1.20?2.38]? 1.43?[0.94?2.02]?
24?h?Systolic?Blood?Pressure?
[mmHg]?
117.5?±?8.8? 123.4?±?8.7?**? 125.6?±?7.6? 120.2?±?9.2?
24?h?Diastolic?Blood?Pressure?
[mmHg]?
72.5?±?9.4? 80.4?±?7.3?***? 82.0?±?6.7? 78.3?±?7.6?
Data?presented?as?mean?±?SD?or?median?[25?75th?percentile].?Baseline?differences?between?obese?and?lean?
men?were?assessed?by?means?of?independent?Student’s?T?test?or?Mann?Whitney?U?test?where?appropriate;?
*?p?<?0.05,?**?p?<?0.01,?***?p?<?0.001?compared?to?baseline?values?of?the? lean?men.?Analyzed? in?a?24? lean?
and?52?obese?men;?b?25?lean?and?50?obese?men.?
?
?
In?addition,?VAT?(20.7%;?2.4?to?46.6%),?SAT?(34.6%;?7.6?to?53.5%),?IHL?(26.5%;?11.8?to?
44.7%),? and? MVR? (18.3%;? 5.8? to? 34.0%)? were? independent? mediators? of? the?
association?between?BMI?and?WBGD? (Figure?4.4A).?Since? the?confidence? intervals?of?
the? four? mediators? overlap,? we? cannot? conclude? that? any? one? mediator? is? more?
important?than?any?other.?
Effects?of?weight?loss?
In?abdominally?obese?men?randomized?to?the?control?group,?BMI,?VAT,?SAT,?IHL,?MVR,?
and?WBGD?were?unchanged?over?time?(Figure?4.2).?Conversely,?in?abdominally?obese?
men? randomized? to? the? weight? loss? intervention,? BMI? (?3.04? ±? 0.77? kg/m2),? VAT?
(?0.723?±?0.371?L),?SAT?(?0.782?±?0.261?L),?and?IHL?(?1.69?±?2.05%)?decreased,?whereas?
MVR? (39.5? ±? 49.0%)? and? WBGD? (1.31? ±? 1.22? mg/kg/min)? increased? (Figure? 4.2;?
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p?<?0.001?for?each?vs.?baseline;?p?<?0.001?for?each?vs.?control?group).?After?weight?loss,?
IHL? and? MVR? were? similar? to? the? mean? values? in? lean? men? while? VAT? and? SAT?
remained? increased? and? WBGD? remained? impaired.? In? addition,? HOMA?IR?
(0.06?±?0.84),? fasting?plasma?glucose? (0.00?±?0.28?mmol/l),?and? fasting? insulin? levels?
(0.2?±?3.0?mIU/l)?did?not?change?in?the?control?group,?whereas?clamped?insulin?levels?
increased?(15.2?±?28.7?mIU/l;?p?=?0.012).?In?abdominally?obese?men?randomized?to?the?
weight?loss?intervention?on?the?other?hand,?HOMA?IR?(?0.97?±?0.92;?p?<?0.001),?fasting?
plasma?glucose?(?0.21?±?0.33?mmol/l;?p?<?0.05),?fasting?insulin?levels?(?3.8?±?3.5?mIU/l;?
p?<?0.001),? and? clamped? insulin? levels? (?26.1? ±? 35.6? mIU/l;? p?=?0.002)? decreased?
(p?<?0.05?for?each?vs.?control?group).?
?
?
?
?
?
?
?
?
?
?
?
?
?
?
?
?
?
?
?
?
Figure? 4.3? –? Cross?sectional? bivariate? associations? between? abdominal? visceral? adipose? tissue? (VAT),?
subcutaneous? adipose? tissue? (SAT),? intrahepatic? lipid? (IHL)? and? insulin?induced?muscle?microvascular?
recruitment?(MVR),?and?whole?body?glucose?disposal?(WBGD).?(A)?Association?between?VAT?and?WBGD?in?
lean?(n?=?24)?and?abdominally?obese?men?(n?=?52).?(B)?Association?between?SAT?and?WBGD?in?lean?(n?=?24)?
and? abdominally? obese? men? (n? =? 52).? (C)? Association? between? IHL? and?WBGD? in? lean? (n? =? 24)? and?
abdominally?obese?men?(n?=?52).?(D)?Association?between?MVR?and?WBGD?in?lean?(n?=?25)?and?abdominally?
obese?men?(n?=?52).?Data?of?lean?(??open?circles)?and?abdominally?obese?men?(??closed?circles)?are?shown.?
Pearson’s?correlation?coefficients?and?their?p?values?are?reported?for?all?bivariate?associations.?
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Table?4.2?–?Cross?sectional?multivariate?regression?models?with?WBGD?as?dependent?variable?
? ??(Age?adjusted)? p?value? ??(Fully?Adjusted)? p?value?
VAT?[L]? ?1.525? <0.001? ?0.509? ? 0.032?
SAT?[L]? ?1.070? <0.001? ?0.444? ? 0.011?
Ln?IHL?[%]? ?2.539? <0.001? ?1.498? ? <0.001?
MVR?[%]? 0.0279? <0.001? 0.0128? ? 0.003?
The?associations?between?abdominal?visceral?adipose?tissue?(VAT),?abdominal?subcutaneous?adipose?tissue?
(SAT),? log?transformed? intrahepatic? lipid? content? (Ln? IHL)? or? insulin?induced? muscle? microvascular?
recruitment?(MVR),?and?whole?body?glucose?disposal?(WBGD)?were?assessed?by?means?of?linear?regression.?
In?all?models,?age?adjusted?regression?coefficients?and?regression?coefficients?adjusted?for?age?and?each?of?
the?other?variables?are?reported,?as?well?as?their?respective?p?values?(n?=?76?for?all?models).?
?
Association?with?improved?insulin?resistance?
Changes? in?VAT? (r?=? ?0.551;?p?<?0.001),? SAT? (r?=? ?0.528;?p?<?0.001),? IHL? (r?=??0.501;?
p?<?0.001),?and?MVR? (r?=?0.499;?p?<?0.001)?were?associated?with? changes? in?WBGD?
(Figure?4.5).?Changes? in?VAT,?SAT,? IHL,?and?MVR?were?associated?with?one?another,?
which?was?reflected?by?the?attenuation?in?the?individual?regression?coefficients?when?
the?age?adjusted?associations?were?additionally?adjusted?for?the?other?variables?(Table?
4.3).?In?a?multivariate?regression?model,?changes?in?IHL?and?changes?in?MVR,?but?not?
changes?in?VAT?or?SAT,?were?independently?associated?with?changes?in?WBGD?(Table?
4.3).?Consequently,? the?association?between?weight? loss? intervention?and?change? in?
WBGD?was? independently?mediated? by? changes? in? IHL? (26.6%;? 4.4? to? 69.6%)? and?
changes?in?MVR?(26.3%;?2.4?to?59.9%),?but?not?statistically?significantly?by?changes?in?
VAT?or?SAT?(Figure?4.4B).?
?
Table?4.3?–?Multivariate?regression?models?in?the?RCT?with??WBGD?as?dependent?variable.?
? ??(Age?adjusted)? p?value? ??(Fully?Adjusted)? p?value?
??VAT?[L]? ?1.331? <0.001? ?0.516? 0.190?
??SAT?[L]? ?1.366? <0.001? ?0.245? 0.567?
??IHL?[%]? ?0.295? <0.001? ?0.170? 0.031?
??MVR?[%]? 0.0146? <0.001? 0.0089? 0.017?
The? associations? between? change? in? abdominal? visceral? adipose? tissue? (?VAT),? change? in? abdominal?
subcutaneous?adipose?tissue?(?SAT),?change?in?intrahepatic?lipid?content?(?IHL)?or?change?in?insulin?induced?
muscle?microvascular? recruitment? (?MVR),? and? change? in?whole? body? glucose? disposal? (?WBGD)?were?
investigated? by? means? of? linear? regression.? In? all? models,? age?adjusted? regression? coefficients? and?
regression?coefficients?adjusted?for?age?and?all?of?the?other?variables?are?reported,?as?well?as?p?values?for?
both?models?(n?=?49).?
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Figure?4.4?–?Multiple?mediator?models.? (A)?Multiple?mediator?model?with?VAT,?SAT,?Ln? IHL,?and?MVR?as?
statistically?significant?mediators?(percentage?of?total?effect?mediated?(??of?mediated?effect?(95%?CI?using?
the? Monte? Carlo? method))? of? the? association? between? BMI? and? WBGD? (n? =? 76,? age?adjusted).? The?
confidence? intervals?of?the?mediators?overlap,?which? implies?that?no?mediator?contributes?more?than?the?
other.?(B)?Multiple?mediator?model?with??IHL?and??MVR?as?statistically?significant?mediators?(percentage?of?
total?effect?mediated?(??of?mediated?effect?(bootstrapped?95%?CI)))?of?the?association?between?the?weight?
loss? intervention?and? ?WBGD? (n?=?49,?age?adjusted).?The?variables? ?VAT?and? ?SAT?were?not? statistically?
significant?mediators?of?this?association.?The?confidence? intervals?of?the?mediators?overlap,?which? implies?
that?no?mediator?contributes?more?than?the?other.?
?
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Sensitivity?analyses?
We? conducted? sensitivity? analyses? by? including? the? individual? left? out? for? protocol?
violations?in?the?analyses,?as?well?as?using?waist?circumference?or?total?fat?mass?in?our?
model? instead?of?BMI?to?reflect?obesity,?which?did?not?materially?change?the?results?
(data? not? shown).? Moreover,? we? used?WBGD? with? glucose? space? correction? and?
WBGD?with?adjustment?for?insulin?levels?during?the?clamp?as?outcome?in?our?models,?
which? did? not? materially? change? the? results? (data? not? shown).? Additionally,? we?
performed? multiple? mediation? analyses? in? the? intervention? group? only,? using? a?
repeated?measures?design.?These?analyses?confirmed?that?changes?in?IHL?and?changes?
in?MVR?were?statistically?significant?mediators,?whereas?changes? in?VAT?or?SAT?were?
not?(data?not?shown).?
?
?
?
?
?
?
?
?
?
?
?
?
?
?
?
?
?
?
?
?
?
Figure?4.5?–?Bivariate?associations?between?change? in?abdominal?visceral?adipose?tissue?volume?(?VAT),?
change? in?abdominal? subcutaneous?adipose? tissue?volume? (?SAT),? change? in? intrahepatic? lipid? content?
(?IHL)? and? change? in? insulin?induced?muscle?microvascular? recruitment? (?MVR),? and? change? in?whole?
body? glucose? disposal? (?WBGD;? n? =? 49).? (A)? Association? between? ?VAT? and? ?WBGD.? (B)? Association?
between??SAT?and??WBGD.?(C)?Association?between??IHL?and??WBGD.?(D)?Association?between??MVR?and?
?WBGD.?Data?of? abdominally?obese? controls? (?? closed?diamonds,?n? =? 26)? and? abdominally?obese?men?
undergoing? the? weight? loss? intervention? (?? open? triangles,? n? =? 23)? are? shown.? Pearson’s? correlation?
coefficients?and?their?p?values?are?reported?for?all?bivariate?associations.?
?
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Discussion?
In? this? report? we? identified? VAT,? SAT,? IHL,? and? MVR? as? mutually? independent?
contributors? to? obesity?associated? insulin? resistance,? which? therefore? constitute?
separate?targets?for? intervention.?To?our?knowledge,?no?studies?have?simultaneously?
determined?multiple? tissue? contributors? to? insulin? resistance? using? state? of? the? art?
techniques? in? humans,? or? assessed? their?mutual? independence,? either? in? the? basal?
steady?state?or?after?a?minimal?weight?loss?intervention.?Studies?on?the?contributions?
of?VAT,? SAT,? and? IHL? to? insulin? resistance? in? the?basal? state?have?been? ambiguous.?
Some? argue? in? favor? of? mutually? independent? contributions? of? VAT? and? IHL,11,14?
whereas?others?find?that?IHL,?not?VAT,?associates?with?insulin?resistance.5,15?Similarly,?
the?SAT?contribution?to?insulin?resistance,?independent?of?VAT,?is?both?supported2?and?
disputed.16,17?In?addition,?the?contribution?of?MVR?to?insulin?resistance?has?never?been?
studied? in? parallel? with? VAT,? SAT,? or? IHL.? By?measuring? VAT,? SAT,? IHL,? and?MVR?
simultaneously,? our? data? clarify? that,? at? least? in? abdominally? obese? men,? these?
variables?contribute?to?insulin?resistance?independently?and?to?a?similar?extent.?
?
By?decreasing?obesity?and?insulin?resistance?with?a?weight?loss?intervention,?we?show?
that? changes? in? IHL? and? MVR? contribute? to? improved? insulin? sensitivity,? which?
supports? their? tight? connection? with? insulin? resistance.? Our? data? are? insufficiently?
precise? to? exclude? that? changes? in? VAT? and? SAT? contribute? to? improved? insulin?
resistance?with?weight?loss.?At?least?for?changes?in?VAT,?involvement?seems?probable?
as? it? is?estimated?to?mediate,?albeit?not?statistically?significantly,?~30%?of?the?change?
in?WBGD,?an?effect?size?consistent?with?its?contribution?to?WBGD?in?the?basal?state.?As?
we?observed?significant?bivariate?but?not?multivariate?associations?between?changes?
in?VAT?and?SAT?on?the?one?hand?and?WBGD?on?the?other,?the?degree?of?VAT?and?SAT?
reduction?achieved?here?may?have?been? insufficient? to? improve? insulin? resistance? in?
an? independent?way.?This?observation? is? in? line?with?studies?using? interventions?such?
as?omentectomy? (0.3? to?1.0?kg?VAT? loss)18,19?or? liposuction? (0.4? to?1.7?kg?SAT? loss)20?
which?have?limited?effects?on?insulin?resistance.??
?
In?addition?to?establishing?relationships?between?VAT,?SAT,?IHL,?and?MVR?on?the?one?
hand?and?WBGD?on? the?other,?we?aimed? to?provide?a?deeper?understanding?of? the?
processes?that?contribute?to?obesity?associated?insulin?resistance.?Multiple?mediation?
analyses,?as?compared?to?multivariate?regression,?can?provide?a?superior?reflection?of?
the?causal?chain?one? tries? to? investigate.?This?helps?unravel?contributions? to?disease?
etiology?and?to?develop?targeted,?effective?therapies.21?Specifically,?the?advantage?of?
testing? the?mediating? effect? of?multiple? variables? simultaneously? is? that? one? learns?
whether?or?not?mediation?is?independent?of?the?effect?of?the?other?mediators,?which?
offers? the? possibility? to? compare? competing? theories? against? one? another?within? a?
single?model.22,23?In?addition,?particularly?when?potential?mediators?have?little?random?
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error? (i.e.? the?measurement? is?precise?and? reflects? the?underlying?mechanism?well),?
multiple?mediation?analyses?can?be?used?to?estimate?the?proportion?of?the?total?effect?
that? independent?mediators? account? for.? A?mediated? proportion? is? essentially? the?
product?of?two?effects;?in?our?analyses,?the?effect?of?obesity?on?each?mediator?is?the?
first,?and?the?independent?effect?of?each?mediator?on?insulin?resistance?is?the?second?
effect.? Such?multiple?mediator?models? are? therefore? the? integrated?product?of? two?
multivariate? regression?models,?which? has? clear? advantages? over? the? conventional?
approach?of?analyzing?each?effect?with?separate? regression?analyses.?By?using? these?
multiple?mediation?analyses?in?this?report?we?were?able?to?provide?an?estimate?of?the?
magnitude?of? the? independent? contributions?of?VAT,?SAT,? IHL,?and?MVR? to?obesity?
associated?insulin?resistance.??
?
Of?note,?the?fact?that?we?found?complete?statistical?mediation?(i.e.,?a?sufficient?set?of?
potential?component?causes)24? in? the?cross?sectional?model?provides?no? information?
about? the? existence? of? other? possible? contributors? that? were? not? included? in? our?
statistical? model.? For? example,? determinants? and? consequences? of? the? mediators?
identified?could?contribute? if? included? in?the?analyses.?We?therefore?do?not?claim?to?
have?identified?all?tissue?contributors?to?obesity?associated?insulin?resistance.??
?
Our? study?has? some? limitations.?First,?no?additional?measurements?were? conducted?
between?baseline?and?follow?up,?so?we?could?not?determine?a?temporal?hierarchy?of?
improvements? for?various?contributors? to? insulin? resistance.?We?emphasize? that? the?
aim?of?this?study?was?not?to?provide?an?accurate?time?course?for?the?exerted?effects.?
Rather?we?used?a?weight?loss?intervention,?an?instrument?to?modify?insulin?resistance,?
to?probe?the?contributions?of?changes? in?VAT,?SAT,?IHL,?and?MVR?to? improvement?of?
insulin?resistance.?Also,?this?study?was?carried?out? in?men?only.?Nevertheless,?studies?
have?shown?similar? (bivariate)?associations?between?VAT,?SAT,? IHL,?MVR,?and? insulin?
resistance? in? women,? as? well? as? improvements? in? these? variables? with? weight?
loss.2,25?28?Amounts?of?IHL?and?VAT?are,?however,?typically?greater?in?men,?whereas?the?
amount?of?SAT? is?greater? in?women;2,10? this?might?affect? the?relative?contribution?of?
each?mediator? in?women? in? the?multiple?mediator?models.?Whilst?we? identified? the?
relative? contribution? of? each? mediator? in? men? in? this? study,? their? proportional?
contributions?in?women?remain?to?be?explored.??
?
Here?we?have?established?for?the?first?time?the?mutually?independent?contributions?of?
VAT,?SAT,? IHL,?and?MVR? to? insulin?resistance.?This? finding? implies? that,?compared? to?
interventions?with?a?single?target?tissue,?interventions?aimed?at?multiple?contributors?
to? insulin? resistance? will? yield? superior? effectiveness.? Hence,? therapies? aimed? at?
multiple? therapeutic? targets? for? insulin? resistance?will?be?most?effective? in? reducing?
the?global?burden?of?type?2?diabetes?and?cardiovascular?diseases.??
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Abstract?
Obesity?associated? insulin? resistance? is? a? major? risk? factor? for? type? 2? diabetes.?
Experimental?evidence? suggests? that?natural?killer? (NK)? cell?accumulation? in?visceral?
adipose?tissue?(VAT)?is?a?primary?event?causing?insulin?resistance.?Data?on?the?role?of?
NK?cells?in?insulin?resistance?in?humans?are,?however,?absent.??
?
We?show? that?NK?cell?accumulation? in?VAT? is?associated?with? inflammatory?adipose?
tissue?macrophages?and? is? reflected?by?CD11B? surface?expression?on? circulating?NK?
cells.? In? addition,? CD11B? on? circulating? NK? cells?was? associated?with? VAT? volume,?
systemic? low?grade? inflammation? (LGI),? and? insulin? resistance.? Moreover,? CD11B?
surface? expression? on? circulating?NK? cells? partially? explained? the? pathway? between?
VAT,?LGI,?and?insulin?resistance.?NK?cells?from?obese?donors?produced?higher?levels?of?
TNF?and?were?able?to?drive?inflammatory?polarization?of?macrophages.?We?confirmed?
NK? cells’? involvement? in?obesity?associated? insulin? resistance? in? a?population?based?
cohort?of?839?individuals.?Taken?together,?these?data?show?that?NK?cell?accumulation?
in?VAT?contributes?to?LGI?and?subsequent?insulin?resistance?in?humans.?
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Introduction?
The?global?prevalence?of?obesity?is?rising?at?an?alarming?rate.?Obesity?is?a?major?driver?
of? insulin? resistance,? which? increases? the? risk? of? developing? type? 2? diabetes,?
hypertension,?dyslipidemia,?and?cardiovascular?events.1?Ever?since?Hotamisligil?et?al.?
discovered? in? 1993? that? tumor? necrosis? factor? (TNF)? is? a? determinant? of? insulin?
resistance?and? is?produced?by?hypertrophic?adipose? tissue? (AT),2? insights?have?been?
emerging? that? chronic? low?grade? inflammation? (LGI)? in? AT? caused? by? massive?
macrophage?infiltration?in?AT?is?important?for?the?development?of?insulin?resistance.3?6?
Not?only?quantitative,?but?also?qualitative?shifts?in?macrophage?phenotype?take?place?
in? expanding? AT.?While? under? lean? conditions?most?macrophages? display? an? anti?
inflammatory? or? so?called? “M2"? phenotype,? obesity? induces? the? polarization? of? AT?
macrophages? toward? the? inflammatory? “M1”? state.7? Phenotypically,? these? AT?
macrophage? (ATM)? subsets? could?be?distinguished?by? the? surface?expression?of? the?
integrin? CD11C.7? The? accumulation? of? inflammatory? CD11C+? ATMs? correlates? with?
insulin? resistance? in? humans.8? The? inflammatory? cytokines? that? are? secreted? from?
CD11C+? ATMs? are? thought? to? be? major? contributors? to? the? low?grade? chronic?
inflammatory?state?of?AT?that?drives?systemic?insulin?resistance.9?Many?factors?in?AT?of?
obese? individuals? have? been? proposed? to? trigger? macrophage? accumulation? and?
polarization,?such?as?adipocyte?cell?death,??lipotoxicity?by?fatty?acids,?increased?insulin?
levels,? hyperglycemia,? and? hypoxia.9? However,? the? exact? driver? of? macrophage?
accumulation?and?activation?remains?unclear.?Recently,?several?studies?showed,?using?
experimental? mouse? models,? that? natural? killer? (NK)? cells? control? macrophage?
accumulation?and?polarization?via?the?production?of?interferon?gamma?(IFN?),?TNF?or?
IL?6? in? AT,? resulting? in? impaired? insulin? sensitivity? and? glucose? handling.9?11? These?
important? findings? may? provide? essential? insight? in? the? origin? of? inflammatory?
macrophages?and?could?offer?new?pathways?to?target?inflammation?in?the?context?of?
insulin?resistance?development.?NK?cells?are?innate?lymphoid?cells?that?are?specialized?
in? surveilling,? recognizing? and? eliminating? virally? infected,? transformed? or? stressed?
cells.? In? addition,? NK? cells? also? produce? cytokines? to? shape? an? inflammatory?
environment.12?Moreover,?human?obesity? is?associated?with?an?activated?phenotype?
of?NK?cells?in?AT.13?However,?no?data?is?available?showing?whether?NK?cells?contribute?
to?AT?macrophage?accumulation?and?polarization?and?consequent?insulin?resistance?in?
humans.?Therefore,?the?aim?of?this?study? is?to?evaluate?whether?NK?cells?accumulate?
in?human?AT?and,?through?LGI,?contribute?to? insulin?resistance?and?the?development?
of?type?2?diabetes?in?humans.??
?
We?addressed?this?by?first?conducting?two?cross?sectional?studies?using?biopsies?from?
visceral? and? subcutaneous? adipose? tissue,? followed? by? an? in?depth? metabolic?
phenotyping?study?in?a?larger?study?population.?Finally,?we?validated?our?findings?in?a?
large?population?based?cohort?study.?
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Results?&?discussion?
VAT? NK? cells? accumulate? in? obesity? and? are? associated? with?
inflammatory?macrophage?polarization??
To? investigate? whether? NK? cells? accumulate? in? human? AT,? we? analyzed? stromal?
vascular? fractions? of? VAT? and? subcutaneous? adipose? tissue? (SAT)? in? lean? and?
abdominally? obese? men? using? flow? cytometry? (baseline? characteristics,?
SupplementaryTable? S5.1).14? Obese? men? had? a? higher? waist? circumference? (124.0?
[121.3?130.3]?vs.?89.0?[86.0?93.0]?cm;?p?<??0.0001)?and?were?more?insulin?resistant?as?
reflected? by? higher? HOMA?IR? (5.63? [3.54?7.16]? vs.? 1.73? [1.27?3.30];? p?<?0.0001)?
compared?to?lean?men.?Moreover,?obese?men?displayed?increased?levels?of?NK?cells?in?
their?VAT?(Figure?5.1A),?but?not?in?SAT?(3.77?±?1.84?vs.?3.52?±?2.10?%;?p?=?0.758;?Figure?
5.2A)? or? blood? (0.28? [0.15?0.44]? vs.? 0.20? [0.14?0.41]? x109/l;? p?=?0.401;? Table? S5.1).?
These? data? are? in? line? with? previous? studies? in? mice? showing? that? VAT? is? the?
predominant?AT?depot?displaying?NK?cell?accumulation.9?11,15?In?a?second?study,?using?
adipose? tissue?biopsies? from? female?controls?and? female?obese?women? (BMI?28.1?±?
3.1?vs.?42.6?±?1.6?kg/m2;?p?=?0.001),?we?found?that?the?fraction?of?CD56dimCD16bright?NK?
cells? in? VAT? was? increased? in? obese? individuals? (50.1? ±? 7.3%? vs.? 87.4? ±? 4.5%;?
p?=?0.0021)?while?the?fraction?of??CD56brightCD16??cells?was?decreased?(43.5?±?10.8%?vs.?
2.9?±?1.2%;?p?<?0.0001)?compared?to?controls.?In?SAT?of?these?individuals,?a?significant?
decrease?of?CD56brightCD16??NK?cells? (12.6?±?4.1%?vs.?1.4?±?0.9%;?p?=?0.0018),?but?no?
increase? in? CD56dimCD16bright?NK? cells? (85.1? ±? 3.3%? vs.? 91.7? ±? 3.3%;? p?=?0.285)?was?
observed.?These?data?are?in?concordance?with?a?study?showing?that,?despite?total?NK?
cells? in?VAT?being?equal,? there?was? a? shift? towards?more?CD56dim?NK? cells? and? less?
CD56bright?NK?cells?in?VAT?of?obese?individuals.16?It?was?previously?shown?that?VAT,?but?
not?SAT,?from?humans?contained?ligands?of?the?activating?receptor?NKp46.11?We?now?
report?a?trend?towards?increased?surface?expression?of?NKp46?in?the?CD56dimCD16bright?
NK? cell? subset? in? VAT? (635? ±? 96? vs? 397? ±? 45?mean? fluorescence? intensity? (MFI),?
p?=?0.06;?Figure?5.3A),?albeit?not?statistically?significantly.?No?difference?was?found? in?
surface?expression?level?of?NKG2D?(2704?±?181?vs.?2970?±?497?MFI;?p?=?0.772),?another?
activating? receptor? of? VAT? NK? cells.? In? SAT,? NKp46? surface? expression? was? not?
different.? Interestingly,? in?contrast?to?blood?NK?cell?subsets,?neither?VAT?nor?SAT?NK?
cell? subsets? displayed? increased? CD11B? expression? (data? not? shown).? The?
aforementioned?experimental?mouse?studies?showed? that?NK?cell? infiltration? in?VAT?
leads? to? inflammatory? macrophage? polarization,? which? is? hallmarked? by? an?
accumulation? of? “M1”? polarized? CD11C+?macrophages? compared? to? resident? “M2”?
CD11C??polarized?macrophages.?We?next? investigated?whether? increased? levels?of?NK?
cells?in?VAT?is?associated?with??macrophage?polarization?and?found?that?an?increase?in?
VAT?resident?NK?cells?was?associated?with?a?higher?inflammatory?macrophage?ratio?in?
VAT? (M1/M2? ratio;? r?=?0.511;?p?=?0.003;? Figure?5.1B).?Additional? adjustment? for? the?
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potential?confounder?age?did?not?materially?change?this?association.? In?SAT,?NK?cells?
did?not? coincide?with?macrophage?polarization? (r?=?0.109;?p?=?0.597;? Figure?5.2B?C).?
These? findings?support? the? involvement?of?VAT?resident?NK?cells? in?M1?macrophage?
polarization,? as? previously? described? in? rodents.9?11? In? contrast,? while? NK? cells? are?
present?in?SAT,?they?do?not?seem?to?exert?the?same?effects?as?in?VAT.?This?observation?
is? in? line?with?the? findings?of?O’Rourke?et?al.,?showing?that?compared?to?SAT,?VAT? is?
particularly?enriched?in?IFN??producing?NK?cells.16?Hence,?SAT’s?contribution?to?insulin?
resistance? appears? to? be?mediated?by?different? pathways? compared? to?VAT,?which?
may?involve?adipocyte?lipolysis?and?adipokine?dysregulation.17?
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Figure?5.1?–?Biopsy?Study,?visceral?adipose?tissue.?(A)?NK?cells? in?visceral?adipose?tissue?(VAT)? in? lean?and?
obese? individuals?(n?=?31;?*?p?<?0.05).?(B)?Association?between?NK?cells? in?VAT?and?M1?to?M2?ratio? in?VAT?
(n?=?31).? (C)? CD11B? expression? on? circulating?NK? cells? (NK?CD11B)? in? lean? and? obese? individuals? (n?=?31;?
***?p?<?0.001).?(D)?Association?between?NK?cells?in?VAT?and?NK?CD11B?(n?=?29).?Differences?between?groups?
were?assessed?by?means?of?independent?Student’s?t?tests?(panels?A,?C).?Box?plots?are?as?follows:?black?line,?
median;? box? edges,? 1st? and? 3rd? quartiles;? whiskers,? minimum? and? maximum? of? all? data.? Pearson’s?
correlation?coefficients,?regression?coefficients,?and?their?p?values?are?reported?for?all?bivariate?associations?
(panels?B,?D).?Data?of?lean?(??open?circles)?and?obese?men?(??closed?circles)?are?shown.?
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Figure?5.2?–?Biopsy?Study,?subcutaneous?adipose?tissue.?(A)?NK?cells?in?subcutaneous?adipose?tissue?(SAT)?
in?lean?and?obese?individuals?(n?=?26).?(B)?M1?macrophage?polarization?(M1?to?M2?ratio)?in?SAT?in?lean?and?
obese? individuals? (n? =? 31).? (C)?Association?between?NK? cells? in? SAT? and?M1?to?M2? ratio? in? SAT? (n?=?26).?
(D)?Association?between?NK?cells? in?SAT?and?CD11B?expression?on?circulating?NK?cells?(NK?CD11B;?n?=?24).?
Differences?between?groups?were?assessed?by?means?of? independent?Student’s? t?tests? (panels?A?B).?Box?
plots?are?as?follows:?black?line,?median;?box?edges,?1st?and?3rd?quartiles;?whiskers,?minimum?and?maximum?
of?all?data.?Pearson’s? correlation? coefficients,? regression? coefficients,?and? their?p?values?are? reported? for?
bivariate? associations? (panels? C?D).? Data? of? lean? (?? open? circles)? and? obese?men? (?? closed? circles)? are?
shown.?
?
VAT?NK?cells?are?reflected?by?CD11B?on?circulating?NK?cells?
Since?biopsies?are?burdensome? for?study?participants?and?are?virtually? impossible? to?
implement?in?large?studies,?we?searched?for?a?proxy?for?NK?cell?accumulation?in?VAT.?
We?primarily?focused?on?NK?cells?in?peripheral?blood.?Interestingly,?NK?cell?numbers?in?
blood?were?not?associated?with?NK?cell?numbers?in?VAT?(r?=?0.058,?p?=?0.759).?We?did,?
however,?find?a?suitable?candidate?in?CD11B?expression?on?these?circulating?NK?cells.?
CD11B?has?been?described?as?a?maturation?marker?of?NK?cells.18,19?This? integrin?can?
mediate?cell?adhesion,?but?is?also?part?of?the?complement?receptor?3?complex,?which?
is? involved? in? cytotoxic? activation? of? NK? cells.20? We? found? that? CD11B? surface?
expression,?measured?as?MFI,?on?total?circulating?NK?cells?(from?here?on?referred?to?as?
NK?CD11B)? is? higher? in? obese? compared? to? lean?men? (Figure? 5.1C).?Moreover,?NK?
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CD11B?was?closely?associated?with?NK?cell?accumulation? in?VAT?(r?=?0.561,?p?=?0.002;?
Figure? 5.1D).? Additional? adjustment? for? the? potential? confounder? age? did? not?
materially? change? this? association.? NK? cells? in? SAT? on? the? other? hand? were? not?
associated?with?NK?CD11B?(r?=?0.091;?p?=?0.671;?Figure?5.2D).?Since?VAT?NK?cells?were?
associated?with?an?increase?in?the?M1/M2?ratio,?we?confirmed?that?the?M1/M2?ratio?
was?associated?with?NK?CD11B?as?well? (r?=?0.364;?p?=?0.048).? In?conclusion,?NK?cells?
accumulate? in? VAT? of? obese? individuals? and? are? associated? with? inflammatory?
macrophage?polarization.?Moreover,?CD11B?surface?expression?on?circulating?NK?cells?
can?be?used?as?a?surrogate?marker?for?VAT?NK?cell?accumulation?in?studies?where?VAT?
biopsies?are?neither?available?nor?feasible.??
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Figure?5.3?–?NK?cell?function.?(A)?Surface?expression?of?NKp46?on?VAT?NK?cells?from?lean?(n?=?3)?and?obese?
individuals? (n?=?6).? (B)?Blood?derived?NK? cells? from? lean? (n?=?6;?white?bars)?and?obese? individuals? (n?=?8;?
black?bars)?were? isolated?and?co?cultured?with?either?human?monocyte?derived?macrophages?where?after?
surface?expression?of?M1?markers? (CCR7,?CD86?and?CD64),?or? incubated?with?monocytes? that?were? first?
polarized?to?an?M2?phenotype?where?after?loss?of?M2?markers?(loss?of?CD209?and?CD206;?i.e.,?polarization?
towards?M1)?was?assessed.?An?aggregate? total?effect?of?polarization? towards?an?M1?state?was?calculated?
(i.e.,?a?z?score?composed?of??CD209,??CD206,?CCR7,?CD86,?and?CD64);?compared?to? lean? individuals,?obese?
individuals? displayed? more? polarization? towards? the? M1? phenotype? (mean? difference? 1.08? (95%?CI?
0.06?2.10;?*?p?<?0.05)).?(C)?Intracellular?TNF? levels?were?measured? in?blood?derived?NK?cells?of? lean?(n?=?4)?
and?obese?individuals?(n?=?6)?using?flow?cytometry.?(D)?Association?between?CD11B?surface?expression?and?
intracellular?TNF?levels?of?blood?derived?NK?cells?(n?=?8).  
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Figure?5.4?–?Metabolic?phenotyping?study.?(A)?CD11B?expression?on?circulating?NK?cells?(NK?CD11B)?in?lean?
and?abdominally?obese? individuals? (n?=?64;?**?p?<?0.01).? (B)?Association?between?visceral?adipose? tissue?
volume? (VAT)?and?NK?CD11B? in? lean?and?abdominally?obese? individuals? (n?=?63).? (C)?Association?between?
NK?CD11B?and?low?grade?inflammation?(z?LGI;?composite?z?score?of?CRP,?SAA,?IL?6,?IL?8,?sICAM?1,?and?TNF)?
in? lean? and? abdominally?obese? individuals? (n? =?64).? (D)?Association?between?NK?CD11B? and?whole?body?
glucose? disposal? (WBGD)? during? a? hyperinsulinemic,? euglycemic? clamp? in? lean? and? abdominally? obese?
individuals? (n?=?64).?Difference?between?groups?was?assessed?by?means?of? independent?Student’s? t?tests?
(panel?A).?Box?plots?are?as?follows:?black?line,?median;?box?edges,?1st?and?3rd?quartiles;?whiskers,?minimum?
and?maximum?of?all?data.?Pearson’s?correlation?coefficients,?regression?coefficients,?and?their?p?values?are?
reported?for?all?bivariate?associations?(panels?B?D).?Data?of? lean?(??open?circles)?and?obese?men?(??closed?
circles)?are?shown. 
?
NK? cells? from? obese? individuals? produce? enhanced? levels? of? TNF? and?
induce?inflammatory?polarization?of?macrophages?
In?the?second?study,?we?investigated?whether?NK?cells?from?obese?individuals?directly?
affect?macrophage?polarization.?Hence,?NK?cells?were? isolated?from?peripheral?blood?
and? co?cultured?with? human?monocyte?derived?macrophages.?We? investigated? the?
capacity?of?NK?cells? to?either?promote? the?expression?of?M1?surface?markers? (CCR7,?
CD86?and?CD64)? in? resting?macrophages?or? to? inhibit?M2?surface?marker?expression?
(CD206? and?CD209)? in?M2?polarized?macrophages,? as? a?model? for? resident? adipose?
tissue?macrophages.7?Compared?to?NK?cells?from?lean?individuals,?NK?cells?from?obese?
donors? promoted? M1? polarization? in? monocyte?derived? macrophages? (p?=?0.040;?
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Figure?5.3B).?This?observation?that?NK?cells?can?induce?M1?polarization?in?obesity?is?in?
line? with? the? association? between? VAT? NK? cell? numbers? and? M1/M2? ratio?
demonstrated?in?the?first?study?(Figure?5.1B).?
?
Furthermore,?compared?to?lean?donors,?peripheral?blood?NK?cells?from?obese?subjects?
displayed?higher?intracellular?TNF?levels?(124?±?22?vs.?184?±?19?MFI,?p?=?0.002;?Figure?
5.3C).? These? data? are? in? accordance? with? the? report? of? Lee? et? al.? showing? that?
epididymal?adipose?tissue?NK?cells?from?obese?mice?produce?enhanced?levels?of?TNF.9?
Although? IFN??also?has?been? implicated? in?the?causal?contribution?of?mouse?adipose?
tissue?inflammation?and?concomitant?insulin?resistance,11?we?did?not?observe?elevated?
IFN?? levels? in? the? NK? cells? of? obese? individuals? (data? not? shown).? Finally,? CD11B?
surface?expression?on?NK? cells?was? closely?associated?with?TNF?production? in? these?
cells? (r?=?0.806,? p?=?0.016;? Figure? 5.3D).? Additional? adjustment? for? the? potential?
confounder?age?did?not?materially?change?this?association.?The?expression?of?CD11B?
on?NK? cells?may? thus? be? a? reflection? of? their? activation? level? and? their? capacity? to?
polarize?macrophages?towards?a?more?inflammatory?state.?However,?whether?CD11B?
has?a?role?in?either?the?migration?of?NK?cells?into?VAT?or?in?macrophage?polarization,?
or?is?a?mere?reflection?of?a?closely?related?mechanism?should?be?elucidated?by?future?
studies.?Collectively,? these?data? show? that?NK? cells? from?obese? individuals?promote?
inflammatory?polarization?of?macrophages,?possibly?via? the? increased?production?of?
TNF.?
NK?cells?are?inversely?associated?with?insulin?resistance?and?partially?
mediate?the?association?between?VAT?volume?and?insulin?resistance?
To?determine?the?relation?between?VAT?NK?cells?and?insulin?resistance,?we?performed?
analyses? in? a? third? study? including? 25? lean? (waist? circumference? <94? cm)? and?
53?abdominally?obese?men?(waist?circumference?102?110?cm).21?We?used?state?of?the?
art? in?depth?metabolic?and? inflammatory?phenotyping?to?provide?precise?estimations?
of?VAT?and?SAT?volumes?and? insulin?resistance.?FACS?data?were?available? in?22? lean?
and?42?abdominally?obese?men?who?were?consecutively?enrolled.? In? this?study,?VAT?
and? SAT? volumes?were? determined? by?magnetic? resonance? imaging? (MRI),? plasma?
cytokine? levels? with? the? MSD? system,22? and? insulin? sensitivity? by? means? of? a?
1?mU/kg/min?euglycemic?insulin?clamp.?By?design,?obese?men?had?an?increased?waist?
circumference? compared? to? lean?men? (106.6? [103.5?109.1]? vs.? 85.8? [80.6?89.8]? cm;?
p?<?0.001),?as?well?as?higher?VAT?(2.384?±?0.751?vs.?0.872?±?0.434?L;?p?<?0.001)?and?SAT?
volumes? (3.067?±?0.798?vs.?1.437?±?0.527?L;?p?<?0.001),?and?a?decreased?whole?body?
glucose?disposal?(WBGD;?4.04?±?1.23?vs.?6.85?±?1.85?mg/kg/min;?p?<?0.001;?Table?S5.2;?
STAR?Methods).?NK?CD11B?was? significantly?higher? in?obese? compared? to? lean?men?
(Figure?5.3A),?reflecting? increased?VAT?NK?cell?accumulation.?As?expected,? increased?
VAT? volume?was? inversely? associated?with?WBGD? (r?=??0.640,?p?<?0.001).?Moreover,?
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VAT?volume?was?associated?with?higher?NK?CD11B?(r?=?0.302;?p?=?0.016;?Figure?5.3B),?
confirming? the? relationship? between? NK?CD11B? and? VAT? expansion.? In? addition,?
NK?CD11B?was?associated?with?a?LGI?z?score? (i.e.,?composite?score?of?CRP,?SAA,? IL?6,?
IL?8,? sICAM?1,? and? TNF;? r?=?0.491;? p?<?0.001;? Figure? 5.3C),? and?WBGD? (r?=??0.309;?
p?=?0.013;?Figure?5.3D).?Additional?adjustment?for?age?did?not?materially?change?any?of?
these?associations.?
?
We? next? explored?whether? VAT?NK? cells,? by?means? of?NK?CD11B,? and? consecutive?
systemic?LGI?contribute?to?the?association?between?VAT?volume?and?insulin?resistance.?
We? investigated? the? contribution?of? this?pathway? to? insulin? resistance?by?means?of?
multiple?mediation?analyses.?VAT?NK? cells,?by?means?of?NK?CD11B,?and? subsequent?
LGI?partially?explained? the?association?between?VAT?and? insulin? resistance? (???0.075?
(?0.233?to? ?0.011);?Figure?S5.1).?As?a?result,?53.9%?of?the?contribution?of?LGI?to?VAT?
associated? insulin?resistance?appears?to?be?explained?by?NK?CD11B.?This? is? indicative?
that,? in?humans,?NK?cell?accumulation? in?VAT? leads? to?systemic?LGI?and?subsequent?
induction? of? insulin? resistance? and? thereby? constitutes? a? separate? target? for?
intervention.??
?
Finally,?as?recent?literature?in?mice?suggests?that?the?inflammatory?cytokines?TNF?and?
IL?6? in?particular?may?be? responsible? for? the?association?between?VAT?NK? cells?and?
insulin? resistance,9,10? we? explored? whether? VAT? NK? cells? contribute? to? insulin?
resistance? via? these? cytokines? in? humans? as? well.?We? found? that? NK?CD11B? was?
associated? with? both? TNF? (r?=?0.349;? p?=?0.005)? and? IL?6? (r?=?0.274;? p?=?0.029).? In?
additional?pathway?analyses?we?found?that?VAT?NK?cells?contribute?to?VAT?associated?
insulin?resistance?mainly?through?TNF?(???0.048?(?0.170?to??0.006)),?but?not?statistically?
significantly?via?IL?6?(???0.018?(?0.077?to?0.043)).??
?
Collectively,? our? data? thus? show? that,? in? humans,? NK? cell? accumulation? in? VAT? is?
associated? with? inflammatory? macrophage? polarization,? systemic? LGI,? and? insulin?
resistance.? Interestingly,? our? multiple? mediation? analyses? argue? for? a? robust?
involvement?of?NK? cells?and? LGI? in?obesity?associated? insulin? resistance.?These?data?
are? in? line?with?previously?published?data?showing?that?more?TNF?producing?NK?cells?
accumulate? in?the?AT?of?obese?mice.9? Intriguingly,? in?mice,?obesity?regulated?NK?cell?
numbers? in?VAT?by?enhanced?recruitment?and? local?proliferation.9,11?Here?we?show?a?
close? association? between? NK?CD11B? and? NK? cell? accumulation? in? human? VAT.?
Moreover,?NK?CD11B?mediated?the?association?between?VAT?volume,?LGI,?and?insulin?
resistance.? These? results? are? at? least? suggestive? that? in?humans,? recruitment?of?NK?
cells?from?the?circulation?plays?an? important?quantitative?role? in?the?development?of?
VAT? inflammation?and? systemic? LGI.?This?does,?however,?not?exclude? the?possibility?
that? either? recruited? or? resident? NK? cells? may? proliferate? in? AT? during? the?
development? of? obesity.? Nevertheless,? it? is? tempting? to? speculate? that? increased?
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integrin?expression?on?NK?cell?surface?may?lead?to?enhanced?recruitment?of?NK?cells?in?
VAT,? although? blocking? CD11B? on?NK? cells? failed? to? attenuate? in? vitro? adhesion? to?
endothelial?cells.23?Since?CD11B?has?been?linked?to?NK?cell?activation,20?circulating?NK?
cells?of?obese?people?were?found?to?display?an?activated,?but?exhausted,?phenotype,?
rendering? these? cells? less? functional.24? It? would? be? of? great? interest? to? evaluate?
whether? CD11B? also? mechanistically? contributes? to? VAT? NK? cell? accumulation,? or?
merely? reflects?NK? cell? activation? in? VAT.? In? the? former? case,? CD11B?would? be? an?
interesting? target? to?prevent?NK? cell? accumulation? in?human?VAT? to? reduce? insulin?
resistance,?as?was?shown?in?mice.9,11,15?
Validation?of?findings?in?external?cohort?
We? aimed? to? validate? our? findings? in? a? population?based? cohort? study.?Hereto,?we?
used?an?observational?population?based?cohort?study?enriched?with?type?2?diabetes.?
In?this?study,?individuals?underwent?VAT?and?SAT?quantification?by?means?of?MRI;?NK?
cells?were?determined?in?blood?by?flow?cytometry;?insulin?sensitivity?was?quantified?by?
means?of? the?Matsuda? Index;?and?glucose?metabolism? status?was?assessed? through?
fasting?plasma?glucose?and?an?oral?glucose?tolerance?test?as?described?elsewhere.25?
First,?we? reconfirm? that?VAT? is?associated?with?LGI? (standardized???0.252;?p?<?0.001;?
n?=?696;?fully?adjusted?model)?and? insulin?resistance?by?means?of?the?Matsuda? Index?
(standardized? ???0.462;?p?<?0.001;?n?=?397;? fully? adjusted?model).?More? importantly,?
VAT? volume?was? associated?with?NK? cell? accumulation? in? VAT? as? assessed? by? NK?
CD11B? (p?=?0.006;?Table?5.1).?There?was?no? interaction?with? sex?or?diabetes? status.?
When? diabetic? individuals? or? individuals? that? used? blood?pressure?lowering,? lipid?
lowering,?glucose?lowering,?or?anti?inflammatory?medication?were?excluded?from?the?
analysis,?the?results?did?not?materially?change.?Adjusting?the?model?for?SAT?volume?did?
not?alter?the?results?(data?not?shown).?In?addition,?NK?CD11B?was?positively?associated?
with?the?z?score?of?LGI,?plasma?TNF? levels,?and?plasma? IL?6? levels?(p?<?0.05?for?each;?
Table? S5.4).? Finally,?we? found? that? NK?CD11B,? as? a?measure? of? VAT?NK? cells,?was?
associated? with? insulin? resistance? (p?=?0.013;? Table? 5.2).? There? was? again? no?
interaction?with?sex?or?diabetes?status,?nor?did?the?exclusion?of?diabetic?individuals?or?
individuals? that? used? blood?pressure?lowering,? lipid?lowering,? glucose?lowering,? or?
anti?inflammatory?medication?materially?change?the?results?(data?not?shown).?We?can?
therefore? conclude? that? the? findings? of? the? first? three? independent? studies? were?
validated?in?a?cohort?study?that?was?obtained?from?the?general?population.?
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Table?5.1?–?Associations?between?VAT?and?NK?CD11B?(n?=?696).?
NK?CD11B?[AU]?? Model?
??(95%?CI)? p?value?
VAT?[cm2]? 1? 3.90?(1.84;?5.97)? <0.001?
? 2? 3.21?(0.94;?5.48)? 0.006?
Model?1:?Adjusted?for?age,?sex,?and?glucose?metabolism?status.?Model?2:?Fully?adjusted?model?(model?1?+?
systolic?blood?pressure,?total?to?HDL?cholesterol?ratio,?smoking?status,?prior?cardiovascular?disease,?and?use?
of? antihypertensive,? anti?inflammatory,? glucose?lowering? or? lipid?lowering? medication).? Multiple? linear?
regression?analyses?in?individuals?with?normal?glucose?metabolism?(n?=?405),?prediabetes?(n?=?93),?and?type?
2?diabetes?(n?=?198).?The?beta?of?each?model?is?presented?along?with?its?respective?95%?CI?and?p?value.?
?
Table?5.2?–?Associations?between?NK?CD11B?and?the?Matsuda?Index?(n=540).?
Matsuda?Index?? Model?
??(95%?CI)? p?value?
NK?CD11B? 1? 2337?(609;?4064)? 0.008?
? 2? 2212?(440;?3783)? 0.013?
Model?1:?Adjusted?for?age,?sex,?and?glucose?metabolism?status.?Model?2:?Fully?adjusted?model?(model?1?+?
systolic?blood?pressure,?total?to?HDL?cholesterol?ratio,?smoking?status,?prior?cardiovascular?disease,?and?use?
of? antihypertensive,? anti?inflammatory,? glucose?lowering? or? lipid?lowering? medication).? Multiple? linear?
regression?analyses?in?individuals?with?normal?glucose?metabolism?(n?=?313),?prediabetes?(n?=?71),?and?type?
2?diabetes?(n?=?156).?The?beta?of?each?model?is?presented?along?with?its?respective?95%?CI?and?p?value.?NK?
CD11B?was? transformed? to? 1? /?NK?CD11B? and? the?Matsuda? Index? to? SQRT?Matsuda? Index? to? fulfill? the?
assumptions?of?the?regression?model?and?are?presented?as?such.?
?
?
In?conclusion,?we?show? for? the? first? time? that?NK?cells? in?VAT?contribute? to?LGI?and?
subsequent? insulin?resistance? in?humans.?Since?experimental?studies?suggest?that?NK?
cell?accumulation?is?an?early?event?in?the?development?of?VAT?inflammation,?targeting?
these? cells? may? hold? great? promise? to? inhibit? this? pathway? leading? to? insulin?
resistance.?These?findings?pave?the?way?for?novel?therapeutic?strategies?to?target?the?
inflammatory? component? of? insulin? resistance? development,? which? has? until? now?
been? proven? rather? unsatisfactory.26? Moreover,? we? identified? CD11B? surface?
expression?on?circulating?NK?cells? to?be?a? reflection?of?NK?cell?accumulation? in?VAT.?
Aside?from?the?obvious?benefit?of?this?minimally?invasive?measurement?as?a?marker?of?
VAT? inflammation,? future? studies? should? address? whether? CD11B? on? NK? cells?
contributes?to?their?accumulation?and?can?be?used?as?therapeutic?target.??
539883-L-sub01-bw-Kusters
Processed on: 13-1-2020 PDF page: 164
Chapter?5?
164?
Acknowledgements?
Maria?Vroomen,?José?van?de?Gaar,?and?Jos?op? ‘t?Roodt?are?greatly?acknowledged?for?
their? technical?assistance.?We? thank?Marleen?van?Greevenbroek? for?epidemiological?
counseling.? Part? of? this? study? was? financed? by? The? Netherlands? Organization? for?
Scientific? Research? (NWO)? (Veni? 916.12.056),? The? Netherlands? Heart? Foundation?
(2013T143),?and?a?Seventh?Framework?Program?(FP7)?Grant?(CIG?322070)?to?KW.?The?
metabolic?phenotyping?study?was?supported?by? research?grant?CH001? from? the?Top?
Institute?Food?and?Nutrition,?a?public?private?partnership?on?precompetitive?research?
in? food?and?nutrition.?The?public?partners?are?responsible? for?the?study?design,?data?
collection?and?analysis,?decision? to?publish,?and?preparation?of? the?manuscript.?The?
validation?study?was?supported?by?the?European?Regional?Development?Fund?via?OP?
Zuid,?the?Province?of?Limburg,?the?Dutch?Ministry?of?Economic?Affairs?(grant?31O.041),?
Stichting? De?Weijerhorst? (Maastricht,? the? Netherlands),? the? Pearl? String? Initiative?
Diabetes? (Amsterdam,? the?Netherlands),? CARIM? School? for? Cardiovascular?Diseases?
(Maastricht,?the?Netherlands),?Stichting?Annadal?(Maastricht,?the?Netherlands),?Health?
Foundation? Limburg? (Maastricht,? the?Netherlands)? and? by? unrestricted? grants? from?
Janssen?Cilag?B.V.? (Tilburg,? the?Netherlands),?Novo?Nordisk? Farma?B.V.? (Alphen? aan?
den? Rijn,? the? Netherlands)? and? Sanofi?Aventis? Netherlands? B.V.? (Gouda,? the?
Netherlands).?
?
539883-L-sub01-bw-Kusters
Processed on: 13-1-2020 PDF page: 165
? Visceral?adipose?tissue?NK?Cells,?inflammation,?and?insulin?resistance?
165?
5?
References?
1.? DeFronzo,?R.A.,?and?Ferrannini,?E.?(1991).?Insulin?resistance.?A?multifaceted?syndrome?responsible?for?
NIDDM,? obesity,? hypertension,? dyslipidemia,? and? atherosclerotic? cardiovascular? disease.? Diabetes?
Care?14,?173?194.?
2.? Hotamisligil,?G.S.,?Shargill,?N.S.,?and?Spiegelman,?B.M.? (1993).?Adipose?expression?of?tumor?necrosis?
factor?alpha:?direct?role?in?obesity?linked?insulin?resistance.?Science?259,?87?91.?
3.? Carvalheira,?J.B.,?Qiu,?Y.,?and?Chawla,?A.?(2013).?Blood?spotlight?on?leukocytes?and?obesity.?Blood?122,?
3263?3267.?
4.? Ohman,?M.K.,?Wright,?A.P.,?Wickenheiser,?K.J.,? Luo,?W.,? and? Eitzman,?D.T.? (2009).?Visceral? adipose?
tissue?and?atherosclerosis.?Current?vascular?pharmacology?7,?169?179.?
5.? Weisberg,?S.P.,?McCann,?D.,?Desai,?M.,?Rosenbaum,?M.,? Leibel,?R.L.,?and?Ferrante,?A.W.,? Jr.? (2003).?
Obesity? is? associated? with? macrophage? accumulation? in? adipose? tissue.? The? Journal? of? clinical?
investigation?112,?1796?1808.?
6.? Xu,?H.,?Barnes,?G.T.,?Yang,?Q.,?Tan,?G.,?Yang,?D.,?Chou,?C.J.,?Sole,?J.,?Nichols,?A.,?Ross,?J.S.,?Tartaglia,?L.A.,?
et?al.? (2003).?Chronic? inflammation? in? fat?plays?a?crucial? role? in? the?development?of?obesity?related?
insulin?resistance.?The?Journal?of?clinical?investigation?112,?1821?1830.?
7.? Lumeng,?C.N.,?Bodzin,? J.L.,?and?Saltiel,?A.R.? (2007).?Obesity? induces?a?phenotypic? switch? in?adipose?
tissue?macrophage?polarization.?The?Journal?of?clinical?investigation?117,?175?184.?
8.? Wentworth,?J.M.,?Naselli,?G.,?Brown,?W.A.,?Doyle,?L.,?Phipson,?B.,?Smyth,?G.K.,?Wabitsch,?M.,?O'Brien,?
P.E.,? and? Harrison,? L.C.? (2010).? Pro?inflammatory? CD11c+CD206+? adipose? tissue?macrophages? are?
associated?with?insulin?resistance?in?human?obesity.?Diabetes?59,?1648?1656.?
9.? Lee,?B.C.,?Kim,?M.S.,?Pae,?M.,?Yamamoto,?Y.,?Eberle,?D.,?Shimada,?T.,?Kamei,?N.,?Park,?H.S.,?Sasorith,?S.,?
Woo,?J.R.,?et?al.?(2016).?Adipose?Natural?Killer?Cells?Regulate?Adipose?Tissue?Macrophages?to?Promote?
Insulin?Resistance?in?Obesity.?Cell?metabolism?23,?685?698.?
10.? Theurich,?S.,?Tsaousidou,?E.,?Hanssen,?R.,? Lempradl,?A.M.,?Mauer,? J.,?Timper,?K.,?Schilbach,?K.,?Folz?
Donahue,?K.,?Heilinger,?C.,?Sexl,?V.,?et?al.?(2017).?IL?6/Stat3?Dependent?Induction?of?a?Distinct,?Obesity?
Associated?NK?Cell?Subpopulation?Deteriorates?Energy?and?Glucose?Homeostasis.?Cell?metabolism?26,?
171?184?e176.?
11.? Wensveen,? F.M.,? Jelencic,? V.,? Valentic,? S.,? Sestan,?M.,?Wensveen,? T.T.,? Theurich,? S.,? Glasner,? A.,?
Mendrila,?D.,?Stimac,?D.,?Wunderlich,?F.T.,?et?al.?(2015).?NK?cells?link?obesity?induced?adipose?stress?to?
inflammation?and?insulin?resistance.?Nature?immunology?16,?376?385.?
12.? Vivier,? E.,? Raulet,?D.H.,?Moretta,?A.,? Caligiuri,?M.A.,? Zitvogel,? L.,? Lanier,? L.L.,? Yokoyama,?W.M.,? and?
Ugolini,?S.?(2011).? Innate?or?adaptive? immunity??The?example?of?natural?killer?cells.?Science?331,?44?
49.?
13.? O'Rourke,?R.W.,?Gaston,?G.D.,?Meyer,?K.A.,?White,?A.E.,?and?Marks,?D.L.?(2013).?Adipose?tissue?NK?cells?
manifest?an?activated?phenotype?in?human?obesity.?Metabolism?62,?1557?1561.?
14.? Wouters,?K.,?Gaens,?K.,?Bijnen,?M.,?Verboven,?K.,?Jocken,?J.,?Wetzels,?S.,?Wijnands,?E.,?Hansen,?D.,?van?
Greevenbroek,?M.,?Duijvestijn,?A.,?et?al.? (2017).?Circulating? classical?monocytes?are?associated?with?
CD11c+?macrophages?in?human?visceral?adipose?tissue.?Sci?Rep?7,?42665.?
15.? O'Rourke,? R.W.,?Meyer,? K.A.,?Neeley,? C.K.,?Gaston,?G.D.,? Sekhri,? P.,? Szumowski,?M.,? Zamarron,? B.,?
Lumeng,?C.N.,?and?Marks,?D.L.?(2014).?Systemic?NK?cell?ablation?attenuates? intra?abdominal?adipose?
tissue?macrophage?infiltration?in?murine?obesity.?Obesity?22,?2109?2114.?
16.? O'Rourke,?R.W.,?Metcalf,?M.D.,?White,?A.E.,?Madala,?A.,?Winters,?B.R.,?Maizlin,?II,?Jobe,?B.A.,?Roberts,?
C.T.,?Jr.,?Slifka,?M.K.,?and?Marks,?D.L.?(2009).?Depot?specific?differences?in?inflammatory?mediators?and?
a?role?for?NK?cells?and?IFN?gamma?in?inflammation?in?human?adipose?tissue.?Int?J?Obes?(Lond)?33,?978?
990.?
17.? Preis,?S.R.,?Massaro,?J.M.,?Robins,?S.J.,?Hoffmann,?U.,?Vasan,?R.S.,? Irlbeck,?T.,?Meigs,?J.B.,?Sutherland,?
P.,?D'Agostino,?R.B.,?Sr.,?O'Donnell,?C.J.,?et?al.? (2010).?Abdominal?subcutaneous?and?visceral?adipose?
tissue?and?insulin?resistance?in?the?Framingham?heart?study.?Obesity?18,?2191?2198.?
18.? Chiossone,?L.,?Chaix,?J.,?Fuseri,?N.,?Roth,?C.,?Vivier,?E.,?and?Walzer,?T.?(2009).?Maturation?of?mouse?NK?
cells?is?a?4?stage?developmental?program.?Blood?113,?5488?5496.?
539883-L-sub01-bw-Kusters
Processed on: 13-1-2020 PDF page: 166
Chapter?5?
166?
19.? Fu,? B.,?Wang,? F.,? Sun,? R.,? Ling,? B.,? Tian,? Z.,? and?Wei,? H.? (2011).? CD11b? and? CD27? reflect? distinct?
population?and?functional?specialization?in?human?natural?killer?cells.?Immunology?133,?350?359.?
20.? Ross,?G.D.,?and?Vetvicka,?V.?(1993).?CR3?(CD11b,?CD18):?a?phagocyte?and?NK?cell?membrane?receptor?
with?multiple?ligand?specificities?and?functions.?Clin?Exp?Immunol?92,?181?184.?
21.? Kusters,?Y.H.,?Schalkwijk,?C.G.,?Houben,?A.J.,?Kooi,?M.E.,?Lindeboom,?L.,?Op?'t?Roodt,?J.,?Joris,?P.J.,?Plat,?
J.,?Mensink,? R.P.,? Barrett,? E.J.,? et? al.? (2017).? Independent? tissue? contributors? to? obesity?associated?
insulin?resistance.?JCI?Insight?2.?
22.? van?Bussel,?B.C.,?Ferreira,?I.,?van?de?Waarenburg,?M.P.,?van?Greevenbroek,?M.M.,?van?der?Kallen,?C.J.,?
Henry,? R.M.,? Feskens,? E.J.,? Stehouwer,? C.D.,? and? Schalkwijk,? C.G.? (2013).? Multiple? inflammatory?
biomarker? detection? in? a? prospective? cohort? study:? a? cross?validation? between? well?established?
single?biomarker?techniques?and?an?electrochemiluminescense?based?multi?array?platform.?PLoS?One?
8,?e58576.?
23.? Allavena,? P.,? Paganin,? C.,?Martin?Padura,? I.,? Peri,? G.,? Gaboli,?M.,? Dejana,? E.,?Marchisio,? P.C.,? and?
Mantovani,? A.? (1991).?Molecules? and? structures? involved? in? the? adhesion? of? natural? killer? cells? to?
vascular?endothelium.?J?Exp?Med?173,?439?448.?
24.? Viel,? S.,? Besson,? L.,? Charrier,? E.,?Marcais,? A.,? Disse,? E.,? Bienvenu,? J.,?Walzer,? T.,? and? Dumontet,? C.?
(2017).?Alteration?of?Natural?Killer? cell?phenotype? and? function? in?obese? individuals.?Clin? Immunol?
177,?12?17.?
25.? Schram,?M.T.,?Sep,?S.J.S.,?van?der?Kallen,?C.J.,?Dagnelie,?P.C.,?Koster,?A.,?Schaper,?N.,?Henry,?R.M.A.,?
and? Stehouwer,? C.D.A.? (2014).? The? Maastricht? Study:? an? extensive? phenotyping? study? on?
determinants?of?type?2?diabetes,?its?complications?and?its?comorbidities.?Eur?J?Epidemiol?29,?439?451.?
26.? Donath,?M.Y.?(2014).?Targeting? inflammation? in?the?treatment?of?type?2?diabetes:?time?to?start.?Nat?
Rev?Drug?Discov?13,?465?476.?
27.? DeFronzo,?R.A.,?Tobin,?J.D.,?and?Andres,?R.?(1979).?Glucose?clamp?technique:?a?method?for?quantifying?
insulin?secretion?and?resistance.?Am?J?Physiol?237,?E214?223.?
28.? Fuentes,?L.,?Wouters,?K.,?Hannou,?S.A.,?Cudejko,?C.,?Rigamonti,?E.,?Mayi,?T.H.,?Derudas,?B.,?Pattou,?F.,?
Chinetti?Gbaguidi,?G.,?Staels,?B.,?et?al.? (2011).?Downregulation?of? the? tumour? suppressor?p16INK4A?
contributes?to?the?polarisation?of?human?macrophages?toward?an?adipose?tissue?macrophage?(ATM)?
like?phenotype.?Diabetologia?54,?3150?3156.?
29.? van?Bussel,?B.C.,?Henry,?R.M.,?Schalkwijk,?C.G.,?Dekker,?J.M.,?Nijpels,?G.,?and?Stehouwer,?C.D.?(2012).?
Low?grade?inflammation,?but?not?endothelial?dysfunction,?is?associated?with?greater?carotid?stiffness?
in?the?elderly:?the?Hoorn?Study.?J?Hypertens?30,?744?752.?
539883-L-sub01-bw-Kusters
Processed on: 13-1-2020 PDF page: 167
? Visceral?adipose?tissue?NK?Cells,?inflammation,?and?insulin?resistance?
167?
5?
Supplementary?material?
?
?
?
?
?
?
?
?
?
?
?
?
?
Figure?S5.1?–?Pathway?analysis.?Serial?multiple?mediator?model? in?which?CD11B?expression?on?circulating?
NK?cells?(NK?CD11B)?statistically?significantly?contributes?through?low?grade?inflammation?(z?LGI;?composite?
z?score?of?CRP,?SAA,? IL?6,? IL?8,?sICAM?1,?and?TNF)? to? the?association?between?abdominal?visceral?adipose?
tissue?(VAT)?and?insulin?resistance?by?means?of?whole?body?glucose?disposal?(WBGD;?n?=?63;?age?adjusted).?
Data?presented?as???of?mediated?effect?(bootstrapped?95%?CI).?Significant?associations?are?represented?by?
black?lines,?whereas?grey?lines?represent?associations?that?are?not?statistically?significant.?
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Table?S5.1?–?Biopsy?study?population?characteristics.?
? Lean?
(n?=?15)?
Obese?
(n?=?17)? p?value?
Age?[Yr]? 52.1?±?6.1? 49.5?±?5.8? 0.215?
Weight?[kg]? 76.0?[73.0???81.0]? 115.0?[111.2???133.8]? <0.001?
Fat?Free?Mass?[kg]? 58.2?±?5.8? 76.2?±?7.9? <0.001?
Fat?Mass?[kg]? 16.2?[14.7???20.5]? 41.8?[36.9???48.9]? <0.001?
BMI?[kg/m2]? 23.6?[22.7???24.1]? 37.1?[35.1???38.7]? <0.001?
Waist?Circumference?[cm]? 89.0?[86.0???93.0]? 124.0?[121.3???130.3]? <0.001?
Hip?Circumference?[cm]?a? 92.5?[89.5???94.5]? 114.8?[111.6???118.8]? <0.001?
HOMA?IR? 1.73?[1.27???3.30]? 5.63?[3.54???7.16]? <0.001?
Fasting?Plasma?Glucose?[mmol/l]? 5.44?±?0.93? 6.08?±?0.97? 0.069?
HbA1c?[%]? 5.2?[5.1???5.5]? 5.6?[5.5???6.1]? <0.001?
Diabetes?Status?[Y/N]? 0?/?15? 3?/?14? N/A?
Glucose?lowering?Therapy?[Y/N]?? 0?/?15? 3?/?14? N/A?
Systolic?Blood?Pressure?[mmHg]?b? 132.3?±?15.1? 145.6?±?18.1? 0.053?
Diastolic?Blood?Pressure?[mmHg]?b? 83.6?±?9.2? 83.8?±?8.4? 0.956?
White?Blood?Cell?Count,?Blood?[x10^9/L]? 7.81?±?2.27? 6.63?±?1.39? 0.094?
Neutrophilic?Granulocyte?Count,?Blood?[x10^9/l]? 4.62?[3.61???6.18]? 3.70?[3.11???4.70]? 0.235?
Eosinophilic?Granulocyte?Count,?Blood?[x10^9/l]? 0.22?[0.20???0.38]? 0.15?[0.11???0.26]? 0.040?
Basophilic?Granulocyte?Count,?Blood?[x10^9/l]? 0.05?±?0.02? 0.04?±?0.02? 0.105?
Lymphocyte?Count,?Blood?[x10^9/l]? 1.99?±?0.50? 1.78?±?0.69? 0.333?
Monocyte?Count,?Blood?[x10^9/l]? 0.46?[0.37???0.69]? 0.54?[0.41???0.57]? 0.761?
NK?Cell?Count,?Blood?[x10^9/l]?a? 0.20?[0.14???0.41]? 0.28?[0.15???0.44]? 0.401?
NK?CD11B?MFI,?Blood?[AU]?c? 4953?±?1083? 7126?±?1342? <0.001?
SAT?NK?Cell?Count?[%?of?Live]?d? 3.52?±?2.10? 3.77?±?1.84? 0.758?
VAT?NK?Cell?Count?[%?of?Live]?e? 2.70?[1.64???4.09]? 3.79?[2.66???6.02]? 0.025?
VAT?M1/M2?Ratio? 0.78?[0.62???1.09]? 1.05?[0.85???2.55]? 0.074?
VAT?TNF?Expression?[Fold?of?Control]?f? 0.66?[0.48???1.33]? 1.28?[0.71???2.17]? 0.062?
Data?presented?as?mean?±? SD?or?median? [IQR].?Baseline?differences?between? lean?and?obese?men?were?
assessed?by?means?of?independent?Student’s?T?test?or?Mann?Whitney?U?test,?where?appropriate.?a?Analyzed?
in?15?lean?and?16?obese?men;?b?analyzed?in?11?lean?and?17?obese?men;?c?analyzed?in?14?lean?and?16?obese?
men;?d?analyzed?in?12?lean?and?14?obese?men;?e?analyzed?in?15?lean?and?16?obese?men;?f?analyzed?in?15?lean?
and?16?obese?men.?
?
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Table?S5.2?–?Metabolic?phenotyping?study?population?characteristics.?
? Lean?
(n?=?22)?
Obese?
(n?=?42)? p?value?
Age?[Yr]? 55.0?[23.2???61.2]? 52.4?[46.5???61.4]? 0.661?
Weight?[kg]? 75.8?±?8.2? 96.4?±?8.8? <0.001?
Fat?Free?Mass?[kg]? 62.8?±?5.6? 70.6?±?6.0? <0.001?
Fat?Mass?[kg]?? 13.0?±?4.6? 25.9?±?4.8? <0.001?
BMI?[kg/m2]? 23.4?±?1.9? 30.1?±?2.0? <0.001?
Waist?Circumference?[cm]? 85.8?[80.6???89.8]? 106.6?[103.5???109.1]? <0.001?
Hip?Circumference?[cm]? 96.8?±?4.4? 107.3?±?5.5? <0.001?
Visceral?Adipose?Tissue?Volume?[l]a?? 0.872?±?0.434? 2.384?±?0.751? <0.001?
Subcutaneous?Adipose?Tissue?Volume?[l]a? 1.437?±?0.527? 3.067?±?0.798? <0.001?
Whole?Body?Glucose?Disposal?[mg/kg/min]?? 6.85?±?1.85? 4.04?±?1.23? <0.001?
HOMA?IR? 1.7?±?0.5? 2.9?±?1.3? <0.001?
Fasting?Plasma?Glucose?[mmol/l]? 5.36?±?0.28? 5.66?±?0.46? 0.002?
HbA1c?[%]b? 5.15?±?0.38? 5.28?±?0.39? 0.211?
Systolic?Blood?Pressure?[mmHg]? 116.5?±?8.1? 122.1?±?8.4? 0.012?
Diastolic?Blood?Pressure?[mmHg]? 71.1?±?8.6? 79.7?±?6.9? <0.001?
White?Blood?Cell?Count,?Blood?[x10^9/l]c? 4.89?±?1.32? 5.67?±?1.25? 0.027?
Neutrophilic?Granulocyte?Count,?Blood?[x10^9/l]d? 2.59?±?0.88? 3.16?±?1.01? 0.032?
Eosinophilic?Granulocyte?Count,?Blood?[x10^9/l]d? 0.22?±?0.13? 0.21?±?0.13? 0.789?
Basophilic?Granulocyte?Count,?Blood?[x10^9/l]d? 0.03?[0.00???0.05]? 0.03?[0.00???0.06]? 0.894?
Lymphocyte?Count,?Blood?[x10^9/l]d?? 1.60?±?0.37? 1.77?±?0.46? 0.151?
Monocyte?Count,?Blood?[x10^9/l]d?? 0.46?±?0.14? 0.52?±?0.15? 0.128?
NK?Cell?Count,?Blood?[x10^9/l]d?? 0.10?[0.08???0.15]? 0.14?[0.10???0.19]? 0.037?
NK?CD11B?MFI,?Blood?[AU]?? 10999?±?2445? 12865?±?2664? 0.008?
Low?grade?Inflammation?z?score? ?0.21?±?0.73? 0.11?±?0.60? 0.059?
Plasma?TNF?[pg/ml]? 1.85?[1.50???2.05]? 1.96?[1.62???2.31]? 0.161?
Plasma?IL?6?[pg/ml]? 0.58?[0.32???0.97]? 0.64?[0.47???0.90]? 0.344?
Data?presented?as?mean?±? SD?or?median? [IQR].?Baseline?differences?between? lean?and?obese?men?were?
assessed?by?means?of?independent?Student’s?T?test?or?Mann?Whitney?U?test?where?appropriate.?a?Analyzed?
in?21?lean?and?42?obese?men;?b?analyzed?in?22?lean?and?41?obese?men;?c?analyzed?in?21?lean?and?39?obese?
men;?d?analyzed?in?21?control?and?38?obese?men.?
?
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Table?S5.3?–?Validation?study?population?characteristics?–?The?Maastricht?Study.?
? NGT?
(n?=?480)?
Prediabetes?
(n?=?109)?
T2DM?
(n?=?250)? p?value?
Age?[Yr]? 58.5?±?8.5? 60.3?±?8.5?***? 63.7?±?8.2?###? <0.001?
Sex?[M/F]? 199/281? 49/60? 160/90?###? <0.001?
Smoking?Status?[never/former/?current]? 207/218/55? 35/56/18? 78/130/42?##? 0.010?
Weight?[kg]? 74.1?±?13.2? 78.1?±?12.9**? 87.5?±?15.9?###? <0.001?
Fat?Free?Mass?[kg]? 47.4?[40.9???57.7]? 49.7?[41.3???57.0]? 55.8?[46.6???62.3]###? <0.001?
Fat?Mass?[kg]?? 23.9?[20.0???28.8]? 26.8?[22.0???34.8]***? 30.9?[24.4???39.4]###? <0.001?
BMI?[kg/m2]? 25.5?±?3.5? 27.5?±?4.4***? 29.9?±?5.1###? <0.001?
Waist?Circumference?[cm]? 89.4?±?10.9? 96.7?±?11.2***? 105.1?±?13.1###? <0.001?
Hip?Circumference?[cm]? 99.2?[95.0???104.0]? 100.5?[95.8???107.1]**? 103.6?[99.0???111.3]?###? <0.001?
Visceral?Adipose?Tissue?[cm2]?a?? 112.8?[69.4???172.9]? 160.8?[117.0???220.7]***? 248.5?[171.0???317.3]###? <0.001?
Fasting?Plasma?Glucose?[mmol/l]? 5.20?±?0.41? 5.85?±?0.61***? 7.61?±?1.51###? <0.001?
HOMA?IR?b? 1.20?[0.88???1.65]? 1.71?[1.21???2.70]***? 2.27?[1.30???3.19]###? <0.001?
Matsuda?Index?c? 4.27?[3.10???6.18]? 2.07?[1.34???3.44]***? 1.79?[1.10???2.97]###? <0.001?
HbA1c?[%]? 5.3?[5.1???5.5]? 5.6?[5.3???5.9]***? 6.6?[6.1???7.0]###? <0.001?
Systolic?Blood?Pressure?[mmHg]? 130.2?±?17.0? 133.8?±?16.0?*? 138.4?±?16.9###? <0.001?
Diastolic?Blood?Pressure?[mmHg]? 77.4?±?9.9? 76.3?±?9.6? 75.5?±?9.5? 0.125?
Glucose?lowering?Therapy?[%]? 0? 0? 75.6? N/A?
Blood?Pressure?Lowering?Therapy?[%]? 20.8? 44.0***? 69.2###? <0.001?
Lipid?Lowering?Therapy?[%]? 14.2? 39.4***? 72.0###? <0.001?
Anti?inflammatory?Therapy?[%]? 12.7? 16.5? 13.2? 0.572?
History?of?Cardiovascular?Disease?[%]? 11.9? 17.4? 25.6###? <0.001?
White?Blood?Cell?Count,?Blood?[x10^9/l]? 5.05?[4.30???5.90]? 5.60?[4.70???6.80]***? 6.00?[5.10???7.30]###? <0.001?
Neutrophilic?Granulocyte?Count,?Blood?
[x10^9/l]?
2.76?[2.24???3.35]? 3.23?[2.47???4.14]***? 3.46?[2.85?–?4.19]?###? <0.001?
Eosinophilic?Granulocyte?Count,?Blood?
[x10^9/l]?
0.14?[0.09???0.20]? 0.17?[0.11?–?0.22]?*? 0.17?[0.11?–?0.24]?###? <0.001?
Lymphocyte?Count,?Blood?[x10^9/l]? 1.63?[1.37???1.98]? 1.72?[1.43???2.07]? 1.84?[1.52???2.24]?###? <0.001?
Monocyte?Count,?Blood?[x10^9/l]? 0.42?[0.34???0.50]? 0.46?[0.36???0.58]?***? 0.48?[0.40???0.61]?###? <0.001?
NK?Cell?Count,?Blood?[x10^9/l]? 0.19?[0.13???0.27]? 0.21?[0.14???0.27]? 0.22?[0.14???0.31]?#? 0.121?
NK?CD11B?MFI,?Blood?[AU]?? 8866?±?2188? 9140?±?2200? 9419?±?2291?###? 0.006?
Low?grade?Inflammation?Z?score? ?0.34?±?0.92? 0.27?±?0.94?***? 0.53?±?0.91?###? <0.001?
Plasma?TNF?[pg/ml]? 2.06?[1.75???2.40]? 2.17?[1.93???2.62]?***? 2.46?[2.15???2.82]?###? <0.001?
Plasma?IL?6?[pg/ml]? 0.47?[0.30???0.71]? 0.59?[0.42???0.90]?***? 0.81?[0.56???1.10]?###? <0.001?
Data?presented?as?mean?±?SD?or?median?[IQR].?Baseline?differences?between? individuals?with?prediabetes?
and?normal?glucose?metabolism?(NGM),?and?type?2?diabetes?(T2DM)?and?NGM?were?assessed?by?means?of?
independent?samples?Student’s?T?test,?Mann?Whitney?U?test,?or?chi?square?test?where?appropriate.?P?value?
prediabetes?compared?to?NGM;?*?p?<?0.05,?**?p?<?0.01,?***?p?<?0.001.?P?value?T2DM?compared?to?NGM;?
#?p?<?0.05,? ##?p?<?0.01,? ###?p?<?0.001.?Differences?between?all?groups?were?assessed?by?means?of?one?way?
ANOVA,?Kruskal?Wallis?test,?or?chi?square?test?where?appropriate;?respective?p?values?reported?in?separate?
column.?a?Analyzed? in?405?NGM,?93?prediabetes,?and?198?T2DM;? ?b?analyzed? in?310?NGM,?73?prediabetes,?
and?179?T2DM;?c?analyzed?in?313?NGM,?71?prediabetes,?and?156?T2DM.?
?
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Table?S5.4?–?Associations?between?NK?CD11B?and?z?LGI,?plasma?TNF?or?plasma?IL?6?(n=839).?
z?LGI?? Model? ??(95%?CI)? p?value?
NK?CD11B?(x1000)? 1? 0.039?(0.010;?0.067)? 0.007?
? 2? 0.028?(0.000;?0.055)? 0.048?
z?TNF?? Model? ??(95%?CI)? p?value?
NK?CD11B?(x1000)? 1? 0.040?(0.011;?0.070)? 0.007?
? 2? 0.034?(0.005;?0.064)? 0.023?
z?IL?6?? Model? ??(95%?CI)? p?value?
NK?CD11B?(x1000)? 1? 0.073?(0.044;?0.102)? <0.001?
? 2? 0.042?(0.014;?0.071)? 0.004?
Model?1:?Adjusted?for?age,?sex,?and?glucose?metabolism?status.?Model?2:?Fully?adjusted?model?(model?1?+?
systolic?blood?pressure,?total?to?HDL?cholesterol?ratio,?smoking?status,?prior?cardiovascular?disease,?and?use?
of? antihypertensive,? anti?inflammatory,? glucose?lowering? or? lipid?lowering? medication).? Multiple? linear?
regression? analyses? in? individuals?with? normal? glucose?metabolism? (n?=?480),? prediabetes? (n?=?109),? and?
type?2?diabetes?(n?=?250).?The?beta?of?each?model?is?presented?along?with?its?respective?95%?CI?and?p?value.?
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Star*methods?
Experimental?model?and?subject?details?
Biopsy?studies??
Age?matched?men?who?were? scheduled? to? undergo? abdominal? or? bariatric? surgery?
were? recruited.? The? decision? to? undergo? surgery?was?made? independently? of? this?
research? protocol,? between? patient? and? physician.? The? control? group? consisted? of?
15?lean?men.?The?obese? group?was? composed?of?17?men.?Within?obese? individuals?
there? were? three? patients? with? type? 2? diabetes,? each? was? on? glucose?lowering?
medication.? Six? obese? individuals? were? on? lipid?lowering? medication? and? 10? used?
antihypertensive?medication.?None?of?the?lean?individuals?used?any?medication.?Lean?
individuals?were? included?due? to? surgery?of? inguinal? hernia,? except? for? one? person?
undergoing? laparoscopic? cholecystectomy.? Clinical? characteristics? of? the? individuals?
included? in? the?study?are?summarized? in?Supplementary?Table?S5.1.?Major?exclusion?
criteria?were?presence?of?a?history?of?heart,?lung?or?kidney?disease,?and/or?presence?of?
endocrine? anomalies.? The? study? protocol? was? approved? by? the? Medical? Ethical?
Committee?Jessa?hospital?and?Hasselt?University,?Hasselt,?Belgium,?in?accordance?with?
the?Declaration?of?Helsinki,? and? all? individuals? gave? their?written? informed? consent?
before?participating? in? the?study.?Body?weight,?height,?waist/hip?circumference,?and?
blood?pressure?were?determined?at?the?morning?of?surgery.?Fat?and? lean?body?mass?
were?estimated?by?bio?electrical? impedance?analyses? (Bodystat?1500;?Bodystat? Ltd.,?
Isle?of?Man,?U.K.).?Fasting?venous?blood?samples?were?collected?after?an?overnight?fast?
for?measurement?of?plasma?glucose,?serum?insulin,?and?glycated?hemoglobin.?Plasma?
glucose? was?measured? by? the? glucose? oxidase?method? using? an? AU2700? analyzer?
(Beckman? Coulter,? Brea,? CA,? USA).? Serum? insulin? was? assessed? by? immunoassay?
(ADVIA? Centaur? Insulin? IRI;? Siemens?Medical? Solutions? Diagnostics,? Tarrytown,? NY,?
USA).?Glycated?hemoglobin?was?assessed?by?high?performance?liquid?chromatography?
using? a? HA?8160? Hi?Auto? A1C? analyzer? (Menarini,? Zaventem,? Belgium).? Blood? cell?
counts?were?done?with?ADVIA?2120?Hematology?System?(Siemens).?After?an?overnight?
fast,?blood?was?drawn? and? adipose? tissue?biopsies?were? taken? from? the? abdominal?
subcutaneous? adipose? tissue? depot? (SAT)? and? the? omentum?majus? (VAT).? For? each?
adipose?tissue?depot,?approximately?1?3?g?adipose?tissue?was?collected.?The?tissue?was?
immediately? brought? to? the? laboratory? for? further? processing.? Stromal? vascular?
fraction? (SVF)? cells? were? obtained? by? collagenase? digestion? of? adipose? tissue?
fragments? in? Dulbecco’s? Modified? Eagle’s? Medium? (DMEM)?Ham’s? F12? with?
Collagenase? 11? (Sigma? Aldrich? C7657,? 0.0875?mg/ml),? collagenase? 1? (Sigma?Aldrich?
C0130,?1.216?mg/ml)? and?DNAse?1? (Sigma?Aldrich?DN25,?0.09?mg/ml)?under?gentle?
shaking?(60?cycles/min)?at?37°C.?The?resulting?suspension?was?filtered?through?a?200?
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μm? filter?and? fat?cells?were?removed?as? floating? fraction?after?centrifugation? (5?min,?
1250? rpm).? SVF? cells? were? washed? once? with? DMEM?Ham’s? F12? to? eliminate?
collagenase,? filtered? through? a? 70? μM? filter? and? stained? for? flow? cytometry.? In? an?
additional? study,? we? collected? adipose? tissue? biopsies? from? female? controls? and?
female?obese?women? (BMI?=?28.1?±?3.1?vs?42.6?±?1.6;?p?=?0.001)? for?assessment?of?
adipose?tissue?NK?cell?subsets.?
Metabolic?phenotyping?study?
In?this?cross?sectional?study?with?blinded?analyses,?53?abdominally?obese?and?25?lean?
men? were? recruited? by? advertisements? and? enrolled? at? the?Maastricht? University?
Medical?Center? in?Maastricht,?The?Netherlands,? from?August,?2012? to?May,?2014?as?
described?previously.21?Participants?were?aged?18?65?years,?non?smokers,?nondiabetic,?
free?of?CVD,?had?a?waist?circumference?below?94?cm?(lean)?or?between?102???110?cm?
(abdominally? obese),? and? a? stable? body? weight? for? at? least? 3?months.?Men? were?
excluded?when? fasting? plasma? glucose?was? >?7.0?mmol/l,?when?HbA1c?was? >?6.5%,?
when?serum?total?cholesterol?was?>?8.0?mmol/l,?when?serum?triacylglycerol?was?>?4.5?
mmol/l,? when? they? had? a? contra?indication? for? MRI,? and/or? when? they? used?
medication? affecting?blood?pressure,?or? serum? lipid?or? glucose?metabolism.?Clinical?
characteristics? of? the? individuals? included? in? the? study? are? summarized? in?
Supplementary?Table?S5.2.?All?participants?gave?written? informed?consent.?The?study?
was? approved?by? the? institutional?medical?ethical? committee? (NL41397.068.12)? and?
performed?in?accordance?with?the?Declaration?of?Helsinki.?
?
Metabolic?and?vascular?measurements?were? conducted? in?a? temperature?controlled?
room? (T? =? 24°C? ±? 0.5°C)? after? a? 12?hour? overnight? fast?with? the? individuals? in? the?
supine?position.?Individuals?were? instructed?to?refrain?from?alcohol?and?meals?rich? in?
lipids?for?a?period?of?24?hours?prior?to?each?study?day,?and?strenuous?physical?exercise?
for?a?period?of?48?hours?prior? to?each?study?day.?After? insertion?of? two? intravenous?
catheters? and? a? 30?minute? acclimatization? period,? baseline? vascular?measurements?
were? performed? and? blood? was? taken? and? frozen? for? flow? cytometry? analysis.?
Metabolic?insulin?sensitivity?was?assessed?by?a?1?mU/kg/min?euglycemic?insulin?clamp?
as? described? previously.27? Briefly,? insulin? (Novorapid,? Novo? Nordisk,? Bagsvaerd,?
Denmark)?was? infused? in?a?primed?continuous?manner? for?180?minutes.?Meanwhile,?
isoglycemia? was?maintained? with? a? variable? rate? 20%? glucose? infusion.?Metabolic?
insulin? sensitivity? was? estimated? from? the? steady?state? glucose? infusion? rate?
(90???150?min?of?the?clamp).?Information?on?visceral?and?subcutaneous?adipose?tissue?
volumes?was?obtained? through? two?dimensional?T1?weighted? turbo? spin?echo? (TSE)?
imaging?on?a?3.0T?Philips?Achieva?MRI?scanner?with?a?dedicated?sixteen?element?torso?
coil? (XL? Torso? coil,? Philips? Healthcare,? Best,? The? Netherlands).? Nine? 5? mm? thick?
transverse?slices?with?10?mm?gaps?centered?at?the?top?of?the?L4?vertebral?body?were?
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acquired? using? the? following? scan? parameters:? repetition? time? (TR)? =? 526?ms,? echo?
time?=?10?ms,?turbo?spin?echo?factor?=?4,?number?of?signal?averages?(NSA)?=?1,?field?of?
view?(FOV)?=?400?x?322?mm,?acquired?matrix?size?=?308?x?164,?acquired?in?plane?voxel?
size?=?1.3?x?1.96?mm,?reconstructed?matrix?size?=?512?x?412,?and?a?reconstructed?voxel?
size?of?0.78?x?0.78?mm.?Images?were?analyzed?offline?after?completion?of?the?trial?with?
dedicated? software? (Hippo? Fat,? IFC? CNR,? Pisa,? Italy)? to? provide? subcutaneous? and?
visceral?fat?volumes.?
Validation?study?(The?Maastricht?Study)?
For? this? validation? dataset?we? used? data? from? the?Maastricht? Study,? a? population?
based?cohort?study.?The?rationale?and?methodology?have?been?described?previously?
(Schram? et? al.,? 2014).? In? brief,? the? study? focuses? on? the? etiology,? pathophysiology,?
complications? and? comorbidities? of? T2DM? and? is? characterized? by? an? extensive?
phenotyping? approach.? Eligible? for? participation?were? all? individuals? aged? between?
40?and?75?years?and? living? in?the?southern?part?of?the?Netherlands.? Individuals?were?
recruited? through?mass?media?campaigns?and? from? the?municipal? registries?and? the?
regional?Diabetes?Patient?Registry?via?mailings.?Recruitment?was?stratified?according?
to?known?T2DM?status?,?with?an?oversampling?of?individuals?with?T2DM,?for?reasons?of?
efficiency.? Clinical? characteristics? of? the? individuals? included? in? the? study? are?
summarized? in? Supplementary? Table? S5.3.? For? this? study,? fresh? whole? blood? of?
1104?participants?of?the?Maastricht?Study?consecutively?enrolled?between?January?and?
November?2013?were?used?for?flow?cytometry.?The?examinations?of?each?participant?
were?performed?within?a?time?window?of?three?months.?The?study?has?been?approved?
by?the? institutional?medical?ethical?committee? (NL31329.068.10)?and?the?Minister?of?
Health,? Welfare? and? Sports? of? the? Netherlands? (Permit? 131088?105234?PG).? All?
individuals?gave?written?informed?consent.??
?
To?determine?glucose?metabolism,?all? individuals? (except? those?who?used? insulin?or?
those? with? a? fasting? glucose? level? above? 11.0? mmol/l)? underwent? a? standardized?
seven?point? oral? glucose? tolerance? test? after? an? overnight? fast? as? previously?
described.25?Diabetes?mellitus?and?prediabetes?were?defined?according? to? the?WHO?
2006? criteria,? the? latter? defined? as? presence? of? either? impaired? fasting? glucose? or?
impaired? glucose? tolerance.? People? with? diabetes? mellitus? and? people? who? used?
glucose?lowering?medication?were?considered?as?having?type?2?diabetes?if?they?had?no?
self?reported? type?1?or?other? specific? type?of?diabetes.? Fasting?blood? samples?were?
collected? from? all? individuals? and?HbA1c,? and? total,? LDL? and?HDL? cholesterol?were?
determined? as? described? elsewhere.25? Office? blood? pressure? was? determined?
according?to?a?standardized?protocol.?Smoking?status?was?assessed?by?questionnaire,?
and?history?of?CVD?and?medication?use?during?an?interview.?The?magnetic?resonance?
images? were? acquired? using? a? 3T? MRI? system? (MAGNETOM? Prismafit,? Siemens?
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Healthineers,?Erlangen,?Germany)?with?body?matrix?and?supine?radiofrequency?coils.?
Subjects?were??positioned?supine.?After?an?initial?scout?view,?a?single?slice?transversal?
image?at? the? top? level?of? the?L4?vertebral?body?was?obtained?during?breath?hold? to?
assess?areas?of? the?visceral?and? subcutaneous?adipose? tissue?compartments?using?a?
T1?weighted? TSE? pulse? sequence? with? the? following? parameters:? acquired? and?
reconstructed?in?plane?voxel?size?2?x?2?mm3,?slice?thickness?8?mm,?TR?550?ms,?NSA?=?1,?
parallel? imaging? (GRAPPA)? factor?=?2,?turbo? factor?=?7.?Depending?on?the?size?of?the?
patient,?the?FOV?was?384?x?312?mm2?with?a?TE?of?36?ms?or?500?x?406?mm2?with?a?TE?of?
38?ms.??
Method?details?
Flow?cytometry?
Fresh?heparinized?whole?blood?(50?μl)?(study?1?and?3)?or?thawed?whole?blood?(study?2)?
was?used? for? staining? for? flow? cytometry?using?CD3?fitc? (BD?561807),?CD19?fitc? (BD?
555412),?CD66b?fitc? (BD?555724),?CD56?PE? (BD?345810),?HLA?DR?V500? (BD?561224),?
CD14?APC?H7? (BD? 641394),? CD16?PerCP? (BD? 560717),? CD11B?BV421? (BD? 562632),?
CD11c?PE?Cy7? (BD? 561356),? and? CX3CR1?APC? (Biolegend? 341609).? The? complete?
gating?strategy?was?published?elsewhere?(Wouters14?and?Supplemental?Figure?S3.3?in?
chapter?three).?Briefly,?from?single?blood?cells,?live?cells?were?gated?based?on?forward?
and? side? scatters.?From? live? cells,?NK? cells?were?gated?as?negative? for?CD3? (T? cells),?
CD19?(B?cells),?CD66b?(granulocytes),?HLA?DR?(monocytes,?dendritic?cells)?and?positive?
for?CD56.?For? samples? from? female?donors,?we?used?PBMCs?and? stained? them?with?
CD16?FITC,? CD56?PerCP?Cy5.5,? NKP46?PE,? NKG2D? ?APC,? and? CD11B?Horizon? V450.?
Singlets?were?gated?based?on?both?forward?and?side?scatters.?Live?cells?were?defined?
as? negative? for? live?death? staining.? NK? cells? were? CD3?? and? CD56+,? which? were?
subdivided?according?to?CD56?and?CD16?surface?expression.?
?
Isolated?SVF?cells?were?stained?with?CD45?PE?Cy7?(BD?557748),?CD3?fitc?(BD?561807),?
CD19?fitc?(BD?555412),?CD56?fitc?(BD?562794),?CD66b?fitc?(BD?555724),?CD11B?BV421?
(Biologend? 301324),? and? CD11c?APC?Cy7? (Biolegend? 337218).? Cocktail? 2? included?
CD45?PE?Cy7? (BD? 557748),? CD3?V500? (BD? 561416),? CD4?PerCP? (Biolegend? 300528),?
CD8?APC?H7?(BD?641400),?CD19?BV421?(Biolegend?302234),?and?CD56?APC?(Biolegend?
318310).?SVF?cells?from?VAT?and?SAT?were?gated?for?live?single?cells?based?on?forward?
and?side?scatters.?Immune?cells?were?selected?based?on?CD45?expression.?Lymphocyte?
populations?in?AT?were?identified?based?on?CD19?for?B?cells?and?CD3?for?T?cells.?T?cells?
were? further?subdivided? in?CD8+?Tc?cells?and?CD4+?Th?cells.?Non?B??and?T?cells?were?
gated?for?CD56?to?identify?NK?cells?(cocktail?2).?From?CD45+?cells?B?cells?(CD19),?T?cells?
(CD3),?NK?cells?(CD56)?and?granulocytes?(CD66b)?were?excluded?for?the?identification?
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of?macrophages? (defined? as?CD11Bhi),?which?were? subdivided? in?CD11B+CD11C?? and?
CD11B+CD11C+?macrophages? (cocktail? 1).? The? adipose? tissues? from? female? donors?
were? stained?with?CD16?FITC? (BD? 555406),?NKp46?PE? (BD? 557991),?CD56?PerCP?Vio?
(Miltenyi? 130?100?681),? NKG2D?APC? (Miltenyi? 130?096?610),? CD3?APC?Vio770?
(Miltenyi?130?096?610),?CD11B?V421? (562632),?and?a? fixable?viability?stain?V510? (BD?
564406).?SVF?single?cells?were? identified?based?on?scatter?parameters,?and? live?cells?
were?gated?based?on?live?death?marker.?NK?cells?were?identified?as?CD11B+CD3??cells,?
which?were?further?subdivided?according?to?CD56?and?CD16?expression.?Samples?were?
measured?with?a?FACS?Canto?II?(BD?Biosciences).?Results?were?analyzed?with?FACSdiva?
software? (BD?Biosciences).?Each?panel?was?optimized?using? fluorescence?minus?one?
(FMO)? controls? and? isotype? controls,? yielding? similar?measures? as? auto?fluorescent?
samples.?For?each?experiment,?an?auto?fluorescence?control?was?performed.?
NK?cell?isolation?and?measurements 
PBMCs? were? isolated? from? fresh? blood? using? density? gradient? centrifugation?
(Histopaque,? Sigma?Aldrich? H889?500ML).? For? flow? cytometry? of? surface? markers,?
250?000? PBMCs? were? stained? with? Live/death? fixable? viability? stain? (BD? 564406),?
CD3?APC?Vio770? (Miltenyi?130?096?610),?CD56?PerCP?Vio700? (Miltenyi?130?100?681),?
CD11B?BV421?(BD?562632),?CD16?FITC?(BD?555406),?NKp46/CD335?(Miltenyi?130?092?
607),?NKG2D? (Miltenyi? 130?092?673),? and?measured?with?with? a? FACS?Canto? II? (BD?
Biosciences).?Results?were?analyzed?with?FACSdiva?software?(BD?Biosciences).?Singlets?
were? identified?based?on?scatter?plots.?Live?cells?were?gated?using?the?viability?stain,?
after?which?NK?cells?were?identified?as?CD3?CD56+?cells.??
?
For?intracellular?staining?assays?and?for?co?culture?experiments,?PBMCs?were?used?for?
NK? cell? isolation? using? magnetic? bead? separation? assays? (Human? NK? isolation? kit,?
Miltenyi? 130?092?657).? Per?well,? 50,000? NK? cells?were? plated? in? 96? round?bottom?
plates.?Monensim?(BD?#?554724)?and?Brefeldin?(BD?#?51?2301)??were?added?according?
to?manufacturer’s?instructions?for?15?hours.?Hereafter,?cells?were?stained?with?viability?
stain? (BD? 564406),? CD3?APC?Vio770? (Miltenyi? 130?096?610),? CD56? PerCP?Vio700?
(miltenyi? 130?100?681),? CD11B? BV421? (BD? 562632).? Hereafter? Fixation? and?
permeabilization?solutions?were?added?(Invitrogen?00?5123?43,?00?5223?56,?00?8333?
56).? After? incubation,? TNF?PE? (Biolegend? 502909)? and? IFNg?V450? (BD? #? 560371)?
antibodies?were? added,? and?measured?with?with? a? FACS?Canto? II? (BD? Biosciences).?
Results? were? analyzed? with? FACSdiva? software? (BD? Biosciences).? Singlets? were?
identified?based?on?scatter?plots.?Live?cells?were?gated?using?the?viability?stain,?after?
which?NK? cells?were? identified?as?CD3?CD56+? cells.?All?experiments? included? isotype?
controls? and? auto?fluorescent? controls.? For? co?culturing? experiments,? human?
peripheral? blood? cells? from? a? healthy? donor? were? differentiated? into? human?
monocyte?derived?macrophages? as? described? previously.28? In? short,? 5? x? 106? PBMCs?
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were?plated?in?24?well?Primaria?plates?(Corning?353847).?After?2h,?non?adherent?cells?
were?discarded?and?culture?medium?was?added?(RPMI1640?Glutamax,?Gibco?#?61870?
010;? Pen/Streptomycin? 5000? U,? Gibco? #? 15070;? Sodium? Pyruvate? 100mMol? (100x)?
Gibco?#?11360?039;?NEN?AminoAcids? (100x)?Gibco?#?11140?035)?supplemented?with?
10%? Inactivated? Human? AB? serum;?Milan? Anal.? #? 000084;? lot#? 00625.? Cells? were?
differentiated? for? 7? days? before? further? use.? M2?polarized? macrophages? were?
obtained?by?incubation?with?20?ng/ml?IL?4?(Miltenyi?130?093?924)?and?100?μg/ml?IL?10?
(Thermofisher?PHC0105)?for?16?hours.?Next,?50,000? isolated?NK?cells?were?added?on?
confluent?macrophages? for?24h.?Hereafter,? cells?were?harvested? for? flow? cytometry?
analysis? using? Live/death? fixable? viability? stain? (BD? 564406)? and? CD64?BV421?
Biolegend? 305019),? CCR7?FITC? (Biolegend? 353216),? CD86?APC? or? CD206?BV421? (BD?
564062)?and?CD209?FITC?(Biolegend?330103)?for?flow?cytometry.?
Plasma?biomarkers?of?low?grade?inflammation?
The?assessment?of?biomarkers?of? low?grade? inflammation? (C?reactive?protein,?serum?
amyloid?A,?interleukin?6,?interleukin?8,?soluble?intercellular?adhesion?molecule?1,?and?
tumor? necrosis? factor)? were? assessed? by? a?multiarray? detection? system? based? on?
electro?chemiluminescence? technology? (MesoScaleDiscovery,? SECTOR? Imager? 2400,?
Gaithersburg,? Maryland,? USA)? as? described? previously.29? Briefly,? this? system? uses?
multiarray? plates? fitted? with? multielectrodes? per? well? with? each? electrode? being?
coated?with?a?different?catching?antibody.?The?assay?procedure?then?follows?that?of?a?
classic?sandwich?ELISA?with?any?of? the?analytes?of? interest?captured?on? the?relevant?
electrode.? These? captured? analytes? were? then? in? turn? detected? by? a? secondary?
analyte?specific? ruthenium?conjugated? antibody,? which? is? capable? of? emitting? light?
after?electrochemical?stimulation.?A?particular?advantage?of?this?system? is?the?ability?
to? measure? different? biomarkers? of? low?grade? inflammation? and/or? endothelial?
dysfunction?simultaneously?in?relatively?small?(25?or?50??l)?serum?samples.?
Quantification?and?statistical?analysis?
For?each?analyses,?the?number?of?individuals,?data?expression,?and?statistical?test?used?
are?indicated?in?each?figure?and?table?legend.?Throughout?the?results?section,?data?are?
expressed?as?mean?±?SD?or?median?[IQR].?Differences?between?groups?were?assessed?
by?means?of?two?tailed?independent?Student’s?t?tests?or?Mann?Whitney?U?tests?where?
appropriate.?We?used?Pearson’s?correlation?coefficients?and?linear?regression?analyses?
to?investigate?the?associations?between?VAT,?VAT?NK?cells,?CD11B?surface?expression,?
z?scores? of? LGI,? plasma? TNF? levels,? and? insulin? resistance? where? appropriate.? Log?
transformation,?square?root?transformation,?or?reciprocal?transformation?of?variables?
were?performed? if?warranted? to?not?violate? the?assumptions?of? the? statistical? tests.?
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Analyses?were?performed?using? SPSS? version? 20.?Multiple?mediation? analyses?were?
carried?out?with?the?PROGRESS?plug?in? for?SPSS?version?2.13? (A.F.?Hayes,?Ohio?State?
University,?OH,?USA).?All?regression?and?mediation?models?were?adjusted?for?potential?
confounders?and?specified?per?analysis.?Two?tailed?p?values?of?<?0.05?were?considered?
statistically?significant.?
Additional?resources?
The?first?biopsy?study?(ClinicalTrial.gov,?NCT02598544)?and?the?metabolic?phenotyping?
study?have?been? registered? (ClinicalTrial.gov,?NCT01675401).?The?validation? study? is?
registered?at?the?Dutch?research?database?ToetsingOnline? (NL31329.068.10)?and?has?
been?approved?by?the?Minister?of?Health,?Welfare?and?Sports?of?the?Netherlands,?on?
the?basis?of?the?Health?Council's?opinion?(Permit?131088?105234?PG).?
?
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Nederlandstalige?samenvatting?
Wereldwijd? lijden? steeds?meer?mensen? aan? overgewicht? en? obesitas,?waardoor? er?
tevens?meer?mensen?ziektes?als?diabetes?(type?2)?en?hart??en?vaatziekten?ontwikkelen.?
Deze?ziekten?leiden?op?hun?beurt?weer?tot?veel?ziektelast,?ziektekosten?en?overmatige?
sterfte.? Eerdere? onderzoeken? hebben? getoond? dat? er? een? aanzienlijke? overlap? is?
tussen?de?risicofactoren?voor?diabetes?en?hart??en?vaatziekten.?
?
Wanneer?iemand?diabetes?ontwikkelt,?zijn?er?vaak?twee?cruciale?veranderingen?in?het?
lichaam.? Enerzijds? raakt? het? lichaam? ongevoelig? voor? de?werking? van? het? hormoon?
insuline,?hetgeen?men? insulineresistentie?noemt.?Anderzijds?kunnen?de?bètacellen? in?
de?alvleesklier?onvoldoende?insuline?aanmaken?om?de?glucosewaarde?in?het?bloed?(de?
“bloedsuiker”)?onder?controle?te?houden.??
?
Deze?twee?processen?houden?nauw?verband?met?elkaar.?Insuline?is?immers?nodig?om?
voedingsstoffen?als?glucose?te?verplaatsen?van?het?bloed?naar?andere?organen,?zoals?
het?hart,?spieren?en?vetweefsel.?In?het?geval?van?insulineresistentie?is?er?meer?insuline?
nodig? om? dit? effect? te? bereiken,? waardoor? de? bètacellen? in? de? alvleesklier? meer?
insuline?moeten?aanmaken.?Als?de?bètacellen?echter?onvoldoende?aan?die?verhoogde?
vraag? kunnen? voldoen,? zal? diabetes? ontstaan.? Het? onvoldoende? aanmaken? van?
insuline?door?bètacellen? (hetgeen?men?bètaceldisfunctie?kan?noemen)? is?echter?niet?
zwart?wit,? het? ontstaat? waarschijnlijk? geleidelijk.? Het? is? echter? onduidelijk? of? bij?
mensen? met? obesitas? er? reeds? sprake? is? van? enige? vorm? van? bètaceldisfunctie.?
Bijkomend?probleem?is?dat?het?moeilijk?is?om?bètaceldisfunctie?te?onderscheiden?van?
de?noodzakelijke?compensatie?voor?insulineresistentie.?
?
Bij? de? ontwikkeling? van? hart?? en? vaatziekten? zijn? er? een? aantal? welbekende?
risicofactoren? als? hoge? bloeddruk? (hypertensie),? hoog? cholesterol?
(hypercholesterolemie),? roken? en? oudere? leeftijd.? Bij? de? algemene? bevolking? zijn?
enkele? risicofactoren?minder?bekend?die?wel?belangrijk?zijn,? zoals? insulineresistentie?
en? verslechterde? functie? van? de? bloedvaten? (vaatdisfunctie).? Op? zijn? beurt? kan?
vaatdisfunctie?zich?op?verschillende?niveaus?manifesteren.?Zo?kan?de?werking?van?de?
binnenste? laag? cellen? van? de? bloedvaten,? het? endotheel,? verminderd? zijn?
(endotheeldisfunctie),?maar?ook?de?elasticiteit? van?de? grote? slagaders? kan? afnemen?
(vaatverstijving).? Endotheeldisfunctie? kan? ook? in? de? kleinste? bloedvaten? (de?
microcirculatie)? van? spieren? voorkomen? en? leiden? tot? insulineresistentie.? Dit?
mechanisme,?alsook?andere?functies?van?de?microcirculatie? in?de?spieren,?worden? in?
hoofdstuk?twee?verder?beschreven?en?hieronder?beknopt?besproken.??
?
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Microcirculatie?van?de?spier?
In?de?skeletspieren?lopen?de?allerkleinste?bloedvaatjes?(de?capillairen)?parallel?aan?de?
spiervezels,?waardoor?deze?optimaal? voedingsstoffen? (zoals? glucose,? aminozuren?en?
vetzuren)? en? zuurstof? aan? spiercellen? kunnen? aanbieden? en? afvalstoffen? kunnen?
afvoeren.?In?rust?is?slechts?een?deel?van?de?bloedvaatjes?van?de?spier?doorbloed.?Er?is?
dus? een? grote? reservecapaciteit? die? benut? kan? worden,? zoals? bijvoorbeeld? tijdens?
sporten.?Ook?een?stijging? in? insuline?–?zoals?na?het?eten?van?een?maaltijd?–? leidt? tot?
doorbloeding? van? meer? bloedvaatjes.? Hierdoor? wordt? het? contactoppervlak? voor?
(glucose)transport? sterk? vergroot.? Dit? is? mogelijk? doordat? het? endotheel? van? de?
allerkleinste? aanvoerende? bloedvaten,? de? terminale? arteriolen,? stikstofoxide?
produceren? als? de? insulinespiegel? in? het? bloed? stijgt.? Stikstofoxide? zorgt? voor?
vaatverwijding?van?de? terminale?arteriolen,?waardoor?er?meer?capillairen?doorbloed?
worden;? dit? wordt?microvasculaire? rekrutering? genoemd? (grafisch? weergegeven? in?
figuur? 2.1).? Enerzijds? wordt? door? microvasculaire? rekrutering? een? normale?
glucosespiegel?in?het?bloed?hersteld?en?anderzijds?wordt?er?energie?opgeslagen?in?de?
spieren?voor?toekomstige?inspanningen.?Bij?mensen?met?obesitas?is?er?vaak?sprake?van?
onvoldoende?microvasculaire?rekrutering?als?gevolg?van?endotheeldisfunctie:?er?wordt?
minder? stikstofoxide? geproduceerd? en? er? ontstaat? weinig? tot? geen? vaatverwijding.?
Hierdoor? kan? het? lichaam? voedingsstoffen? als? glucose? niet? goed? opslaan,? stijgt? de?
glucosespiegel? in? het? bloed? tot? hogere? waardes? en? blijft? deze? glucosespiegel? ook?
gedurende? langere? tijd? verhoogd.?Mede? hierdoor? kan? op? den? duur? onherstelbare?
schade?ontstaan,?bijvoorbeeld?aan?slagaders?in?het?hele?lichaam?en?de?microcirculatie?
van?bijvoorbeeld?ogen?en?nieren.?
Doelstellingen?van?dit?proefschrift?
Het?onderzoek?beschreven?in?dit?proefschrift?had?diverse?doelstellingen,?te?weten:?
1.? Welke? mechanismen? leiden,? onafhankelijk? van? elkaar,? tot? insulineresistentie??
(hoofdstukken?vier?en?vijf)?
2.? Is? er? reeds? sprake? van? veranderde? bètacelfunctie? bij?mensen?met? obesitas? en?
draagt?vervetting?van?de?alvleesklier?hieraan?bij??(hoofdstuk?zes)?
3.? Leidt? gewichtsverlies? tot? verbeterde? insulinegevoeligheid,? bètacelfunctie,?
vaatfunctie? en? een? gunstiger? cardiovasculair? risico?? (hoofdstukken? vier,? zes? en?
zeven)?
4.? Hoe?betrouwbaar?en?nauwkeurig?zijn?de?meetmethodes?die?we?hebben?gebruikt?
om?bovenstaande?te?onderzoeken?(hoofdstuk?drie)??
?
Een?verschil? in?aanpak? ten?opzichte?van?voorgaande?onderzoeken? is?dat?wij?gebruik?
hebben? gemaakt? van? een? statistische? methode? genaamd? meervoudige? mediatie?
analyse.?Hiermee?konden?meerdere?alternatieve?hypotheses? in?één?statistisch?model?
getoetst?worden,?met?onder?andere?als?doel?om?de?onafhankelijkheid?van?bepaalde?
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mechanismen? te? onderzoeken.? Onafhankelijkheid? is? essentieel,? als? er? immers?
verschillende? manieren? zijn? om? ziek? te? worden,? zijn? er? ook? verschillende?
behandelingen?mogelijk? én? noodzakelijk.? In? het? vervolg? van? deze? Nederlandstalige?
samenvatting?worden?de?belangrijkste?bevindingen?van?dit?proefschrift?beschreven.??
Belangrijkste?bevindingen?van?dit?proefschrift??
Onderliggende?mechanismen?van?insulineresistentie?
Als? obesitas? ontstaat,? kunnen? er? diverse? veranderingen? in? het? lichaam? optreden.?
Zowel?onderhuids?(subcutaan)?vet?als?vet?in?de?buikholte?(visceraal?vet)?nemen?toe,?er?
kan? leververvetting?optreden?en?er?kan?sprake?zijn?van?verminderde?microvasculaire?
rekrutering? in? de? spieren.? Ieder? van? deze? veranderingen? zou? kunnen? leiden? tot?
insulineresistentie.? Echter,? of? dit? onafhankelijke? bijdragen? zijn,? was? niet? eerder?
onderzocht.? In? hoofdstuk? vier? hebben? wij? laten? zien,? mede? met? behulp? van?
meervoudige?mediatie?analyses,? dat? subcutaan? en? visceraal? vet,? leververvetting? en?
microvasculaire? rekrutering? –? onafhankelijk? van? elkaar? –? een? deel? van? de?
insulineresistentie?in?obesitas?kan?verklaren.?Dit?betekent?dus?dat?ieder?een?separaat?
behandeldoel? vormt? in? de? preventie? en? behandeling? van? insulineresistentie.?
Bovendien?hebben?we,?door?een?deel?van?de?mensen?met?obesitas?af?te?laten?vallen,?
onderzocht? of? veranderingen? in? subcutaan? en? visceraal? vet,? leververvetting? en?
microvasculaire? rekrutering? leiden? tot? minder? insulineresistentie.? Het? bleek? dat?
veranderingen? in? leververvetting? en? microvasculaire? rekrutering? onafhankelijk? van?
elkaar? de? verbetering? in? insulineresistentie? kunnen? verklaren.? Hoewel?
gewichtsreductie?ook?tot?vermindering?van?subcutaan?en?visceraal?vet?leidde,?droegen?
zij?niet?statistisch?significant?bij?aan?de?vermindering?van?insulineresistentie.??
?
Als?we? verder? inzoomen?naar?de?wijze?waarop?een?overmaat? aan? visceraal? vet? kan?
leiden? tot? insulineresistentie,? dan? blijkt? dit? deels? verklaard? te? worden? door? een?
laaggradige? ontstekingsreactie? (inflammatie)? die? ontstaat? in? het? viscerale?
vetcompartiment.? In? het? viscerale? vet? zijn? macrofagen? (een? type? witte? bloedcel)?
verantwoordelijk?voor?de?productie?van? inflammatoire? signaalmoleculen? (cytokines),?
zoals?tumor?necrosis?factor.?Wat?ertoe?leidt?dat?macrofagen?aanwezig?zijn?in?visceraal?
vet? en? deze? ontstekingsreactie? op? gang? brengen,? is? onduidelijk? in? mensen.? In?
hoofdstuk?vijf?hebben?wij? in?vier?onafhankelijke?studies?onderzocht?of?een? toename?
van?natural?killer?cellen?(NK?cellen;?een?ander?type?witte?bloedcel)?in?visceraal?vet?kan?
leiden? tot?een? toename? van? inflammatoire?macrofagen? in? visceraal? vet,? laaggradige?
inflammatie?en?insulineresistentie.??
?
?
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Onze?volgende?bevindingen?ondersteunen?de?betrokkenheid?van?NK?cellen:?
1. mensen?met?obesitas?hadden?meer?NK?cellen?in?hun?visceraal?vet;?
2. de?hoeveelheid?NK?cellen? in? visceraal? vet?was?geassocieerd?met? inflammatoire?
veranderingen?van?macrofagen;?
3. als?NK?cellen?en?macrofagen?buiten?het?lichaam?samengebracht?worden,?zorgen?
NK?cellen? afkomstig? van? mensen? met? obesitas? ervoor? dat? macrofagen?
inflammatoire?veranderingen?ondergaan;?
4. de?mate?van?CD11B? (een?eiwit?aan?het?celoppervlak)?expressie?op?NK?cellen? in?
het?bloed?was?geassocieerd?met?de?hoeveelheid?NK?cellen?in?visceraal?vet;?
5. CD11B?expressie?was?geassocieerd?met?tumor?necrosis?factor?productie?door?NK?
cellen,?bloedspiegels?van?inflammatoire?cytokines?en?insulineresistentie;?
6. meervoudige?mediatie?analyses?ondersteunen?de?hypothese?dat?meer?NK?cellen?
in?visceraal?vet?leiden?tot?laaggradige?inflammatie?en?insulineresistentie;?
7. al?deze?observaties?waren?specifiek?voor?visceraal?vet?en?werden?niet?gevonden?
in?subcutaan?vet;?
8. de? associatie? tussen? CD11B? expressie,? laaggradige? inflammatie? en?
insulineresistentie? werd? bevestigd? in? een? groot? onderzoek? uitgevoerd? bij?
bewoners?van?de?regio?Maastricht?(de?Maastricht?Studie).?
?
In?eerdere?onderzoeken? in?muizen?werd?het?mechanisme?hoe?NK?cellen?macrofagen?
beïnvloeden? en? tot? inflammatie? en? insulineresistentie? leiden? reeds? gedetailleerd?
beschreven.?Derhalve?zijn?wij?van?mening?dat?onze?onderzoeksbevindingen?een?sterke?
aanwijzing? zijn? dat? NK?cellen? ook? in? mensen? betrokken? zijn? bij? het? ontstaan? van?
insulineresistentie.?
Onderliggende?mechanismen?van?bètaceldisfunctie?
Als? insulineresistentie? ontstaat,? produceren? de? bètacellen? in? de? alvleesklier? meer?
insuline? als? reactie? op? de? stijgende? glucosespiegel? in? het? bloed.? Bij? mensen? met?
diabetes? is?er?sprake?van?een?gestoorde?bètacelfunctie:?de? insulineproductie?kan?de?
insulinebehoefte? niet?meer? bijbenen.? Het? is? plausibel? dat? er? reeds? in? een? vroeger?
stadium,?bijvoorbeeld?bij?mensen?met?overgewicht?of?obesitas,?een?zekere?mate?van?
maladaptie?van?bètacellen?is.??
?
Tevens?kan?er?bij?mensen?met?obesitas?vervetting?van?de?alvleesklier?ontstaan.?Een?
dergelijke? vervetting? van? de? alvleesklier? zou? de?werking? van? de? bètacellen? kunnen?
belemmeren;?wellicht?dat?zo?een?subtiele?vorm?van?bètaceldisfunctie?kan?ontstaan.?In?
hoofdstuk? zes? hebben?wij? onderzocht? of? er? –? rekening? houdend?met? de?mate? van?
insulineresistentie?–?aanwijzingen?zijn?voor?bètaceldisfunctie?bij?mensen?met?obesitas.?
Een?van?de?eigenschappen?van?bètacelfunctie?(de?zg.?potentiatie?factor)?bleek?te?zijn?
veranderd?bij?mensen?met?obesitas.?Door?gewichtsreductie?bij?mensen?met?obesitas?
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herstelde?deze?bètacelfunctie?zich?tot?het?niveau?van?slanke?mensen.?Bovendien?kon,?
met? behulp? van?meervoudige?mediatie?analyses,? een?mogelijke? betrokkenheid? van?
alvleeskliervervetting? meer? aannemelijk? gemaakt? worden.? In? onze? studie? kon? de?
exacte? locatie? van? de? vetstapeling? in? de? alvleesklier? niet? vastgesteld?worden.?Naar?
aanleiding?van?deze?studieresultaten?en?eerdere?observaties?van?de?microcirculatie?in?
de?spier?hebben?wij?de?hypothese?geformuleerd?dat?vetcellen?die?zich?in?de?nabijheid?
van?de?kleine?bloedvaten?van?de?alvleesklier?bevinden,?aldaar?via?endotheeldisfunctie?
leiden?tot?afname?van?vasodilatatie?en?bètaceldisfunctie.??
Effecten?van?gewichtsverlies?
In? de? meerderheid? van? de? hoofdstukken? in? dit? proefschrift? zijn? de? effecten? van?
gewichtsreductie?bij?mensen?met?obesitas?onderzocht.? In?hoofdstuk?vier?hebben?wij?
laten?zien?dat?gewichtsreductie?leidt?tot?een?verbeterde?microvasculaire?rekrutering?in?
spier? en? een? afname? van? subcutaan? vet,? visceraal? vet,? leververvetting? en?
insulineresistentie.? Vervolgens? werd? in? hoofdstuk? zes? beschreven? dat?
gewichtsreductie? leidt? tot?een?herstel?van?bètacelfunctie,?mogelijk?door?afname?van?
alvleeskliervervetting.? Tot? slot? laten? wij? in? hoofdstuk? zeven? zien? dat? traditionele?
risicofactoren?voor?hart??en?vaatziekten,?zoals?hypertensie?en?hypercholesterolemie,?
verbeteren? door? gewichtsreductie.? Anderzijds? werden? diverse? aspecten? van?
vaatfunctie? onderzocht,? hetgeen? wisselende? resultaten? opleverde.? Door?
gewichtsreductie? verbeterde? de? microcirculatie? van? het? netvlies? (de? retina):? de?
verhouding? tussen? de? diameters? van? retinale? arteriolen? en? venulen? werd?
genormaliseerd?tot?het?niveau?van?slanke?mensen.?Bovendien?daalde?de?bloedspiegel?
van? sE?selectine,? een? maat? voor? endotheeldisfunctie.? Echter,? een? andere?
veelgebruikte? uitkomstmaat? voor? endotheeldisfunctie? (flow?mediated? dialation)?
verschilde? in?onze?studie?niet? tussen?mensen?met?of?zonder?obesitas?en?verbeterde?
ook? niet? door? gewichtsreductie.? Tevens? zorgde? gewichtsreductie? niet? voor? een?
statistisch?significante?verbetering?in?vaatstijfheid?van?de?grote?lichaamsslagaders.?Dit?
is? ook? niet? te? verwachten,? aangezien? de? verstijving? van? bloedvaten? een? langdurig?
proces? is,? waarvan? de? reversibiliteit? door? een? kortdurende? interventiestudie? (een?
gewichtsreductieprogramma?van?acht?weken?in?ons?geval)?waarschijnlijk?zeer?beperkt?
is.??
?
Samenvattend? toont? onze? interventiestudie? dat? gewichtsreductie? bij? mensen? met?
obesitas?enerzijds? leidt?tot?een?verbetering?van?de?processen?die? leiden?tot?diabetes?
(insulineresistentie? en? bètaceldisfunctie),? alsook? verbeteringen? van? traditionele?
risicofactoren? voor? hart?? en? vaatziekten? (hypertensie? en? hypercholesterolemie).?
Anderzijds? zagen? wij? dat? gewichtsreductie? leidde? tot? een? verbetering? van? enkele?
vaatfunctiemetingen?(bijv.?microvasculaire?rekrutering,?vaatdiameters?in?de?retina,?sE?
selectine),?doch?niet? alle? (bijv.? flow?mediated?dilation? en? vaatstijfheid).?Hoewel?het?
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reeds? duidelijk?was? dat? gewichtsreductie? bij?mensen?met? obesitas? leidt? tot?minder?
diabetes,?blijft?het?onduidelijk?of?het?ook?leidt?tot?minder?hart??en?vaatziekten.?
Conclusie?
Samenvattend?laat?dit?proefschrift?zien?dat:??
1. visceraal?vet,?subcutaan?vet,?leververvetting?en?microvasculaire?rekrutering?in?de?
spier? onafhankelijk? van? elkaar? bijdragen? aan? insulineresistentie? en? verbeteren?
door?gewichtsreductie?bij?mensen?met?obesitas;??
2. NK?cellen?in?visceraal?vet?geassocieerd?zijn?met?inflammatoire?veranderingen?van?
macrofagen,?laaggradige?inflammatie?en?insulineresistentie;??
3. er?veranderingen?in?bètacelfunctie?zijn?bij?mensen?met?obesitas,?welke?herstellen?
na?gewichtsreductie?en?mogelijk? ten?dele?verklaard?worden?door?veranderingen?
in?alvleeskliervervetting;?
4. gewichtsreductie? leidt? tot? verbetering? van? traditionele? risicofactoren? voor?hart??
en?vaatzieken?en?enkele,?doch?niet?alle,?vaatfunctiemetingen;?en?
5. de? in? dit? proefschrift? gebruikte? meetmethodes? betrouwbaar? en? nauwkeurig?
waren.?
?
De? bevindingen? beschreven? in? dit? proefschrift? kunnen? enerzijds? leiden? tot? het?
formuleren?en? testen? van? gerichte?preventie??en?behandelstrategieën?en? anderzijds?
aanleiding? geven? tot? gericht? vervolgonderzoek? naar? de? rol? van? bovengenoemde?
processen.? Tot? slot? illustreert? dit? proefschrift? de? meerwaarde? van? intensieve?
samenwerking? tussen? diverse? disciplines,? alsmede? het? simultaan? onderzoeken? van?
diverse?hypotheses.??
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Valorization?addendum?
Besides?education?and?research,?valorization?is?a?main?task?of?universities;?the?impact?
of? research? to? society? is? hereby?maximized.?Here,? the? valorization? potential? of? this?
thesis’?main?findings?will?be?discussed.?We?will?address?the?relevance?and?innovations?
of? this? thesis,? the? framework? for? future? studies? on? insulin? resistance? and? beta?cell?
dysfunction,? the? value? of? reliability? data,? and? the? need? for? in?depth? phenotyping?
studies.?
Relevance?of?the?findings?
In? order? to? develop? successful? strategies? to? prevent? or? treat? obesity?associated?
conditions?like?type?2?diabetes?and?cardiovascular?disease,?a?thorough?understanding?
of?the?pathophysiological?processes?involved?is?vital.?As?a?substantial?proportion?of?the?
general?population?is?obese,?advances?in?this?area?could?substantially?impact?obesity?
related?morbidity,?loss?of?quality?of?life,?mortality,?and?health?care?costs.?In?this?thesis,?
we?identified?independent?contributors?to?insulin?resistance?and?beta?cell?dysfunction,?
the? two? core? processes? involved? in? the? development? of? type? 2? diabetes.? First,?we?
showed?that?visceral?and?subcutaneous?adipose?tissue,? intrahepatic? lipid?and?muscle?
microvascular? recruitment? are? independent? contributors? to? insulin? resistance.? This?
means?that?they?constitute?separate?targets?for?intervention.?Second,?we?identified?NK?
cells?in?visceral?adipose?tissue?to?induce?local?and?systemic?inflammation?and?thereby?
contribute?to?insulin?resistance.?Third,?we?identified,?in?abdominally?obese?individuals,?
early?alterations?in?beta?cell?function?independent?from?compensatory?changes?due?to?
insulin?resistance,?as?well?as?demonstrated?that?a?weight?loss?intervention?can?restore?
these?alterations.?Fourth,?we?showed?that?a?part?of?these?obesity?induced?changes?in?
beta?cell? function? could? be? explained? by? intrapancreatic? lipid.? Finally,? we?
demonstrated?that?a?weight?loss?intervention?improved?traditional?cardiovascular?risk?
factors? (e.g.,?blood?pressure,? serum?cholesterol? levels,? insulin? resistance),?as?well?as?
some,?but?not?all,?vascular?function?measurements.?
?
Likely,? the? identification? of? the? independent? contributors? to? insulin? resistance? and?
beta?cell? function?will? have? a? societal? impact.? The? novel? findings?mentioned? above?
could?eventually?lead?to?therapies?aimed?to?intervene?with?these?pathways?to?prevent,?
delay? the? development,? or? treat? type? 2? diabetes? and? cardiovascular? disease.?
Moreover,? these? findings? could? lead? to? the? identification? of? distinct? subtypes? of?
obesity,? each? of? which? may? require? a? different? treatment? strategy.? Nonetheless,?
several? future? studies? should? be? undertaken? before? these? contributors? can? be?
considered? a? true? –? and? safe? –? therapeutic? target.?Hence,? several? ideas? for? future?
studies,?as?well?as?how?their?results?may?impact?prevention?and?treatment?strategies?
will?be?further?discussed?below.?
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Future?studies?on?insulin?resistance?
Besides?the?identification?of?independent?tissue?contributors?to?insulin?resistance,?our?
novel?finding?that?NK?cells?in?visceral?adipose?tissue?appear?to?be?involved?in?local?and?
systemic? low?grade? inflammation? and? subsequent? insulin? resistance? is? particularly?
valuable.? Even? though? research? in? rodents? demonstrated? NK? cell? accumulation? in?
visceral? adipose? tissue? is? an? early? event? into? the? development? of? low?grade?
inflammation? and? insulin? resistance,? the? cross?sectional? design? of? our? studies? in?
humans? precludes? any? conclusions? about? a? temporal? association? of? NK? cell?
accumulation?to? induction?of? inflammation?and? insulin?resistance.?To?provide?further?
evidence? for? NK? cell’s? involvement? in? insulin? resistance? in? humans,? valuable?
information? can? be? obtained? by? studying? individuals? in? whom? either? NK? cells? are?
depleted?or?who?have? a? loss?of?function?mutation.? First,? those? individuals? could?be?
evaluated? for? inflammatory?changes? in?visceral?adipose?tissue?and? insulin?resistance.?
Second,? an? intervention? study? subjecting? NK? cell? depleted? individuals? as? well? as?
individuals?with? normal?NK? cell? numbers? and? function,? to? short? term? overfeeding.?
Ideally,?such?a?study?could?involve?repeated?visceral?adipose?tissue?biopsies?along?with?
the?assessment?of? insulin?resistance.?Third,?repeated?visceral?adipose?tissue?biopsies?
obtained? in? intervention?studies? in?obese? individuals?who?are?scheduled? to?undergo?
repeated? abdominal? surgery? (e.g.,? bariatric? vs.? non?bariatric? surgery)?may? provide?
valuable? insights? on? NK? cell’s? contribution? to? insulin? resistance,? as? well? as? the?
reversibility? thereof.? Finally,?Mendelian? randomization? techniques?may? be? used? to?
evaluate?NK?cell?involvement?in?obesity?associated?insulin?resistance,?type?2?diabetes,?
and?cardiovascular?disease.?Currently,?to?the?best?of?our?knowledge,?neither?of?those?
study?ideas?are?being?investigated.?As?the?data?on?NK?cells?in?this?thesis?was?the?result?
of?a?remarkable?cooperation?between?departments,?universities?and?hospitals? in?this?
region,? the? infrastructure? to? successfully?execute? studies?as? those?outlined?above? is?
already?in?place.?
Future?studies?on?beta?cell?function?
Whilst? the? contributors? to? beta?cell? dysfunction? are? incompletely? understood,?
endothelial?dysfunction?and? lipid?accumulation? in? the?pancreas?may?be? involved.?To?
evaluate? endothelial?dysfunction,? the? vasodilatory?potential?of?pancreatic? arterioles?
could?be?determined?by?means?of?imaging?techniques?or?ex?vivo?pressure?myography.?
In?humans,?pancreatic?arterioles?are?difficult?to?obtain?and?the?pancreatic?vasculature?
is? difficult? to? assess? with? current? imaging? techniques.? To? probe? the? concept? of?
pancreatic? endothelial? dysfunction,? studies? in? animals? could? be? considered? to? gain?
arguments? for? its? involvement? in?beta?cell?dysfunction.? In?addition,? the? involvement?
and? localization? of? intrapancreatic? lipid? can? be? evaluated? by? means? of? electron?
microscopy? images? of? distinct? proportions? of? human? pancreas.? Herewith,? one? can?
assess?whether?beta?cells?of?obese? individuals?contain? intracellular? lipid?depositions,?
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as?well?as?identify?adipocytes?in?the?direct?vicinity?of?pancreatic?(micro)vasculature.?As?
electron?microscopy? images?of? relatively? large?proportions?of?human?pancreas?have?
been? collected? in?another?Dutch? research?project? (Nanoscopy?project),? it? should?be?
feasible?to?demonstrate?whether? intracellular? lipid?depositions? in?beta?cells?of?obese?
individuals?exist.??
The?value?of?reliability?
The?reliability?of?many?measurements?used?in?research?or?clinical?practice?appears?to?
be?misused,?incompletely?considered,?or?ignored?altogether.??Nonetheless,?by?properly?
assessing? and? interpreting? the? reliability? of? measurements,? study? designs,? power?
calculations?and?decision?making?in?clinical?practice?could??benefit?substantially.?In?this?
thesis,? the? reliability? of? a? multitude? of? anthropometric,? vascular,? metabolic? and?
inflammatory??measurements?has?been?assessed.?Reliability?data,?as?presented?in?this?
thesis,?has?been?combined?with?information?on?a?measurement’s?responsiveness?to?a?
dietary?weight?loss?intervention.?As?a?result,?the?study?design,?power?calculation,?and?
selection?of?measurements?has?already? impacted?several?studies?at?our?department.?
Moreover,? insight? into? sources? of? error? have? been? identified? and? addressed?
accordingly.?Collectively,?this?reduces?the?amount?of?money?wasted?on?studies?with?a?
high? probability? of? a? type? 2? error? (e.g.,? due? to? overestimation? of? a?measurement’s?
reliability),?as?well?as?the?time?and?money?spent?on?measurements?that?are?unsuited?
for?a?certain?study?design?or?population.?
The?potential?of?in?depth?phenotyping?in?intervention?studies??
Perhaps? above? all,? this? thesis? illustrates? the? potential? of? combining? in?depth?
phenotyping,? accurate? and? state?of?the? art?measurements,? and?multiple?mediation?
analyses.? It? allowed? for? the? identification? of?mutually? independent? contributors? to?
insulin? resistance? and?beta?cell?dysfunction.? In? contrast? to? the?majority?of? research?
papers? in? this? field,? we? probed? competing? theories? within? a? single? study.? By?
performing?multiple?mediation? analysis? in? a? randomized? controlled? trial,?we? could?
probe?whether? changes? in? certain? variables? contributed? to? changes? in? an? outcome?
variable.?Hence,? this? provided? additional? arguments? for? the? involvement? of? certain?
pathways.? If? this? approach? (i.e.,? the? simultaneous? measurement? of? potential?
contributing? variables? to? an? outcome,? ideally?with? little?measurement? error)?were?
implemented?more?often?in?clinical?trials,?competing?theories?could?be?tested.?Such?an?
insight? would? lead? to?more? targeted? therapies,? as? well? as? reduce? the? number? of?
studies?needed?to?be?conducted?in?a?field?of?research.?
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Dankwoord?
In?dit?veelal?goed?gelezen?hoofdstuk?wil?ik?graag?mijn?dank?uiten?aan?iedereen?die?een?
bijdrage?heeft?geleverd?aan?het?tot?stand?komen?van?dit?proefschrift.??
?
Allereerst?mijn?dank?aan?eenieder?die?heeft?deelgenomen?aan?een?van?de?klinische?
studies? in? dit? proefschrift.? Zonder? jullie? waardevolle? bijdrage? aan? de? wetenschap?
zouden? we? geen? steek? dichterbij? een? succesvolle? oplossing? voor? chronische?
aandoeningen?als?diabetes?en?hart??en?vaatziekten?komen.?
?
Mijn?promotor,?prof.?dr.?C.D.A.?Stehouwer.?Beste?Coen,?ondanks?de?vele?promovendi?
die? je?begeleidde,?was? je?altijd?betrokken?bij?mijn?onderzoek.? Ik?bewonder? je?haast?
onuitputtelijke? kennis,? integriteit,? werktempo? en? vermogen? om? complexe? zaken?
scherp? en? beknopt? te? formuleren.? Onze? inspirerende? –? en? soms? intense? –?
wetenschappelijke?discussies?hebben?mij?naar?een?hoger?niveau?gestuwd.?Ik?ben?trots?
dat?ik?in?jouw?team?en?onder?je?supervisie?mag?promoveren.??
?
Mijn?copromotor?die?promotor?werd,?prof.?dr.?C.G.?Schalkwijk.?Beste?Casper,?toen? ik?
tussen?mijn?coschappen?bij?jou?op?het?lab?mocht?aansluiten,?vond?ik?dankzij?jou?en?je?
collegae? toentertijd?mijn?passie? voor?wetenschap.? Ik?ben? je?enorm?dankbaar?dat? je?
mijn? promotor? wilde? zijn,? op? een? klinische? studie? nota? bene.? Jouw? betrokken? en?
kundige?wijze? van? leidinggeven,?met? aandacht? voor? de? persoon,? is? heel? bijzonder.?
Dank?voor?je?vertrouwen,?geduld,?begrip?en?veelzijdige?hulp?door?de?jaren.?
?
Mijn? copromotor,? dr.? A.J.H.M.?Houben.? Beste? Boy,? je? hebt?mij,? toen? ik? vers? uit? de?
schoolbanken?kwam,?direct?geholpen?met?het?doorgronden?van?de?vele?facetten?van?
de?microcirculatie.?Ik?kan?me?nog?menige?wetenschappelijke?discussie?herinneren?die?
wij? in?de? aanloop?naar?de? afvalstudie? gevoerd?hebben?en?waardoor?deze?naar? een?
hoger?niveau?getild?werd.?Dank?voor?je?vertrouwen?en?je?hulp.?
?
Alle?leden?van?de?beoordelingscommissie.?Prof.?dr.?E.E.?Blaak,?prof.?dr.?L.J.C.?van?Loon,?
dr.?E.?Serné?en?dr.? ir.?M.C.J.M.?van?Dongen,?hartelijk?dank?voor?het?beoordelen?van?
mijn?proefschrift.?Prof.?dr.?N.? Stefan,? thank? you? for?participating? in? the?Assessment?
Committee?of?my?PhD?thesis.??
?
Mijn?opleider?binnen?de?interne?geneeskunde,?prof.?dr.?R.P.?Koopmans.?Beste?Richard,?
jouw? vertrouwen? en? inspanningen?dateren? reeds?uit?mijn? tijd? als? coassistent?bij?de?
Interne? Geneeskunde.? Mede? dankzij? jouw? passie? en? dagelijkse? portie? onderwijs?
destijds,?mij?in?contact?brengen?met?Casper,?maar?ook?door?jouw?vele?inspanningen?in?
de?afgelopen?jaren,?heeft?mijn?loopbaan?zijn?huidige?vorm?gekregen.?Ik?zal?je?hier?mijn?
leven?lang?dankbaar?voor?zijn.?
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Mijn?mentors,?dr.?W.?Mulder?en?prof.?dr.?N.C.?Schaper.?Beste?Wubbo,?tien?jaar?geleden?
vroeg? je?mij?wat? ik?wilde?doen? als? ik? later? groot?was.?Mede?dankzij? jouw? steun? en?
(bij)sturing? sta? ik? nu? hier.? Beste? Nicolaas,? er? lijkt? geen? probleem? in? het? leven? te?
bestaan?waarover? jij? geen? zinnige? adviezen? hebt? of? over?weet? te? reflecteren.?Dank?
voor?je?betrokkenheid?en?steun.?
?
Prof.?dr.?E.J.?Barrett,?dear?Gene,?you?made?it?possible?for?me?to?learn?all?about?CEUS?at?
your? lab? and? write? a? review? together.? Your? knowledge,? leadership,? kindness,? and?
hospitality? are? as? impressive? as? they? are? inspirational.? Thank? you? for? the? unique?
opportunity?to?work?with?you.?
?
Dear?Linda,?not?only?did?you? teach?me?how? to?perform?CEUS,?with? lunches,?dinners,?
bike? rides,? swims,? and? what? more,? you? also? made? sure? I? had? a? great? time? in?
Charlottesville.?
?
Dr.? A.L.? Klibanov,? dear? Sasha,? thank? you? for? your? unique? and? in?depth? insight? into?
microbubbles’?characteristics?and?possibilities.?I?hope?there?will?be?future?projects?we?
can?collaborate?on.?
?
Dear?dr.?A.?Mari?and?dr.?S.J.S.?Sep,?thank?you?for?collaborating?and?reflecting?on?our?
beta?cell?function?paper.??
?
Beste?Jos,?Belg?van?adel,?samen?hebben?we?een?aantal?bijzondere?studies?uitgevoerd;?
we? konden? met? elkaar? lezen? en? schrijven.? Jouw? kundigheid? en? onderhoudende?
gesprekken?met?de?deelnemers?hebben?bijgedragen?aan?onze?bijzonder?lage?drop?out?
rate,?tevreden?deelnemers?en?nauwkeurige?metingen.??
?
Aan?eenieder?binnen?de?afdeling?radiologie?die?geholpen?heeft?bij?onze?studies.?Prof.?
dr.?M.E.?Kooi,?beste?Eline,?dank?voor?de?intensieve?samenwerking?voor,?tijdens?en?na?
afloop? van? onze? studies.? Christine? en? Lucas,? dank? voor? het? optimaliseren,?
implementeren?en?aanleren?van?1H?MRS.?Roland,?bedankt?voor?het?inplannen?van?alle?
MRI?scans,?alsook?aan?alle?MRI?laboranten?voor?jullie?toewijding.?
?
Aan?de?collega’s?binnen?de?afdeling?Humane?Biologie,?Prof.?dr.?R.P.?Mensink,?Prof.?dr.?
J.? Plat? en? dr.? P.J.? Joris.? Beste? Ronald,? Jochem? en? Peter,? dank? voor? jullie? bijdragen?
binnen?de?TIFN?projecten.?Het?waren? intensieve?studies?die?we?samen? tot?een?goed?
eind? gebracht? hebben.? Tevens? een? bijzondere? dank? aan? diëtistes?Nina?Wystyrk? en?
Daisy? Luiten,?door? jullie?bevlogen?begeleiding?behaalden?we? grote? effecten?en? lage?
drop?out?rates.?
?
539883-L-sub01-bw-Kusters
Processed on: 13-1-2020 PDF page: 289
? Dankwoord?
289?
D?
Tevens?dank?aan?eenieder?van?het?Top?Institute?Food?and?Nutrition?(TIFN)?en?Stichting?
de?Drie?Lichten?voor?het?financieren?van?de?studies?in?dit?proefschrift.??
?
Beste? prof.? dr.? L.W.E.? van? Heurn,? Givan? en? Yvonne,? dank? voor? de? aangename?
samenwerking?aan?de?BASIC?studie.?Hopelijk?kunnen?we?in?de?nabije?toekomst?mooie?
resultaten?van?deze?unieke?studie?publiceren.?
?
Aan?de?collegae?binnen?de?afdeling?Biomedische?Technologie?prof.?dr.?ir.?A.P.G.?Hoeks,?
dr.?ir.?K.D.?Reesink?en?dr.?F.C.G.?van?Bussel.?Beste?Arnold,?Koen?en?Frank,?bedankt?voor?
jullie? bijdragen? op? het? gebied? van?meetmethodes,? reproduceerbaarheid,? validatie,?
innovatie?en?het?programmeren?van?diverse?applicaties.?
?
Beste?dr.?C.J.?van?Gool,?beste?Christel,?bedankt?voor?het?onderwijs?binnen?en?buiten?
de?master?epidemiologie?en?je?begeleiding?bij?mijn?scriptie.?
?
Aan?al?mijn? vroegere?en?huidige? collega’s?binnen?onze?onderzoeksafdeling.?Amy?en?
Dennis,? bedankt? voor? het? bijbrengen? van? en? sparren? over? de? metingen? aan? de?
microcirculatie.? Beste? Claudia,? José,? Katrien,?Margee,?Maria,?Marjo,?Mitchell,? Olaf,?
Suzan? en? Vicky,? bedankt? voor? de? samenwerking? bij? ex? vivo? experimenten,? jullie?
ondersteuning?op?het? lab?en?bij?de? logistiek? rondom?onze? studies.?Pauline,?bedankt?
voor?je?hulp?met?de?dataset?van?de?Maastricht?studie.?Dank?aan?het?managementteam?
van?de?Maastricht?studie?voor?de?samenwerking?bij?de?MRI??en?reproduceerbaarheids?
data.?
?
Elisabeth,?Johanna,?Lian,?Marcelle,?Marleen,?Nick?en?Roel,?bedankt?voor?jullie?hulp?bij?
epidemiologische? vraagstukken.? Barry,? bedankt? voor? het?mooie? figuur.? Jean,? dank?
voor?de? fijne?samenwerking?op?het?werk?en?voor?de?vele? foto??en?photoshopsessies?
door?de?jaren?heen,?het?resultaat?was?altijd?prachtig!?Teba?en?Stijn,?bedankt?voor?alle?
gezellige?gesprekken.?Nordin,?niet?alleen?je?bijdragen?aan?de?wetenschap?en?de?unieke?
sfeer? op? de? afdeling? waren? bijzonder,? maar? onze? zwemtrainingen? zijn? echt?
legendarisch.? Thomas,? bedankt? voor? de? gezellige? etentjes? en? fietstochten,? hopelijk?
gaan?er?in?de?toekomst?nog?veel?volgen.?Monica,?Hanneke,?Nynke?en?Mathias,?het?was?
een? genoegen?om? te?helpen?bij? jullie?onderzoeken?op?het? circulatielab,? veel? succes?
met?jullie?verdere?loopbaan.?Bas?en?Dionne,?geruime?tijd?zaten?wij?samen?bij?elkaar?op?
de?kamer.?Dank?voor?de?gemoedelijke,?maar?ook?stimulerende,?sfeer.?Bas,?dank?dat?ik?
jouw?paranimf?mocht?zijn,?het?was?een?hele?eer!??
?
Arts?assistenten?en?stafleden,?bedankt?voor? jullie? interesse? in?mijn?onderzoek?en?de?
aangename?samenwerking?in?de?kliniek.?
?
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Mijn? paranimfen,? Petra? en? Kristaan.? Beste? Petra,? al? vanaf? het?moment? dat? ik? als?
vrijwilliger? tussen? mijn? coschappen? op? de? afdeling? kwam? om? labonderzoek? te?
verrichten,? ondersteun? jij? me? in? meer? opzichten? dan? ik? hier? kan? opnoemen,?
ontzettend?bedankt!?Beste?Kristiaan,?onze?wederzijds?onbaatzuchtige? instelling?heeft?
niet? alleen? tot? een? goede? samenwerking? en?mooi?manuscript? geleid,?maar? ook? de?
basis?gelegd?voor?toekomstige?projecten;?ik?kijk?er?al?naar?uit!?
?
Mijn? trainer? uit? mijn? tijd? als? wielrenner,? Tim? Heemskerk.? Los? van? de? sportieve?
successen?wist? jij?niet?alleen?mijn?enthousiasme?en?eigenwijsheid? in?goede?banen?te?
leiden,?je?leerde?mij?ook?om?“met?de?benen?te?spreken.”?
?
Mijn?vrienden,?familie?en?schoonfamilie,?bedankt?voor?jullie?gastvrijheid,?alle?gezellige?
momenten?en?het? feit?dat? jullie?altijd?voor?me?klaar?staan.?Een?bijzonder?dankjewel?
aan? tante? Yvonne,?nonk? René,?Monique,?Mart,?Dave? en?Daniëlle.?Van? jongs? af? aan?
mocht? ik?aansluiten?bij? jullie?gezin?en?door?de? jaren?heen?hebben?we?al?veel?mooie?
herinneringen?gecreëerd.??
?
Mijn?best?man?Martijn,?bedankt?dat?je?altijd?voor?me?klaar?staat.?Talloze?ups?en?downs?
hebben?we?gedeeld?sinds?we?15?jaar?geleden?aan?geneeskunde?begonnen.?Veel?succes?
met?je?eigen?promotie?en?dat?er?nog?veel?fietstochten?en?bieravonden?mogen?volgen.?
?
Mijn?ouders,?die?mij?op?zo?veel?manieren?hebben?gesteund?om?de?doelen?die? ik?mij?
stelde?te?halen.?In?een?knus?thuis?en?met?aandacht?voor?school?en?sport?groeide?ik?op.?
Van?jongs?af?aan?hebben?jullie?mij?bijgebracht?dat?waar?een?wil?is,?er?ook?een?weg?is;?
opgeven?is?geen?optie.?Later?pasten?jullie?het?hele?huishouden?aan,?zodat?ik?maximaal?
kon?presteren?tijdens?mijn?tijd?als?topsporter,?zonder?ooit?school?of?studie?uit?het?oog?
te?verliezen.?Bedankt?voor?alles?wat?jullie?voor?mij?hebben?gedaan.?
?
Mijn? kinderen,? Sebas? en?Avalon,? jullie? zijn?de? vrolijkheid? zelve? en?de?bright? shining?
lights?in?mijn?leven.?Papa’s?verhaaltje?is?nu?echt?klaar!?
?
Lieve?Lianneke,?ik?kan?je?onmogelijk?genoeg?bedanken?voor?alles?wat?je?door?de?jaren?
heen?voor?mij?hebt?betekend.?Je?bent?zo?veel?meer?dan?mijn?steun?en?toeverlaat,? je?
bent?mijn?alles.?
539883-L-sub01-bw-Kusters
Processed on: 13-1-2020 PDF page: 291
? Dankwoord?
291?
D?
539883-L-sub01-bw-Kusters
Processed on: 13-1-2020 PDF page: 292
Chapter?9?
292?
?
539883-L-sub01-bw-Kusters
Processed on: 13-1-2020 PDF page: 293
? Curriculum?Vitae?
293?
CV?
Curriculum?Vitae?
Yvo?Hubert?Anna?Maria?Kusters?was?born?on?June?9,?1986?in?Heerlen,?the?Netherlands;?
he? grew? up? in? Simpelveld.? He? graduated? from? secondary? school? in? 2004? (VWO,?
Bernardinus?College,?Heerlen,?cum?laude).?In?the?same?year,?he?started?medical?school?
at?Maastricht?University,?and? in? January?2011?he?obtained?his?medical?degree? (cum?
laude).?Whilst? studying? medicine,? he? completed? the? Honors? program? Research? in?
Medicine,?was? awarded? the? top? 3%? student? award,? and?was? a? (semi?)professional?
cyclist.? In?March?2011,?he? started?his?PhD? research?under? supervision?of?Prof.?Coen?
Stehouwer,? Prof.? Casper? Schalkwijk? and? Dr.? Alfons? Houben? at? the? Department? of?
Internal?Medicine? of? the?Maastricht? University?Medical? Centre,? within? the? CARIM?
School?for?Cardiovascular?Diseases.?In?2015,?he?obtained?a?Master’s?degree?of?Science?
in? Epidemiology? at?Maastricht? University? (cum? laude).? During? his? PhD? project,? he?
worked?at?the?University?of?Virginia?in?the?United?States?of?America?for?nine?months,?
under? supervision?of?Dr.?Eugene?Barrett.? In?March?2016,?he?started?his? residency? in?
Internal?Medicine?at?Maastricht?University?Medical?Center.? In? June?2019,?he?started?
his?fellowships?in?Nephrology?and?Intensive?Care?Medicine.?
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